Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,-0.140257730967315,0.00303423061276991,-0.146204822968344,-0.134310638966286,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39477,0.489665553354559,0.0117793266417171,0.466578073136793,0.512753033572324,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,39858,0.201968280609881,0.00412263724510621,0.193887911609472,0.210048649610289,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,0.15281892311714,0.00386564072180762,0.145242267302397,0.160395578931883,1.1125369292536e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37437,0.31112799121441,0.00792602031319929,0.29559299140054,0.326662991028281,1.11253692926606e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,0.195785974423864,0.00507540395652311,0.185838182669079,0.205733766178649,1.11363604139208e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,-0.110118829665093,0.00295209714079009,-0.115904940061041,-0.104332719269144,4.2330313973062e-292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,-0.100424887785624,0.00273218984759545,-0.105779979886911,-0.0950697956843373,4.62368517768254e-284
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40030,0.23073692994915,0.00644570695758745,0.218103344312278,0.243370515586021,3.82018555447612e-270
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40058,0.180224901338371,0.00521877308037521,0.169996106100836,0.190453696575906,3.16262395417024e-252
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,39805,0.133031427445224,0.00390698481027104,0.125373737217093,0.140689117673355,2.29544229438967e-245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,0.0891659857517947,0.00285512268018556,0.083569945298631,0.0947620262049584,7.5301264891652e-208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37021,0.279831421914458,0.00905551701407316,0.262082608566875,0.297580235262042,1.76263723853215e-202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.36728464057038,0.0120824604971639,-0.390966263144822,-0.343603017995939,2.01471733762017e-197
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,39854,0.237265038170005,0.00782122325822443,0.221935440583885,0.252594635756125,1.3613063063386e-196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37445,-0.157586677759312,0.00520895004403455,-0.16779621984562,-0.147377135673004,1.25874098483879e-194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,39868,-0.139475234554792,0.00465112838253551,-0.148591446184562,-0.130359022925023,2.85418074574066e-192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37445,-0.0745137164793519,0.00254806291855981,-0.0795079197997291,-0.0695195131589747,2.29885721278778e-182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,0.158314375759871,0.00548593355508538,0.147561945991904,0.169066805527839,9.33096367497975e-178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,0.388765175058318,0.0136714667372548,0.361969100253299,0.415561249863338,1.32794591684011e-173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,39788,0.249228119505862,0.00879535808459051,0.231989217660065,0.26646702135166,2.26149263155152e-172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,37453,-0.181036428356065,0.00652056639797862,-0.193816738496103,-0.168256118216027,4.56181852855481e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,39858,0.111724274282514,0.00409365496019191,0.103700710560538,0.11974783800449,2.42136489527406e-160
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,0.172397307055206,0.00634245927019596,0.159966086885622,0.18482852722479,4.97392648870117e-159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,0.140106029562264,0.00523434878012273,0.129846705953223,0.150365353171304,1.94358837790484e-154
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,0.123949529971223,0.00467275368844923,0.114790932741863,0.133108127200584,8.75956025780392e-152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,39758,0.200264963066133,0.00756040115484265,0.185446576802642,0.215083349329625,2.47054204286445e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,39976,-0.0933805212746255,0.00355454790061241,-0.100347435159826,-0.0864136073894252,5.58177891208648e-149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0778986237650498,0.00297841544723538,-0.0837363180416311,-0.0720609294884684,4.55158360022682e-147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FURIN,Furin,39913,0.0852393952498768,0.00335582511670519,0.0786619780211346,0.0918168124786189,1.40494083979229e-139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40011,0.295397521299224,0.0118218255005034,0.272226743318237,0.31856829928021,3.06031873101667e-135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,39955,0.0850561988195998,0.00341739064775751,0.0783581131499951,0.0917542844892045,3.31586308408094e-134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40030,-0.0861682259406118,0.00348309443875352,-0.0929950910405687,-0.0793413608406549,1.17848006565053e-132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37039,0.194719841293995,0.00793412839137411,0.179168949646902,0.210270732941088,4.27716813461384e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,39868,0.148915355397482,0.00612854982139745,0.136903397747543,0.160927313047421,4.19249405441005e-128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,39868,0.149203214520601,0.00620857198243961,0.137034413435019,0.161372015606182,2.13182193517877e-125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,39899,0.0707466640868838,0.00297422316654778,0.0649171866804502,0.0765761414933175,6.128548904989e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,-0.127313885666123,0.00535547713052677,-0.137810620841956,-0.116817150490291,9.1251696508526e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,39840,-0.106164082189403,0.00449457031877402,-0.1149734400142,-0.0973547243646056,2.81578849785161e-121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37124,0.0677223749465385,0.0028630250154289,0.0621108459162979,0.0733339039767792,3.39745984914051e-121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,0.0780198901616638,0.00331558920537472,0.0715213353191294,0.0845184450041983,2.12180392332138e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,0.0597195064651228,0.0025430823694274,0.0547350650210451,0.0647039479092005,1.55341327244543e-119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40052,0.121005016991621,0.00518496125901033,0.110842492923961,0.131167541059281,1.64851298120226e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,39949,-0.0642542913501099,0.00275542514628038,-0.0696549246368194,-0.0588536580634003,2.57582137109618e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,-0.0845696211800146,0.00364030931266623,-0.0917046274328404,-0.0774346149271888,1.91158003735561e-117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,39858,-0.061049311762928,0.00265232604426057,-0.0662478708096788,-0.0558507527161773,2.32552197376294e-115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,0.0660069282688349,0.00287613789309064,0.0603696979983772,0.0716441585392925,1.05049654466192e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0768164995315755,0.00338111544080102,-0.0834434857955455,-0.0701895132676055,1.64816864928493e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40030,0.0738787180040108,0.0032987262867849,0.0674132144819124,0.0803442215261092,1.97011048710694e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.187522443518337,0.00839777171538034,0.171062810956191,0.203982076080482,9.20597825057118e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,39908,0.0402678252398669,0.00181185833876195,0.0367165828958935,0.0438190675838403,8.35883287102386e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,39919,0.129948677312613,0.0058495029168151,0.118483651595655,0.14141370302957,1.01846456980618e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.118075450197691,0.00531851256117406,0.10765116557779,0.128499734817592,1.42459078831751e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,39587,0.17385719548872,0.00788042931323269,0.158411554034784,0.189302836942656,2.98591436499529e-106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,0.111894262882976,0.00508744817029179,0.101922864469205,0.121865661296748,1.30172607765277e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.316843758765572,0.0144270787704663,0.288566684375458,0.345120833155686,2.54681040496816e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,0.183630449241681,0.00846458218763421,0.167039868153918,0.200221030329444,7.09837415633898e-103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,39826,0.216329248297827,0.00997706635934202,0.196774198233517,0.235884298362138,9.04418238881005e-103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37437,0.199221966112297,0.00918219940384062,0.181224855280769,0.217219076943825,1.21425161378376e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,0.0690626591543811,0.00318674020435312,0.062816648353849,0.0753086699549132,2.43942646818757e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.0704354312656668,0.00325722745921615,0.0640512654456031,0.0768195970857304,2.96466728408342e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.133050400203078,0.00619057658047937,-0.145183930300817,-0.120916870105338,4.75246393139651e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,39908,-0.0563343292208744,0.00265713602547395,-0.0615423158308033,-0.0511263426109454,2.0764233406024e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,38721,0.0829647670583484,0.00391709168273529,0.0752872673601873,0.0906422667565096,4.07785611624083e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.124704951173804,0.00590523807857714,0.113130684539793,0.136279217807815,1.2620335354994e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.161555376655669,0.00765779403625099,0.146546100344618,0.176564652966721,3.10668407630763e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,-0.0447201130832081,0.00212604253804209,-0.0488871564577706,-0.0405530697086456,6.31241443673909e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40003,0.040501145680891,0.00192737612081905,0.0367234884840856,0.0442788028776963,9.68571779120819e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37445,-0.108151214035135,0.00514847311720471,-0.118242221344856,-0.0980602067254137,1.94083438653786e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.114283126054776,0.00545943428638453,0.103582634853462,0.12498361725609,5.42505721630588e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.16577988177227,0.00792777616749423,0.150241440483981,0.181318323060559,8.16710282243861e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0646926661870452,0.00310236061473823,0.0586120393821583,0.0707732929919321,2.61606972523888e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.129895713110244,0.00623020357749946,0.117684514098345,0.142106912122143,3.05280720705398e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.138089416960891,0.00663976092354496,0.125075485550743,0.151103348371039,8.29358355829185e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,-0.0676690629546909,0.00326379986742078,-0.0740661106948357,-0.0612720152145462,2.96686237154823e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.172771796606396,0.00843439764848107,0.156240377215373,0.189303215997419,7.36611659787908e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,39862,0.107013760269581,0.00526133407785296,0.0967015454769892,0.117325975062173,8.04417208630673e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,39931,0.0826848585191474,0.00410469055122025,0.0746396650387557,0.0907300519995391,3.81997657017545e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0748454173348258,0.00372244202551159,0.0675494309648231,0.0821414037048286,1.34451600945868e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,0.0872637040954184,0.00436418091116056,0.0787099095095437,0.0958174986812931,1.19578740963263e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFM,Afamin,37453,0.0375128791756054,0.00189734764841704,0.033794077784708,0.0412316805665028,8.42266140217891e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,0.0975501237993907,0.0049740501855795,0.0878009854356549,0.107299262163127,1.25535867393074e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.161551459046748,0.0082594040925502,0.145363027025349,0.177739891068146,3.46247116565387e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,0.149472715103819,0.0076425639799259,0.134493289703165,0.164452140504474,3.58187279078405e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,36780,-0.0844851215026446,0.00433869397558585,-0.0929889616947929,-0.0759812813104963,2.92025965755534e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.090322491951478,0.00464473974377504,0.0812188020536789,0.0994261818492771,2.93629123797716e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,39788,0.108039886542181,0.00559711522106473,0.0970695407088938,0.119010232375467,4.40067698271127e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37437,-0.112019220095549,0.00581469120357235,-0.123416014854551,-0.100622425336547,1.29649878408157e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,0.0580515445977043,0.00301831534249433,0.0521356465264155,0.0639674426689932,1.62310567644994e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0609207187491253,0.00316878835620085,0.0547098935709716,0.0671315439272789,1.91159095531794e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.166635768013066,0.0086838743129256,0.149615374359732,0.183656161666401,3.7546766766952e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37124,0.0793755223397348,0.00413841637284947,0.0712642262489498,0.0874868184305197,6.72509088510697e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.201420565636078,0.0106588942801549,0.180529132846974,0.222311998425182,8.77968548628746e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MME,Neprilysin,39788,0.147450181049961,0.00787344718241376,0.13201822457243,0.162882137527491,2.00163362295345e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0651720068266895,0.00348183484930988,0.0583476105220422,0.0719964031313369,2.36188059346303e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,0.0529457702275202,0.00282930644818559,0.0474003295890764,0.0584912108659639,3.59439774314207e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37088,0.0707449131685874,0.00378804994241245,0.063320335281459,0.0781694910557158,7.55855216628226e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.05325071527358,0.00287883983170807,-0.0588932413437278,-0.0476081892034322,1.32516015318248e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0626796810553695,0.0033899067904314,0.056035463746124,0.0693238983646151,1.48992913957098e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37382,0.204417564632833,0.0110657581982454,0.182728678564272,0.226106450701394,2.86688823596795e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0894317782772648,0.00484276808049825,-0.0989236037150413,-0.0799399528394882,3.17589302903356e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40058,0.0473271361423875,0.00257520310220732,0.0422797380620612,0.0523745342227139,1.13025611506543e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37411,0.0818549851762614,0.00445196888161079,0.0731291261683042,0.0905808441842185,1.36370827682691e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37382,0.130595012883853,0.00717784905858923,0.116526428729018,0.144663597038688,4.26501465596934e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37043,0.0944364363304845,0.00522883486721539,0.0841879199907423,0.104684952670227,4.78894132795655e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39489,0.0914085729876663,0.00507270221651675,0.0814660766432934,0.101351069332039,7.27780861593497e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0406447179909969,0.00225787926122103,0.0362192746390037,0.0450701613429901,9.67336547555242e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0768178960245665,0.00427273879237398,0.0684433279915135,0.0851924640576195,1.42783967146701e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,0.105773874712238,0.00588753486126401,0.0942343063841607,0.117313443040316,1.79306394375711e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40058,0.0610495493133328,0.00340260736726213,0.054380438873499,0.0677186597531665,2.71385482428758e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.0481353600230689,0.00268665158267711,-0.053401197125116,-0.0428695229210218,4.33449829913508e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,0.145927880852439,0.00814635209751161,0.129961030741316,0.161894730963561,4.62299142126525e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37309,0.0451811244027056,0.0025244038567282,0.0402332928435184,0.0501289559618929,8.12402237446689e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0686252161440921,0.00385081924701435,-0.0761728218682402,-0.061077610419944,2.30969493523294e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,39879,-0.0346358580481493,0.00195607172928007,-0.0384697586375382,-0.0308019574587603,1.7047103379201e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.114704433572801,0.00647404430503175,0.102015306734938,0.127393560410663,1.85308393961023e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40052,0.0882611671693464,0.00498660562501766,0.0784874201443118,0.098034914194381,1.90158394414049e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40058,0.0528386779215385,0.00299950187008802,0.046959654256166,0.058717701586911,8.15860642947767e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0697086149727082,0.00397196617886778,0.0619235612621274,0.0774936686832891,2.65460273457584e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.159535191141681,0.00910850622567251,0.141682518939363,0.177387863343999,4.87108694379473e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,39858,0.0415037221855253,0.00237425037725591,0.0368501914461037,0.0461572529249469,8.56203519715507e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,39858,0.0989147673507269,0.00566198519849397,0.0878172763616788,0.110012258339775,1.03083154177495e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.0910659243191358,0.00523740220719653,0.0808006159930306,0.101331232645241,4.18145275015055e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,39984,0.0856523022861398,0.00492725295187839,0.0759948865004581,0.0953097180718214,4.50560780950258e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40012,-0.0912120056210204,0.00527824580886504,-0.101557367406396,-0.0808666438356449,2.59222309147469e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0931801743651986,0.00541417111384782,0.0825683989820569,0.10379194974834,8.75258551509454e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,0.129742692367861,0.00753887131612311,0.11496650458826,0.144518880147462,8.99827403457354e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,39933,0.110611970843636,0.00645838041259813,0.0979535452349436,0.123270396452328,3.54063006684858e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,0.0614905997486937,0.0035967401544165,0.0544409890460373,0.06854021045135,6.0308275396906e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0512842651948378,0.00301878958594354,0.0453674376063884,0.0572010927832871,3.67781809367473e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,0.0631577888944763,0.0037329770567714,0.0558411538632044,0.0704744239257483,1.15230326032599e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37424,0.0476030074855763,0.00282778384990672,0.0420605511397591,0.0531454638313934,5.97748572887073e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0967430095502292,0.00576744321976555,0.0854388208394888,0.10804719826097,1.6797792604397e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,39931,-0.0729535619862468,0.00435580188648488,-0.0814909336837572,-0.0644161902887365,1.96124058780268e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.091342692472893,0.00545909552449025,0.0806428652448921,0.102042519700894,2.63964455141603e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,0.0463297758731513,0.00277289301798825,0.0408949055578943,0.0517646461884082,4.83193230968897e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,39908,0.0563292097060209,0.00337625908779501,0.0497117418939427,0.0629466775180992,5.70779236456613e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.12037021636796,0.00721989201127211,0.106219228025866,0.134521204710053,7.04263506323427e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37043,0.107444535288149,0.00651099308776404,0.0946829888361311,0.120206081740166,1.43517802583442e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,39949,0.0512452005201723,0.00311910989039664,0.0451317451349949,0.0573586559053497,3.6379097038713e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.112752604496985,0.00686965789178897,0.0992880750290784,0.126217133964891,6.0630600513609e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,39866,0.0751491098970005,0.00458752545530668,0.0661575600045994,0.0841406597894016,7.99200383145798e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37437,-0.061105666956456,0.00372924942862644,-0.0684149958365638,-0.0537963380763482,9.08433738902725e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,-0.04373488632507,0.00267713067951058,-0.0489820624569107,-0.0384877101932292,1.64612581460506e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,39858,0.0527205361545883,0.0032724923506496,0.0463064511473151,0.0591346211618616,6.17727006205285e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,-0.102250717978117,0.00635065474915988,-0.114698001286471,-0.089803434669764,7.20669411158028e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.0792341780677615,0.00492535285316376,0.0695804864755605,0.0888878696599625,1.10475032975753e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40052,0.0681483507432049,0.00425439394635929,0.0598097386083407,0.0764869628780691,2.62219834079968e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,39865,0.0498125149378934,0.00311216602536208,0.0437126695281837,0.055912360347603,3.23872853768414e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,0.123167275478426,0.00770423502222457,0.108066974834865,0.138267576121986,4.30609223119272e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,39846,0.0450418863640017,0.00283083826658726,0.0394934433614906,0.0505903293665127,1.44113486306443e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,0.0791092239768361,0.00497243624305074,0.0693632489404566,0.0888551990132155,1.46374017117989e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.066628008492978,0.00419670890948192,0.0584024590303934,0.0748535579555625,2.53380143878005e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40058,0.0440964272355972,0.00278023336097086,0.0386471698480943,0.0495456846231001,3.14185554002018e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39464,0.0938119465464147,0.0059196417236685,0.0822094487680244,0.105414444324805,4.00301563612217e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,0.0516211426043569,0.00326704728687004,0.0452177299220917,0.0580245552866222,8.05363506912444e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0521290843804675,0.00329991451303478,0.0456612519349193,0.0585969168260156,8.59561478071816e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,0.034139609936457,0.00216263308239685,0.0299008490949592,0.0383783707779549,1.01738857055583e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,39846,-0.283866789209082,0.0181190900758503,-0.319380205757749,-0.248353372660416,6.5397242179673e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,39868,0.0399829065640261,0.00256164046268849,0.0349620912571567,0.0450037218708956,1.61159125200075e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,0.049881214723294,0.00319695302790714,0.043615186788596,0.056147242657992,2.09428515069727e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,39979,0.0926535879262115,0.00594340614661937,0.0810045118788375,0.104302663973585,2.14744282838425e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.0820158475368881,0.00526091576267308,0.0717044526420488,0.0923272424317273,2.54375505247054e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,0.0438811223082386,0.00282077186050728,0.0383524094616443,0.0494098351548329,3.55380290411497e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0564367887969937,0.00364395292424459,0.0492946410654743,0.0635789365285131,1.01804691552425e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37124,0.0422196832540504,0.00272743082663254,0.0368739188338506,0.0475654476742502,1.39935539386317e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,0.199986191796612,0.012938409015455,0.174626910126321,0.225345473466904,1.63910216271461e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,39885,-0.0602381051652509,0.00389838638734888,-0.0678789424844547,-0.0525972678460471,1.77580956067985e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,39868,0.0982281767047324,0.00635915145492807,0.0857642398530734,0.110692113556391,1.92800665501222e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,39974,0.0394602338337132,0.00255910495025956,0.0344443881312045,0.0444760795362219,2.90391423617786e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40052,0.0886896629836993,0.00576536054518119,0.0773895563151442,0.0999897696522545,5.03267090872329e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0521566955047656,0.00339798614235033,0.045496642665759,0.0588167483437723,8.44664492235742e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40052,0.0667317220171027,0.00435217849658715,0.0582014521637918,0.0752619918704135,1.08024680158193e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.0831982869748501,0.00546210652541794,0.0724925581850309,0.0939040157646693,5.05053579830171e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.10868316430142,0.00714925994748852,0.0946706148043421,0.122695713798497,9.14406587968276e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0725258643979181,0.00477357322484031,0.0631696608772311,0.0818820679186051,1.06861747373612e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0548427871478514,0.00362610272324716,0.047735625810287,0.0619499484854159,2.50448450707751e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0425164545047269,0.00281209023469007,0.0370047576447344,0.0480281513647194,2.72769773407663e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,0.0555464895225861,0.00371089825231336,0.0482731289480519,0.0628198500971203,2.60002268708547e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,0.165311703310958,0.0110639368012797,0.14362638718045,0.186997019441466,3.92838785225667e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELN,Elastin,37437,0.0504183854084813,0.00338026820028451,0.0437930597359237,0.057043711081039,6.48957420161799e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.0742067782498138,0.00498563771077214,0.0644349283367004,0.0839786281629272,9.01301443286804e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.100981096692081,0.00679168566668024,0.0876693927853876,0.114292800598774,1.15654148260057e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,0.0848595172562481,0.00570764180783536,0.0736725393128908,0.0960464951996054,1.3113673864916e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,39866,-0.0506441775925474,0.00341914378167069,-0.0573456994046219,-0.0439426557804728,2.60086197914713e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,37453,0.0297559064810795,0.00200865426360495,0.0258189441244138,0.0336928688377452,2.88636825910141e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,0.048687860604127,0.00330123411112848,0.0422174417463152,0.0551582794619389,6.55803797925811e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.031332843972206,0.00212614515075538,0.0271655994767254,0.0355000884676865,7.75344808299638e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40058,0.067260461505358,0.00456859544271888,0.058306014437629,0.076214908573087,9.56837285193159e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37437,0.164758622552206,0.0111992321493167,0.142808127539545,0.186709117564866,1.28514000270608e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0568384802740899,0.00386746931224049,0.0492582404220985,0.0644187201260812,1.39486680677001e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,0.046588282034659,0.00319339716719069,0.0403292235869652,0.0528473404823527,7.59931093578767e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,0.040746235850222,0.00279713388873871,0.0352638534282941,0.0462286182721499,9.18752361004227e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.10831859096354,0.00744188416941282,0.0937324979914909,0.122904683935589,1.09616322777489e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0380385327756194,0.00261369258894399,0.0329156953012892,0.0431613702499496,1.12300511470353e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,39788,0.100561284157186,0.00691885037751881,0.0870003374172496,0.114122230897123,1.47861763976196e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.0792677469215635,0.00548891758198696,0.0685094684608691,0.0900260253822579,5.71411476468614e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,39788,0.105565874308845,0.00733275359371754,0.0911936772651591,0.119938071352532,1.069153843539e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,39897,0.0384243704129213,0.00267008149100206,0.0331910106905573,0.0436577301352854,1.15576049270853e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,39839,0.0700102025610663,0.0048712547836785,0.0604625431850565,0.0795578619370762,1.5106486531917e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0564925649959137,0.00393474528560463,0.0487804642361286,0.0642046657556988,1.86782801054621e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0369126678497831,0.00257608167080632,-0.0419617879245635,-0.0318635477750027,3.13140786200848e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0559027196872225,0.00390442323687437,-0.0635553892314963,-0.0482500501429488,3.26873321733045e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,0.0818324666221389,0.00572699627213468,0.0706075539287549,0.0930573793155228,4.90056506075168e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37445,0.0381744722709498,0.00267017603248692,0.0329409272472754,0.0434080172946241,4.95463474424563e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,-0.0450767578496789,0.0031578993449749,-0.0512662405658297,-0.0388872751335281,6.06435907686093e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40030,-0.0236673251528431,0.00166119979875728,-0.0269232767584074,-0.0204113735472788,8.84031013358734e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,39963,0.0980305832198601,0.00688352552131739,0.084538873198078,0.111522293241642,9.62008705389946e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40052,-0.0380818588935146,0.00267726927162201,-0.0433293066658938,-0.0328344111211355,1.22216047089285e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.0990935718571057,0.00697943667155218,0.0854138759808634,0.112773267733348,2.00158408420922e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,0.057678155133503,0.00406701103107246,0.049706813512601,0.065649496754405,2.23131629664198e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37241,0.033394075033655,0.00235631712182063,0.0287756934748866,0.0380124565924235,2.89538111450266e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,0.129784885159145,0.00916911616922689,0.11181341746746,0.14775635285083,3.2733875273414e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,39931,0.0730267110471341,0.00516215214081855,0.0629088928511298,0.0831445292431385,3.6604030234572e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37124,-0.0315435252759506,0.0022398210272154,-0.0359335744892927,-0.0271534760626084,1.01334860469543e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.048819897060035,0.00347196282645732,0.0420148499201787,0.0556249441998913,1.21056128837374e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0857973362865133,0.0061035693656096,-0.0977603322431081,-0.0738343403299185,1.46520007176683e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,0.0941670614479518,0.00670969504907097,0.0810160591517727,0.107318063744131,1.75057989633558e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37388,0.163845039810748,0.0116982058070971,0.140916556428837,0.186773523192658,2.91824815643125e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,39868,0.0493209748468159,0.00352731693146115,0.0424074336611521,0.0562345160324798,3.62222960825056e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37043,0.0851138345262073,0.00608900386208249,0.0731793869565256,0.097048282095889,4.36417042878186e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,0.0662594001832189,0.00474186977868089,0.0569653354170043,0.0755534649494334,4.59357450220698e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,0.088795969862667,0.00635971797978916,0.0763309226222803,0.101261017103054,4.80263257888947e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,0.120961740710132,0.00866929797506509,0.103969916679005,0.13795356474126,6.19675323610721e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37437,0.127991837531694,0.00919400426077042,0.109971589180584,0.146012085882804,9.40536284852056e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0514371271770405,0.00370108497050811,0.0441830006348446,0.0586912537192364,1.17050096585862e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,39868,-0.0715257244450813,0.00514775869545786,-0.0816153314881787,-0.0614361174019839,1.22518592638582e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0707000168632252,0.00509995328446799,0.0607041084256679,0.0806959253007824,1.89571323970199e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0544464301998008,0.00394024244943137,-0.0621693054006863,-0.0467235549989153,3.51219639228645e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,0.0827520373288619,0.00600044728747409,0.0709911606454127,0.0945129140123112,5.10293839970094e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37056,0.117436083036907,0.00852078707011207,0.100735340379487,0.134136825694326,6.45616899129093e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,39906,-0.0533628194198396,0.00387651926197054,-0.0609607971733018,-0.0457648416663773,7.18731224362639e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEP,Leptin,39868,0.0937579827454115,0.0068124199212827,0.0804056396996974,0.107110325791126,7.48299331492894e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0275471422685409,0.00200341723009168,0.0236204444975612,0.0314738400395206,8.92037515551989e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,39749,-0.0459724382796559,0.003346426753118,-0.0525314347157671,-0.0394134418435446,1.05776262656677e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37383,-0.0257846297171307,0.00188062352124455,-0.0294706518187701,-0.0220986076154914,1.68563908842873e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,0.171491471679178,0.0125219733672689,0.146948403879331,0.196034539479025,1.88573906646792e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLN,Promotilin,39866,0.122399397995955,0.00896424801601195,0.104829471884572,0.139969324107339,3.28613161113264e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.045621883050758,0.00334200297704343,-0.0521722088857631,-0.0390715572157529,3.42572472229694e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40030,0.0888531437834703,0.0065353314479438,0.0760438941455004,0.10166239342144,7.20343444453743e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0399678060453917,0.00294793854802223,0.0341898464912681,0.0457457655995153,1.20752891230732e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,0.0922111784026502,0.00680400009421863,0.0788753382179816,0.105547018587319,1.29145020357812e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,39995,0.0510224588058729,0.00376716099860281,0.0436388232486114,0.0584060943631344,1.4504927179021e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,0.15502594021223,0.0114682329113735,0.132548203705938,0.177503676718522,2.07582331706111e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,39836,0.124518932824051,0.00921593604385917,0.106455698178087,0.142582167470015,2.26457712305622e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0379121551561196,0.00281720521557017,0.0323904329336021,0.0434338773786371,4.66029730751835e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39489,0.0699621475461027,0.00520124375392633,0.0597677097884071,0.0801565853037983,5.13354943331949e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,0.0602928273866339,0.00448848134336269,0.051495403953643,0.0690902508196248,7.20762954644093e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,39858,-0.038378519382164,0.0028652387396073,-0.0439943873117943,-0.0327626514525337,1.07835139278061e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40058,0.0554684723370399,0.00414257966371585,0.0473490161961569,0.063587928477923,1.14076439479426e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0350134090565088,0.00261397757891199,0.0298900130018413,0.0401368051111763,1.1793494461404e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,39866,0.0717960888380747,0.00537044638123546,0.0612700139308532,0.0823221637452962,1.51946920932468e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0768205241262121,0.00574668214423749,0.0655570271235067,0.0880840211289176,1.68630208779754e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.114408676885277,0.00856617071249208,0.0976189822887925,0.131198371481761,2.00410775446003e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0466861313667241,0.00349848632830168,-0.0535431645701953,-0.0398290981632528,2.09195383912132e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37411,0.0578055231509264,0.00433178459009075,0.0493152253543485,0.0662958209475042,2.29222075883443e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,39585,0.0704048927115509,0.00528480166590214,0.0600466814463827,0.0807631039767191,2.84480943510288e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.046600290512943,0.0035012815758767,0.0397377786242247,0.0534628024016613,3.33408127094589e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,0.13398882197885,0.0100787243893629,0.114234522175699,0.153743121782001,4.14553880723264e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37437,-0.0530388440673226,0.00399231140589015,-0.0608637744228673,-0.0452139137117779,5.01081220604181e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.139153233625226,0.0105096691113199,0.118554282167039,0.159752185083413,8.31805559574858e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40030,0.0610452255691544,0.00461315673882924,0.0520034383610491,0.0700870127772597,9.12597513680155e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37437,-0.0359335755781027,0.0027192500422517,-0.041263305660916,-0.0306038454952894,1.27052366109495e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,39749,0.118256652521974,0.00897023420121165,0.100674993487599,0.135838311556349,1.76630532355689e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.129507502463269,0.00982422322088235,0.11025202495034,0.148762979976199,1.78196934309647e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37043,0.0804419886356561,0.00610963169495087,0.0684671105135524,0.0924168667577599,2.4249262793795e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0412321242810292,0.00313674170157753,-0.0473801380161211,-0.0350841105459372,2.90543488574088e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,0.0693459746200423,0.00528193303616715,0.0589933858691547,0.0796985633709299,3.58514044270526e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0322105461626827,0.00245676475439216,-0.0370258050812913,-0.0273952872440741,4.50633227991897e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,0.0901869418689647,0.00688023404238563,0.0767016831458888,0.103672200592041,4.71177305316684e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.0935993595765516,0.00714109398628471,0.0796028153634335,0.10759590378967,4.81620226982774e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,0.112376822462114,0.00857598569639919,0.0955678904971717,0.129185754427057,5.02339680318457e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,0.144658468538529,0.0110444749467518,0.123011297642895,0.166305639434163,5.8474641473515e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,0.0809935012362285,0.00618822054078258,0.0688645889762946,0.0931224134961623,6.71527597788809e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40009,0.0489056465851268,0.00374074597283257,0.0415737844783749,0.0562375086918786,7.32501165933857e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRN,Agrin,39931,0.0426959435835129,0.00327851795007049,0.0362700484013747,0.049121838765651,1.42045885848522e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0577033821668172,0.00443248918338706,0.0490157033673785,0.0663910609662558,1.51495825143647e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,39843,0.0441632588995967,0.00339663076880176,0.0375058625927452,0.0508206552064481,1.86568517727669e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37437,0.0899624885727199,0.00692291762663177,0.0763935700245217,0.103531407120918,2.21558656649181e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,0.0760380693064454,0.00585292809706383,0.0645663302362003,0.0875098083766905,2.31799348404569e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0558864722092708,0.00430901946785733,-0.0643321503662711,-0.0474407940522704,2.84144788073887e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37124,0.059974041980609,0.00463784139914027,0.050883872838294,0.0690642111229239,5.07598751940651e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40052,0.0768291249645504,0.00594984745435437,0.0651674239540158,0.088490825975085,5.86907130324679e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0399418926618835,0.00310136466876111,-0.0460205674126552,-0.0338632179111117,9.07914108544065e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,39866,-0.055360440165795,0.00431254722397652,-0.0638130327247889,-0.046907847606801,1.55708758050685e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37051,0.0336574141903276,0.00262046518424627,0.0285213024292049,0.0387935259514503,1.55858499636319e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0562926162743754,0.00439200760533915,0.0476842813679107,0.0649009511808402,2.01455224928857e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0282715533134621,0.00220559688713832,0.023948583414671,0.0325945232122532,2.13832321464289e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40030,-0.058120860741197,0.00453921692101017,-0.0670177259063769,-0.0492239955760171,2.3599025918506e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.106842500506026,0.00835585837919711,0.0904650180827997,0.123219982929252,2.997571587962e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39315,0.0518207913204931,0.00405676672599364,0.0438695285375455,0.0597720541034406,3.53562174003231e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,39788,0.0460560875479215,0.00361406479059778,0.0389725205583499,0.0531396545374932,5.13298361840587e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,0.102090310054725,0.00802172669899791,0.0863677257246887,0.117812894384761,6.91966446751913e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,0.12313893563185,0.00968704236722751,0.104152332592084,0.142125538671616,7.64361702474878e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0381295064613935,0.00299948714574317,0.0322505116557369,0.0440085012670502,8.26988278519662e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.105134617816224,0.00827178525799939,0.0889219187105457,0.121347316921903,8.44975248665745e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,0.0969409978648388,0.00764864336466725,0.081949656870091,0.111932338859587,1.33834236621966e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0761772529327331,0.00602044951275697,0.0643771718877294,0.0879773339777368,1.73153943430034e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,39847,-0.0651427478894855,0.00515820376869791,-0.0752528272761334,-0.0550326685028376,2.18124396152229e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.025145132134423,0.00199325645944475,-0.0290519147949347,-0.0212383494739113,2.60031140034259e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,39846,0.0367379026521307,0.00291401323491171,0.0310264367117038,0.0424493685925577,2.8631871191417e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40030,0.0333751055221304,0.00264769980910259,0.0281856138962894,0.0385645971479715,2.92290358347459e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40009,0.0756457433048206,0.00600608347952434,0.0638738196849529,0.0874176669246883,3.3350869178318e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0344999949765261,0.00273973791974874,0.0291301086538186,0.0398698812992336,3.48227885586422e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.0916483447045401,0.0072872070548934,0.0773654188769491,0.105931270532131,4.19513759298532e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.0652764971361971,0.00519211350593595,0.0550999546645626,0.0754530396078316,4.48579170072005e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0243508643134516,0.00193888209875924,0.0205506553998835,0.0281510732270197,5.29360849566052e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,39866,0.0578832115076169,0.00462276264430165,0.0488225967247857,0.0669438262904481,8.39646128275664e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,0.134327804544681,0.0107340060614257,0.113289152664286,0.155366456425075,9.84403918198658e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,0.044550069518205,0.0035671468423322,0.0375584617072339,0.0515416773291761,1.25896755928731e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,0.122002100596585,0.00977770093157726,0.102837806770693,0.141166394422476,1.55240024866815e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.112343925010691,0.00900863590624327,0.0946869986344542,0.130000851386928,1.58332166256747e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.109120790260902,0.00875175166529522,0.0919673569969233,0.126274223524881,1.63965971526878e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,-0.0299463792232604,0.00241813590615319,-0.0346859255993207,-0.0252068328472002,4.62180956999999e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.105378846804774,0.00851107639489276,0.0886971370707842,0.122060556538764,4.77838132459377e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.0997040933371586,0.0080614470411039,0.083903657136595,0.115504529537722,6.01755267439967e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,39785,0.0889633859494391,0.00719756769010001,0.074856153276843,0.103070618622035,6.204736522923e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,0.0943299368669797,0.00763771481642819,0.0793600158267804,0.109299857907179,6.94553855266998e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0477550583727898,0.00387732040303143,0.0401555103828482,0.0553546063627314,1.13215608974431e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,37453,0.0254895986687145,0.00207034225997613,0.0214317278391613,0.0295474694982677,1.19731280675706e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0610704592280404,0.00496589373580748,0.0513373075058577,0.070803610950223,1.34263399693165e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40009,-0.0453610626926066,0.00369322685303915,-0.0525997873245633,-0.0381223380606499,1.60895267398929e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,0.149930163575294,0.0122152347037608,0.125988303555923,0.173872023594665,1.92536839838514e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,36763,0.029166816463442,0.00237889077198665,0.0245041905503482,0.0338294423765359,2.28705908051427e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39477,0.0910919569742686,0.00743961388336569,0.0765103137628718,0.105673600185665,2.59300170276336e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0337127633143469,0.00276178659941967,0.0282996615794843,0.0391258650492094,4.05172844253811e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.0921488612795832,0.00755767037899834,0.0773358273367465,0.10696189522242,5.18216761047928e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37424,-0.0458980928461746,0.00377728536741916,-0.0533015721663162,-0.038494613526033,8.48217476658783e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,39788,0.0571417104231418,0.00470975356110978,0.0479105934433666,0.0663728274029169,9.99145319486903e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,0.0335986874315428,0.00277551388731421,0.028158680212407,0.0390386946506787,1.39146721496858e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,0.0441705670387321,0.00365595520214867,0.0370048948425207,0.0513362392349435,1.85016471019701e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.0854532354835162,0.00707262844366128,0.0715908837339401,0.0993155872330923,1.96868538223479e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.0517016898645028,0.00428246905276034,0.0433080505210925,0.060095329207913,2.04973532532072e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,0.0678579933904472,0.00562823046558959,0.0568266616778916,0.0788893251030029,2.49293119530901e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,-0.0445857258673279,0.00369836921570484,-0.0518345295301093,-0.0373369222045464,2.68711790476969e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,39730,-0.0341928344388296,0.00283825950147029,-0.0397558230617114,-0.0286298458159479,2.80607293334741e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,0.0320120919065706,0.0026617860823811,0.0267949911851037,0.0372291926280376,3.57879155285052e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,0.0773215207272278,0.0064337401214994,0.064711390089089,0.0899316513653666,3.99513057084475e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37368,0.120788346773554,0.0100580783527312,0.1010745132022,0.140502180344907,4.69008347876118e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,39660,0.0453922869203428,0.00378265481791213,0.037978283477235,0.0528062903634506,4.93852454200639e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0287043842601787,0.00239498228030595,-0.0333985495295784,-0.0240102189907791,5.87174991720769e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40052,-0.0193004440203343,0.00161445226060722,-0.0224647704511245,-0.0161361175895442,8.42205505209974e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,39875,0.0566870062632917,0.00474919259458014,0.0473785887779147,0.0659954237486688,1.05569938834695e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.068960258350035,0.00579019737352957,0.057611471497917,0.080309045202153,1.44083980625665e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40009,0.0502196916674608,0.00421889210171362,0.0419506631481021,0.0584887201868194,1.55201357301344e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37124,0.0763698101931568,0.00641312967941781,0.0638000760214978,0.0889395443648157,1.56827468566584e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40008,0.0698982325538928,0.00587898955127255,0.0583754130333986,0.081421052074387,1.83338344625046e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,0.0725558551178771,0.00610657969959343,0.060586958906674,0.0845247513290802,2.01933942038233e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,39788,0.0611495334268631,0.00514789300898051,0.0510596631292613,0.0712394037244649,2.09643639284872e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37437,0.033552238246912,0.00282567896080329,0.0280139074837376,0.0390905690100865,2.33453493546304e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,0.0673654099760482,0.00570174692491516,0.0561899860032144,0.0785408339488819,4.44531917460954e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,0.0203273436327864,0.00172370496108412,0.0169488819090615,0.0237058053565113,6.08263689196831e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.057539506597401,0.0048869922241144,0.0479610018381367,0.0671180113566652,7.16741338356353e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,0.0879042418126881,0.00747255154269569,0.0732580407890046,0.102550442836372,8.12662211233116e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,0.0254385376543261,0.00216281563455369,0.0211994190106009,0.0296776562980514,8.27649253172231e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.129629714843334,0.0110213230766397,0.10802792161312,0.151231508073548,8.78528536529038e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,-0.0402662373966177,0.00342837979603789,-0.046985861796852,-0.0335466129963834,1.01150245623791e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39455,0.0464488920783332,0.00395633209859971,0.0386944811650778,0.0542033029915886,1.07567109533045e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.103132377675469,0.00878744349410846,0.0859089884270162,0.120355766923921,1.18181826733162e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,0.0777531576237237,0.00663060713883425,0.0647571676316085,0.0907491476158388,1.25588360536945e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,39798,0.035902278992077,0.0030645521978738,0.0298957566842443,0.0419088012999096,1.43294055435594e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,39866,0.0470580204997712,0.0040188939948407,0.0391809882698835,0.054935052729659,1.53780012858712e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,39749,0.0497005514344505,0.00424496027172763,0.0413804293018643,0.0580206735670366,1.56046039431372e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0312169976707332,0.00267561801339599,0.025972786364477,0.0364612089769893,2.51080591571974e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37169,0.15154407729428,0.0129878294177508,0.126087931635488,0.177000222953071,2.63314486047957e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0590752681976444,0.00506671823445961,0.0491445004581036,0.0690060359371853,2.74753930695134e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40009,0.0680022716218609,0.00583616252314751,0.0565633930764918,0.07944115016723,2.99340196936333e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0596647295788999,0.00512131257769741,0.049626956926613,0.0697025022311868,3.07954322255151e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,0.0719785690595865,0.00617922908534475,0.0598672800523108,0.0840898580668622,3.14507503414255e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0590090485350392,0.00508898775986755,0.0490346325256988,0.0689834645443795,5.81893767100589e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39504,0.0578602870146669,0.00499839272854025,0.048063437266728,0.0676571367626057,7.30341558873625e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.164741010527908,0.0142326801922286,0.13684495735114,0.192637063704676,7.72382993027658e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37420,-0.0396148684214273,0.00342449357137679,-0.0463268758213258,-0.0329028610215288,8.34148142834612e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0713875243910405,0.0061857761397674,0.0592634031570964,0.0835116456249846,1.08977299857733e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,39913,0.0660253246054326,0.00572185247855076,0.0548104937474731,0.0772401554633921,1.10664748523276e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,39585,-0.0271402018450114,0.00235324531136015,-0.0317525626552773,-0.0225278410347455,1.19352933460751e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.113915474544853,0.00988043053293814,0.0945498307002939,0.133281118389411,1.30294616539519e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0730291558164153,0.00634287484925094,0.0605971211118835,0.0854611905209472,1.56297225914576e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.096114564481092,0.00835145468189464,0.0797457133045785,0.112483415657605,1.66417608599261e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,0.0924842307533117,0.00804017110941684,0.0767254953788547,0.108242966127769,1.76830704509365e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,0.0418301775836917,0.00364453864372538,0.0346868818419899,0.0489734733253934,2.25818414162988e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,-0.03463561681653,0.00301889912959786,-0.0405526591105419,-0.0287185745225182,2.36879412147985e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.0818435347538509,0.0071333336331144,0.0678622008329467,0.0958248686747551,2.37025059552401e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,39720,0.0319114601025786,0.00278678234580044,0.0264493667048097,0.0373735535003474,3.05590986421768e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.094880698916534,0.00828799225640654,0.0786362340939772,0.111125163739091,3.14849442910654e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,0.100239343627271,0.00876093748295398,0.0830679061606809,0.117410781093861,3.3935822487396e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.0744982215734619,0.00653293001155638,0.0616936787508114,0.0873027643961125,5.27938377143462e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,0.0975297207372892,0.00859526705208283,0.0806829973152069,0.114376444159372,1.00424288507398e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,0.0947444220480114,0.00835936497168685,0.0783600667035051,0.111128777392518,1.15533661340122e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,39931,0.115213524797109,0.0101733313910705,0.095273795270611,0.135153254323607,1.27709333872627e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37437,0.0502798609774186,0.00444267037657595,0.0415722270393298,0.0589874949155075,1.45834170169338e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0294955368277691,0.0026074935860117,-0.034606224256352,-0.0243848493991862,1.55446864295424e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.129559886443574,0.0114616853229228,0.107094983210645,0.152024789676502,1.71362033303838e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.0829503812169982,0.00735163164611509,0.0685411831906127,0.0973595792433838,2.16485089105089e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,39749,-0.0287642517482332,0.002556444798569,-0.0337748835534285,-0.023753619943038,2.93224685185221e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,39720,0.0582278137680885,0.00518331055064188,0.0480685250888304,0.0683871024473466,3.58947921138891e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37437,0.0298554583127551,0.00265876936697448,0.0246442703534851,0.0350666462720251,3.94581610427875e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0578119254907488,0.00514979721602613,0.0477183229473376,0.06790552803416,4.12094523445824e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,39868,-0.0349301955709146,0.00311341481873115,-0.0410324886156276,-0.0288279025262015,4.21206795341874e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,39859,0.0355336151427528,0.00316770817364462,0.0293249071224094,0.0417423231630963,4.29873027588577e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.06486245084615,0.00578891209627389,0.0535161831374532,0.0762087185548468,4.97340667090192e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40058,0.0381635793454225,0.00340697371076369,0.0314859108723257,0.0448412478185193,5.11869341097465e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0571835404258843,0.0051043476068128,0.0471790191165312,0.0671880617352374,5.29434322816709e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0586272731497857,0.00523990148184388,0.0483570662453717,0.0688974800541998,5.93319151687051e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,39788,0.115784560433667,0.0103548928720175,0.0954889704045123,0.136080150462821,6.42780332456869e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,0.0760457538876204,0.00680361249586106,0.0627106733957327,0.0893808343795081,7.10772388472176e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,39713,0.0897388442268398,0.00804162441550977,0.0739772603724406,0.105500428081239,8.25893380272767e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,39858,0.0504991834267394,0.00452636244527839,0.0416275130339938,0.059370853819485,8.48426093019241e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0632360735217337,0.00567261730810011,0.0521177435978575,0.0743544034456099,9.89223081576372e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.110234270698285,0.00989314831779317,0.0908436999954102,0.129624841401159,9.93816624743481e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.0691127186342859,0.00620243409798488,0.0569559478022355,0.0812694894663362,9.95728317242207e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0434909415057054,0.00390393257592493,0.0358392336568926,0.0511426493545183,1.07153511783277e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELP,P-selectin,39931,0.0643564270153185,0.00578176892846282,0.0530241599155313,0.0756886941151056,1.12932497304734e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,-0.058834979571831,0.00528726965584639,-0.0691980280972899,-0.0484719310463721,1.17214672941341e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,39871,-0.0305274827573592,0.00274384734270226,-0.0359054235490556,-0.0251495419656628,1.19674331208577e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0469194776726337,0.00421756091132582,0.038653058286435,0.0551858970588323,1.21026088656769e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,39913,0.0452594738677377,0.00407143787111146,0.0372794556403593,0.0532394920951162,1.32868157208432e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0328327278538211,0.00295679465574575,0.0270374103285595,0.0386280453790828,1.58863887125799e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40030,0.0612931104593777,0.00552264241041613,0.0504687313349621,0.0721174895837933,1.61690776006506e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.0596924994233035,0.00538245512632817,0.0491428873757003,0.0702421114709067,1.78056653279112e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,39897,-0.0401676576859553,0.00362298773306103,-0.0472687136427549,-0.0330666017291557,1.84311168429755e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37056,0.103565680680514,0.00934450333450759,0.0852504541448788,0.121880907216149,2.02343556665432e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.085331337723402,0.00771010823805042,0.0702195255768231,0.100443149869981,2.38523786091949e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0431879082416044,0.00390878166338699,0.0355266961813659,0.0508491203018429,2.81161163960146e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,0.0477496680847628,0.00432510440517878,0.0392724634506124,0.0562268727189132,3.25421511264309e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,0.0552981032575165,0.00501171504624689,0.0454751417668726,0.0651210647481604,3.31900115585196e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0577556861716841,0.00523946195981502,-0.0680250316129215,-0.0474863407304466,3.72954878460348e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,-0.0281580733267798,0.00255596777163725,-0.0331677701591888,-0.0231483764943707,4.01365037474991e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,39795,0.0504406434567974,0.00458064886875105,0.0414625716740453,0.0594187152395494,4.23880588844779e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,0.0882674923052926,0.00802521953874826,0.072538062009346,0.103996922601239,4.90883329747509e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39477,0.0691244882766748,0.00628708759163318,0.0568017965970738,0.0814471799562758,5.13556335805976e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0497260653163895,0.00452282905884872,0.040861320361046,0.058590810271733,5.37463573708147e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,39880,0.0647053280902206,0.00588904265511548,0.0531628044861943,0.076247851694247,5.52989352245941e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.125524235213554,0.0114260849658641,0.10312910868046,0.147919361746647,5.63383247603829e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37386,0.0306461375660682,0.00279119167712419,0.0251754018789048,0.0361168732532316,6.28505722567892e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.0769187616462636,0.00701147368973557,0.0631762732143819,0.0906612500781453,6.95019361420164e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,39587,0.0526382317530145,0.00480168778899855,0.0432269236865773,0.0620495398194516,7.30514478668547e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.117181348750145,0.0107213610972096,0.0961674809996145,0.138195216500676,1.04138178983948e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNST,Consortin,39868,0.118735287766032,0.0108844609038112,0.097401744394562,0.140068831137502,1.31013155626859e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0453727017570012,0.00416296695738741,0.0372132865205219,0.0535321169934805,1.51470037980629e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,0.101059509974485,0.00929296927865936,0.0828452901883129,0.119273729760658,1.89514172731259e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,39913,0.0589911739100126,0.00542495067570899,0.048358270585623,0.0696240772344022,1.91022103908703e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0256927404310699,0.00236364644100817,0.0210599934066939,0.0303254874554459,1.9986398670874e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0438679041576881,0.00403878467932932,0.0359518861862027,0.0517839221291736,2.18744622115089e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,0.0481388339206762,0.00443058472245584,0.0394548878646628,0.0568227799766897,2.19349701667045e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,39866,0.104394678211644,0.00962511799847599,0.0855294469346307,0.123259909488657,2.59095572062083e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40009,0.0262332409622058,0.00241986630896762,0.0214903029966293,0.0309761789277823,2.73869634273009e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0828749561615814,0.00764464350728199,0.0678914548873087,0.0978584574358541,2.84838946410477e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,0.09433539624053,0.00870573624432217,0.0772721532016586,0.111398639279401,2.88992598023721e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0845990448227861,0.00781673738529548,0.069278239547607,0.0999198500979653,3.46875788762485e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,37453,-0.0298096099225526,0.00275795907053249,-0.0352152097007963,-0.0244040101443089,4.04092243578504e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39476,0.0759733981705748,0.00703760017323813,0.0621797018310281,0.0897670945101215,4.51176446403444e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40058,0.102874632364186,0.00954571642382293,0.0841650281734927,0.121584236554879,5.45511415992639e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0445732969870967,0.00413692752589056,0.0364649190363512,0.0526816749378422,5.61680594339911e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.033447037220871,0.00310419664238856,-0.0395312626399525,-0.0273628118017894,5.76104557998995e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,0.0563481290679035,0.0052451839281794,0.0460675685686719,0.0666286895671352,7.91867501629189e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,39749,0.0566689459828315,0.0052774035788954,0.0463252349681965,0.0670126569974665,8.33785201987251e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,0.0435083629241493,0.00405360653019947,0.0355632941249584,0.0514534317233403,8.74368256563876e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,39713,0.0659035906334478,0.00614135516232279,0.0538665345152951,0.0779406467516004,8.98593298091993e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0591903028779104,0.00552204461040523,0.0483670954415161,0.0700135103143047,1.02238004858962e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,-0.0345721605674428,0.00322427688497643,-0.0408917432619966,-0.028252577872889,1.0287583130373e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0318960462357522,0.00297931507155393,0.0260565886955065,0.0377355037759979,1.2295736569803e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.0826919472412065,0.007738118030632,0.0675252359011677,0.0978586585812452,1.45138537917911e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,-0.0303061188342729,0.00283642967388948,-0.0358655209950963,-0.0247467166734496,1.47688093419801e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0233359590014074,0.00218524025911088,0.0190528880935501,0.0276190299092647,1.63740483664778e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,39866,0.087402385371369,0.00819079787996946,0.0713484215266289,0.103456349216109,1.71152532878e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.106935626972643,0.0100419347931238,0.0872534347781201,0.126617819167165,2.15706545179113e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.047676983781072,0.0044903026303039,-0.0564779769364676,-0.0388759906256763,3.0072894266252e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,-0.0772142427354082,0.00727292674858112,-0.0914691791626272,-0.0629593063081892,3.16056137694551e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39489,0.0694441298663753,0.0065466758958569,0.0566126451104957,0.0822756146222548,3.37476232362553e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.116298184104668,0.0109659860262129,0.0948048514932909,0.137791516716045,3.56508858084044e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,0.094425012892489,0.00891288061436103,0.0769557668883414,0.111894258896637,4.01197834752693e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,39868,-0.0395473098672079,0.00373495406879707,-0.0468678198420501,-0.0322267998923656,4.1137866466759e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,39866,0.0871692977239074,0.00823510900065773,0.0710284840826183,0.103310111365197,4.26274058879021e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0459469928000981,0.00434092420999567,-0.0544552042516896,-0.0374387813485066,4.28063801409557e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.100449432773746,0.00953312704458848,0.0817645037663523,0.119134361781139,7.09441957144064e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.0794026041160044,0.00754239129386941,0.0646195171800204,0.0941856910519885,8.16751185162943e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,0.0632686764656932,0.00601435962096875,0.0514805316085945,0.075056821322792,8.82604455219483e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37333,0.0369981291273226,0.00351746499193044,0.0301038977431389,0.0438923605115062,8.94390990686521e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,39866,0.0665660979311227,0.00633389342326131,0.0541516668215305,0.0789805290407149,9.47356624362695e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0439179572191778,0.00418174495897385,0.0357217370995891,0.0521141773387666,1.02119128514992e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.121401607686725,0.0115605553963537,0.0987429191098723,0.144060296263579,1.06933618176438e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,0.145681688510967,0.0138782990044114,0.118480222462321,0.172883154559614,1.08067732755281e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.0999413694346357,0.00953286965260271,0.0812569449155344,0.118625793953737,1.24230268572951e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0622374104173872,0.00594216725608893,0.0505907625954529,0.0738840582393215,1.38476903254156e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,0.0331987852264488,0.00316868247651247,0.0269881675724844,0.0394094028804133,1.38636905350411e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,39866,0.034286775825173,0.00327472084038165,0.0278683229780249,0.040705228672321,1.43296858414744e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39314,0.0968118809626471,0.00926427294371041,0.0786539059929747,0.114969855932319,1.78119564017045e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.101789868066638,0.00975470609428043,0.0826706441218486,0.120909092011428,2.07855863206333e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0644926933471058,0.00618489209424965,0.0523703048423764,0.0766150818518351,2.24248507933555e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.0911878855818148,0.00875642969226001,0.0740252833849851,0.108350487778644,2.58210175550363e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,0.0281567870768238,0.00270934705203005,0.0228464668548449,0.0334671072988027,3.22244126917629e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37430,0.059076367453456,0.00568695941023277,0.0479299270093998,0.0702228078975122,3.49302285941216e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37437,0.0787399972524102,0.00758624092452471,0.0638709650403417,0.0936090294644786,3.82420645807353e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.0703481743542348,0.00678051330076127,0.0570583682847427,0.0836379804237269,3.88668424328973e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37208,0.0289358639582643,0.00278963886517232,0.0234681717825266,0.0344035561340021,4.11485353793459e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.0276532124948092,0.00267188643854972,-0.0328901099143667,-0.0224163150752517,5.03931758986748e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,39866,0.0958467628255204,0.00927428398654353,0.0776691662118951,0.114024359439146,5.88297473755943e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,39866,0.0876605156550569,0.00848425529394479,0.0710313752789251,0.104289656031189,6.03984802552796e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.0602926642766767,0.00584960051813847,0.0488274472611253,0.0717578812922281,7.83278843194921e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,0.044580828019167,0.00432690313964,0.0361000978654726,0.0530615581728614,8.13290782247494e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37411,0.109904629066214,0.010663875928971,0.0890034322454304,0.130805825886997,8.15299573723094e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.107922977929388,0.0104826372020997,0.0873770090132728,0.128468946845504,8.83082160492791e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.0756385143316184,0.0073499869461979,0.0612325399170705,0.0900444887461663,9.55118020108417e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,0.0655700356800208,0.00637783922341309,0.0530694708021312,0.0780706005579105,1.05902785773677e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37445,0.0752805706672768,0.00732432978490636,0.0609248842888603,0.0896362570456933,1.08866180823771e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.028803682149806,0.00280475014546563,0.0233063718646934,0.0343009924349186,1.19465872050954e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0403754493860869,0.00393345419512731,0.0326658791636374,0.0480850196085365,1.25738912989329e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,0.08922525730172,0.00869421167673336,0.0721846024153226,0.106265912188117,1.27867452459257e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,0.0805355558727005,0.00785029497178834,0.0651489777279954,0.0959221340174057,1.28605636908256e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,39866,0.0798476477742651,0.00778823924385652,0.0645826988563063,0.0951125966922239,1.37618883777465e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0458960646795905,0.00447790432364941,0.0371193722052377,0.0546727571539434,1.41942209985302e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40009,0.0631384860277416,0.00616305591121936,0.0510588964417516,0.0752180756137315,1.48667806913195e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0277265584448298,0.00270650480258773,0.0224218090317579,0.0330313078579018,1.49185422859174e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37124,0.120246894838975,0.0117383746287539,0.0972396805666171,0.143254109111332,1.55544212834589e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,39803,0.0309171159457152,0.00302220300061472,0.0249935980645103,0.0368406338269201,1.73231533346259e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,0.086507677681191,0.00846938039448973,0.0699076921079912,0.103107663254391,2.10123765129288e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37124,0.0711446724496961,0.00697748614565611,0.0574687996042101,0.0848205452951821,2.53177223385931e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37445,0.023082028739135,0.00226675169576379,0.018639195415438,0.027524862062832,2.89037854251468e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0822501768543416,0.00808067399338153,0.0664120558273138,0.0980882978813694,3.03724556065858e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,0.0268351109519468,0.00263853923723398,0.0216635740469682,0.0320066478569254,3.181316533715e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37382,0.107097578645129,0.010531439072868,0.086455958062308,0.12773919922795,3.32146900271466e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37437,0.0469568999754937,0.00462140605496495,0.0378989441077624,0.056014855843225,3.62188503094731e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.0720046714023431,0.00709651618157528,0.0580954996864556,0.0859138431182307,4.07589171499333e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0646846183329232,0.0064070421965778,0.0521268156276307,0.0772424210382157,6.79401914208815e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37437,0.0767095197585237,0.00760734564357191,0.0617991222971228,0.0916199172199246,7.91897599100701e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37124,0.0538000226051516,0.00534269081924187,0.0433283485994376,0.0642716966108657,9.14203387101034e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0525960528214016,0.00522366912769623,0.042357661331117,0.0628344443116862,9.24792803701569e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0333455271756418,0.00331609529531212,-0.0398450739544536,-0.0268459803968301,1.0499641390943e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,0.0779647024507179,0.00776043734671423,0.062754245251158,0.0931751596502778,1.1531441121294e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,39846,0.0377607674949892,0.00376044847107863,0.030390288491675,0.0451312464983033,1.17616320872707e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39489,0.0617050232169857,0.00614676411195404,0.0496573655575558,0.0737526808764156,1.2159797162305e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,0.0475066014190474,0.00473457852461703,0.038226827510798,0.0567863753272967,1.26914981747665e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,0.0439690349606707,0.00438314503823932,0.0353780706857216,0.0525599992356197,1.30275151277466e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,0.0865419022249858,0.00862978695768747,0.0696275197879183,0.103456284662053,1.34332505277414e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0484770069653711,0.00485057809570996,0.0389698738977796,0.0579841400329626,1.90083388619898e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0344548560459897,0.00344901797541184,0.0276947808141825,0.0412149312777969,1.98696807561343e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,0.0518617014802125,0.00519775091031911,0.041674109695987,0.0620492932644379,2.23310164459822e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REN,Renin,39868,0.0662528146761935,0.00664599700045128,0.053226660555309,0.079278968797078,2.44067192704447e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40030,0.0401690186986452,0.00403713232531361,0.0322562393410305,0.0480817980562598,2.94483866983289e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,0.126460268862686,0.0127229383993396,0.10152330959998,0.151397228125392,3.26811203570838e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37124,0.0292996873196373,0.00294701855377946,0.0235235309542296,0.035075843685045,3.28978573038647e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,0.028824374265755,0.00290130739826781,0.0231378117651501,0.03451093676636,3.43613669338534e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,39788,0.0737951658059131,0.00742909564486131,0.059234138341985,0.0883561932698413,3.48433259568556e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37437,0.0296142645013049,0.00298128392534333,0.0237709480076319,0.0354575809949778,3.57421114775505e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,0.0499276515142731,0.00502900157951724,0.0400708084184193,0.0597844946101269,3.67542524619092e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,0.0649836374765844,0.00654875370973673,0.0521480802055004,0.0778191947476684,3.84937073092178e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,0.0563916930382531,0.00568865909787271,0.0452419212064225,0.0675414648700836,4.2759965372635e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0464216924809648,0.00468969363420899,0.0372298929579152,0.0556134920040145,4.91362880773438e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,39794,0.0841788319069534,0.00851210152013182,0.067495112927495,0.100862550886412,5.39505695936665e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,39931,0.0388217361984469,0.00394261303315321,0.0310942146534666,0.0465492577434272,8.21813079199813e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,0.0194283508465812,0.00197430193068075,0.015558719062447,0.0232979826307155,8.73564426441454e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,0.022364752796724,0.00227337301604782,0.0179089416852703,0.0268205639081778,9.26770363561837e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0281051158574603,0.00285865356569974,0.0225021548686888,0.0337080768462318,9.55612738116624e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,0.0550454019430358,0.00559903591233667,0.0440712915548559,0.0660195123312157,9.57707550377384e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.0634737797911602,0.00646827335235415,0.0507959640205461,0.0761515955617743,1.17619373411441e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.0679392661363043,0.00694841476652044,0.0543203731939243,0.0815581590786844,1.67458318178922e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,39866,0.0847125549325221,0.00867802765302622,0.0677036207325907,0.101721489132454,1.89823312198156e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,0.0768642488456738,0.00788525918871173,0.0614091408357988,0.0923193568555487,2.24004703956964e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0580577727110678,0.00595657565349215,0.0463828844302232,0.0697326609919124,2.25317703531475e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.0733719496377796,0.00754944282083179,0.0585750417089493,0.0881688575666099,2.89013494897699e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,0.0667771502150847,0.0068723520152733,0.053307340265149,0.0802469601650204,2.94367129659375e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0188565196509584,0.00194141073566701,0.0150513546090511,0.0226616846928657,3.06492859248292e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0692498483313564,0.00713327447101319,0.0552686303681706,0.0832310662945423,3.30734697095488e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0310886156781052,0.00320416580252115,0.0248084507051637,0.0373687806510467,3.38420614974275e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,39973,0.0523980606341237,0.0054033806565511,0.0418074345472836,0.0629886867209638,3.56042296459138e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,0.0913998417354281,0.00943370946163158,0.0729097711906302,0.109889912280226,3.87629640606932e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,39931,0.0473407253004288,0.00488993336455456,0.0377564559059019,0.0569249946949557,4.16240648873511e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,0.0761361409454929,0.00786355532347966,0.0607235725114728,0.091548709379513,4.23412114156279e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.0759072438783295,0.00784262535269285,0.0605356981870515,0.0912787895696074,4.37405704898151e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39448,-0.116449331656944,0.0120353096010814,-0.140038538475063,-0.0928601248388243,4.41508984142829e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,0.0826140940743668,0.0085401362333924,0.0658754270569177,0.0993527610918159,4.4886724370708e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,39749,0.063345313863641,0.00655027694542142,0.050506771050615,0.076183856676667,4.62282790855681e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,39866,0.056840588171512,0.00588298578082811,0.0453099360410889,0.068371240301935,5.02869274175683e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,0.0289967088538506,0.00300237849701775,0.0231120469996959,0.0348813707080054,5.22299650313427e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,-0.0278164060809149,0.00288121360880428,-0.0334635847541713,-0.0221692274076586,5.40627235889521e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,36543,0.0239119412203766,0.00247602819749788,0.0190589259532807,0.0287649564874724,5.44499595109752e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0637042890936615,0.00659968722351243,0.0507689021355772,0.0766396760517459,5.50136139212646e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.108990851194371,0.0112929651776367,0.0868566394462029,0.131125062942539,5.58312582436832e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39489,0.0336929703599814,0.00349270543736912,0.0268472677027379,0.0405386730172249,5.84637132373268e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0710197174255021,0.0073644811316656,0.0565853344074376,0.0854541004435667,6.18488831396192e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,0.0799584657480149,0.00829330513733829,0.0637035876788319,0.096213343817198,6.28850971606265e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,0.117635588341897,0.0122199902579074,0.0936844074363982,0.141586769247395,7.29238193664923e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,0.0696815929722597,0.00724268582609471,0.055485928753114,0.0838772571914053,7.46176090205095e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,0.0310354914495502,0.00322776659976684,0.0247090689140071,0.0373619139850932,7.89202049637861e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,0.0507341739700583,0.00527933258116942,0.0403866821109662,0.0610816658291503,8.29813175913649e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37368,0.0207594781645334,0.00215988132899309,0.0165261107597069,0.0249928455693598,8.4040879411384e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37249,0.10713096729179,0.0111480764584666,0.085280737433195,0.128981197150384,8.54538882382473e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.0881362312377515,0.00917417734027117,0.07015484365082,0.106117618824683,8.76698326686776e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,39788,0.0316695601535782,0.00329756677156491,0.025206329281311,0.0381327910258454,8.81642084247843e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.0651550778551294,0.00679246059339736,0.0518418550920706,0.0784683006181883,9.89057655068488e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0607164492404855,0.00633550182738713,0.0482988656588068,0.0731340328221643,1.09900413602228e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37445,-0.0460746410224438,0.00481608295811772,-0.0555141636203545,-0.0366351184245331,1.28949344871434e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_E,,39866,0.0263790098447942,0.00276412966630744,0.0209613156988316,0.0317967039907568,1.57813856101594e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,0.0703413833520926,0.0073758379055659,0.0558847410571834,0.0847980256470018,1.68520378918321e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.0988271013032144,0.0103647919034302,0.0785121091724911,0.119142093433938,1.75290281583736e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,37453,0.0210411934355297,0.00220697177106475,0.0167155287642428,0.0253668581068166,1.766970227466e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0269361076081021,0.00282600243589561,0.0213971428337467,0.0324750723824575,1.76842780203927e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0300198719525801,0.00315227961228832,0.023841403912495,0.0361983399926652,1.91057307931832e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,39984,0.0226157885616846,0.00237776065256533,0.0179553776826565,0.0272761994407126,2.14096971170408e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,0.0694446199411434,0.00730748582194763,0.0551219477301261,0.0837672921521608,2.37106429788944e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,39862,-0.0207790260668447,0.0021901310702411,-0.0250716829645173,-0.0164863691691721,2.69013004402849e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,0.0615636018114842,0.00649508182790715,0.0488332414287862,0.0742939621941822,3.0018862132474e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0463307547202381,0.00489003555384232,0.0367462850347071,0.055915224405769,3.11902890954269e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37415,0.0427602385859862,0.00451655071667985,0.0339077991812936,0.0516126779906787,3.33418869512593e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0192173945898038,0.0020305423949836,-0.0231972576839716,-0.0152375314956359,3.36013583066646e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37368,0.0792974123377218,0.00838267739159734,0.062867364650191,0.0957274600252526,3.59189013647719e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,0.101013002269262,0.0107026553413744,0.0800357978001685,0.121990206738356,4.30353626445395e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37306,0.0896981673687538,0.00950787667541512,0.0710627290849402,0.108333605652567,4.58190761567923e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37388,0.0584817183693279,0.00620113609327661,0.0463274916265057,0.07063594511215,4.72239196169625e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0266933126769036,0.00283180582136422,0.0211429732670297,0.0322436520867775,4.81885417253312e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40058,0.0362657561587587,0.00385059816884259,0.0287185837478272,0.0438129285696902,5.19250547422577e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,0.0614065303996279,0.00652329238581411,0.0486208773234322,0.0741921834758235,5.44301067178925e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0406017186794136,0.00431776253951424,-0.0490645332568615,-0.0321389041019657,5.9821230945652e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37437,0.03813215527775,0.00405498103873745,0.0301843924418246,0.0460799181136754,6.09475114923697e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37388,0.0720836731871616,0.00766746784100093,0.0570554362187998,0.0871119101555235,6.24636340296001e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,39858,0.0504600486954983,0.00538479946163802,0.0399058417506878,0.0610142556403088,8.1364557707895e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,39829,0.0627330158483542,0.00670741060918612,0.0495864910543494,0.075879540642359,9.6447456855244e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.050794828512045,0.00543328212169289,0.0401455955535269,0.061444061470563,1.02566579431454e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37371,0.0802629231221469,0.00858943126228645,0.0634276378480654,0.0970982083962283,1.06709048993505e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,39866,0.0623082546264231,0.00667668479162453,0.0492219524348391,0.0753945568180072,1.16986918785961e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,0.0542987781440617,0.00582106539947655,0.0428894899610876,0.0657080663270357,1.21598627742548e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.0197683491595788,0.00212026808653657,-0.0239240746091905,-0.0156126237099671,1.30234355556846e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,-0.0383491718419321,0.00411657417974683,-0.0464176572342359,-0.0302806864496283,1.36410618103983e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0722612072435258,0.00777708298235841,-0.0875042898889482,-0.0570181245981033,1.71153547699423e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,39843,0.0364317564425437,0.00392150548772408,0.0287456056866045,0.0441179071984829,1.73343657770756e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,39790,0.0407096966743715,0.00438286861743176,0.0321192741842053,0.0493001191645378,1.76484217012697e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.0962439893488768,0.0103621172838321,0.0759342394725659,0.116553739225188,1.80765809911248e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,39749,0.0580096224844278,0.00625419129927214,0.0457514075378544,0.0702678374310012,1.9941061907946e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,0.0511915145768186,0.00552011813283396,0.040372083036464,0.0620109461171731,2.0300248308769e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0277840963371614,0.00299634862613925,0.0219112530299285,0.0336569396443944,2.08706269213146e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,0.0238429501197178,0.00257316624068739,0.0187995442879705,0.0288863559514651,2.17261786169391e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,0.0776563846238989,0.00838303881994381,0.061225628536809,0.0940871407109887,2.22464668406492e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,0.106343370077134,0.0114893946897593,0.0838241564852061,0.128862583669062,2.39134768137807e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0297589812379919,0.00321551861737466,0.0234565647479376,0.0360613977280462,2.40994975543309e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.0753214121045411,0.00813790227926416,0.0593711236371834,0.0912717005718989,2.44475024657273e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37388,0.0352916716632716,0.00382744842028854,0.027789872759506,0.0427934705670371,3.38283568698296e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37043,0.0696392341151146,0.00755476260023144,0.054831899418661,0.0844465688115682,3.48259172419518e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0285368595593861,0.00309908053216982,0.0224626617163332,0.0346110574024389,3.79838526698172e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.0612623427002898,0.00665984338992935,0.0482090496560283,0.0743156357445513,4.142695462717e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37377,0.0701733246754506,0.00763431663300776,0.0552100640747554,0.0851365852761458,4.41858968662041e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37382,0.0662145040146335,0.00720370657698253,0.0520952391237477,0.0803337689055192,4.42249369641229e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,0.0515735595380312,0.00561489164962414,0.0405683719047678,0.0625787471712945,4.6986395495366e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0575499636893847,0.0062677982648065,0.045265079090364,0.0698348482884055,4.74568460462861e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0605970497792869,0.00660117795472487,0.0476587409880261,0.0735353585705476,4.95275407319822e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39477,0.0912604151294976,0.00994531626953574,0.0717675952412075,0.110753235017788,5.0128736043389e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0541877304064282,0.00590516645653552,0.0426136041516186,0.0657618566612378,5.11148781998227e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,39817,-0.058737165667129,0.00640774528956842,-0.0712963464346832,-0.0461779848995749,5.46544839644038e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0518179517344168,0.00565325604358673,0.0407375698889868,0.0628983335798468,5.48417380167276e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,39749,0.0337153116661982,0.00368275317695901,0.0264971154393585,0.0409335078930378,6.08907422186064e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,0.0508676052415809,0.00555951635244988,0.0399709531907791,0.0617642572923826,6.40468199580192e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,39868,0.113228434149397,0.0123756198503804,0.0889722192426509,0.137484649056142,6.40639518340804e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37348,0.0406371125757451,0.00444321977479914,0.0319284018171387,0.0493458233343514,6.75135987387747e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.0958694128639977,0.0104892704185793,0.0753104428435823,0.116428382884413,6.99218987082781e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0342815408964293,0.00375927036571309,0.0269133709796317,0.041649710813227,8.46649271787788e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37124,0.0466495223859579,0.00512218100137818,0.0366100476232567,0.0566889971486592,9.63483361961287e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37056,-0.0273449391829454,0.00300357099238185,-0.0332319383280138,-0.021457940037877,9.92916140933287e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,39788,0.0507008987851025,0.00557703715904343,0.0397699059533774,0.0616318916168276,1.09468762695317e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37385,0.0886911692556772,0.00975843164415147,0.0695646432331403,0.107817695278214,1.14021187234014e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.0948533158983855,0.0104364910937405,0.0743977933546542,0.115308838442117,1.14452094314186e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,0.0307234693177913,0.00338401608952533,0.0240907977823216,0.037356140853261,1.22213596869753e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37437,0.0210056488786585,0.00231482992405662,0.0164685822275075,0.0255427155298094,1.29853530919355e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,0.045135463805435,0.00497382349207621,0.0353867697609656,0.0548841578499044,1.30090504030107e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,0.0666422609788927,0.00734543351872027,0.052245211282201,0.0810393106755844,1.3200024390946e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,0.034751790555476,0.0038383534982999,0.0272286176988082,0.0422749634121438,1.53689061668488e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37043,0.0430993207433383,0.00477378167509573,0.0337427086601507,0.0524559328265259,1.98205178593217e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40030,0.101472177211035,0.0112457708013656,0.0794304664403581,0.123513887981711,2.02933489015668e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39489,0.0650472926268383,0.00721235932795153,0.0509110683440533,0.0791835169096233,2.1173318866033e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0377385098862481,0.00418551811709436,0.0295348943767432,0.0459421253957531,2.15892045043564e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.041158495738013,0.00457433861487209,0.0321927920528637,0.0501241994231623,2.56576027889409e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,-0.0272021019311669,0.00302572637809274,-0.0331325256322287,-0.0212716782301051,2.74230608285136e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,0.0727003515693772,0.00809424515811197,0.0568356310594778,0.0885650720792767,3.0232028180468e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,39913,0.0352037757092071,0.00392188868054903,0.027516873895331,0.0428906775230832,3.10681242103271e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.0708514737764906,0.00789760441287606,0.0553721691272536,0.0863307784257277,3.25882944299288e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,0.0695409546358494,0.00776051630960028,0.0543303426690329,0.0847515666026659,3.6372295610971e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,0.0531568598554199,0.00594114243978037,0.0415122206734504,0.0648014990373894,4.04724572479011e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0395866930918063,0.00442538894268968,0.0309129307641345,0.0482604554194781,4.19189257041702e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,0.0697686811083402,0.00780429535763846,0.0544722622073688,0.0850651000093115,4.41268310051876e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37411,0.0462343683476324,0.00517339535656122,0.0360945134487724,0.0563742232464924,4.51137825092182e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40024,0.061937480137242,0.00694305313783482,0.0483290959870857,0.0755458642873982,5.11727317558609e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.0615712363176644,0.00691064580830979,0.0480263705333772,0.0751161021019516,5.65740662680643e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0427417626551773,0.0047991419221207,0.0333354444878208,0.0521480808225339,5.95117063665798e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,-0.0415920060554205,0.00467262629501059,-0.0507503535936412,-0.0324336585171997,6.10646651733672e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,-0.0233098769636136,0.00262152972289223,-0.0284480752204823,-0.0181716787067448,6.64113394597027e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0533997224971095,0.00600941324427054,0.0416212725383392,0.0651781724558797,7.00917262028733e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0330625878761804,0.00371995716458781,0.0257714718335883,0.0403537039187725,7.02907169838977e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0692557018367614,0.00779258228108479,0.0539822405658352,0.0845291631076876,7.05958689224304e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,0.0696635696165768,0.00784790079712744,0.054281684054207,0.0850454551789465,7.59723244067566e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.0311164819240614,0.00350835402890643,0.0242401080274048,0.037992855820718,8.12864533252657e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0534422694167333,0.00602741212851502,0.0416285416448438,0.0652559971886227,8.34251951924828e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0295177078558606,0.00333470973580292,0.0229816767736869,0.0360537389380343,9.72913448797784e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.0919557478567252,0.0103965428739778,0.0715785238237288,0.112332971889722,1.01000324522161e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40058,-0.00803781777747723,0.00090878756246522,-0.00981904139990906,-0.0062565941550454,1.01211088300215e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,-0.0253047823729329,0.00286176930261142,-0.0309138502060513,-0.0196957145398145,1.05426915227021e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37124,-0.0450826991347495,0.00510219629762564,-0.0550830038780958,-0.0350823943914033,1.11620223580786e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0578770563494807,0.00655229149634764,-0.0707195476823221,-0.0450345650166393,1.12258151576733e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,0.0350233320542059,0.00396681658137322,0.0272483715547143,0.0427982925536974,1.16287448740584e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,39810,0.0361218472996023,0.0040912249427075,0.0281030464118956,0.044140648187309,1.16308322303212e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40052,0.0496611672283951,0.00562484940627795,0.0386364623920903,0.0606858720646999,1.16361995845838e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.042620135897463,0.00483224858029074,0.0331489286800931,0.0520913431148328,1.28359368756333e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,39713,0.0572835433231782,0.00649620926285256,0.0445509731679872,0.0700161134783692,1.28456738126963e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.0193795172050405,0.00219761286203228,-0.0236868384146238,-0.0150721959954572,1.3005043801298e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.04864199772819,0.00552212050639586,0.0378186415356541,0.0594653539207259,1.39605157779201e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,0.026259124789423,0.00298165218347062,0.0204150865098206,0.0321031630690254,1.41566253157725e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0301615851866504,0.00342882992279654,0.0234410785379692,0.0368820918353316,1.55315626208962e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,39669,0.0409942063811958,0.00466473496535748,0.0318513258490952,0.0501370869132965,1.67494963719532e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,39858,-0.0211002640179285,0.00240476342952438,-0.0258136003397963,-0.0163869276960608,1.88951511067782e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDK,Midkine,39843,0.0447656958566372,0.00510279200468733,0.0347642235274501,0.0547671681858244,1.91621545722514e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,39858,-0.0227284444259854,0.00259154836304436,-0.0278078792175523,-0.0176490096344184,1.96001669276944e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,39619,0.0374325864909345,0.00427931561418011,0.0290451278871415,0.0458200450947275,2.40227938256907e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,39868,0.0341798806341485,0.00391294639985324,0.0265105056904361,0.0418492555778608,2.67225072606674e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,0.0695266747210841,0.00796769807334489,0.0539099864973281,0.0851433629448401,2.95012965895501e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,36879,0.0616044182184479,0.00706514006582163,0.0477567436894375,0.0754520927474583,3.13035157420913e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.0802315464296974,0.00921596657510802,0.0621682519424857,0.0982948409169092,3.52726309959112e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,0.0408402462133406,0.00469380902986549,0.0316403805148042,0.0500401119118769,3.61124881176836e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,-0.0311466661056169,0.00358507298256048,-0.0381734091514354,-0.0241199230597984,4.04121560803326e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,0.0520005702210304,0.00598677948122473,0.0402664824378299,0.0637346580042309,4.11263042603043e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,0.047012097865888,0.0054167233641008,0.0363953200722504,0.0576288756595256,4.45443105228841e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39489,-0.0644029695650533,0.00743150662702155,-0.0789687225540155,-0.0498372165760911,4.89965101862546e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,39858,0.0314646701213626,0.00363131942978075,0.0243472840389923,0.0385820562037328,4.94954431281772e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,39882,0.0543576423960002,0.0062782031534255,0.0420523642152862,0.0666629205767142,5.24483658638112e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,0.0254369987565328,0.00294407124766015,0.0196666191111189,0.0312073784019467,6.15457837905816e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37388,0.0577274452657629,0.00669689534577861,0.0446015303880369,0.070853360143489,7.4300699008624e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,-0.0223870471251157,0.00259814023616189,-0.027479401987993,-0.0172946922622384,7.53484053140653e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.0943286509312146,0.0109581875891952,0.0728506032563921,0.115806698606037,8.24454365416328e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37056,0.0397513794970721,0.00462415545950009,0.0306880347964519,0.0488147241976922,9.13903045175915e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0611152467326837,0.00712113568685622,0.0471578207864455,0.0750726726789219,1.01546578933754e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPTC,Opticin,39788,-0.0382076122895195,0.00445287191564806,-0.0469352412441897,-0.0294799833348493,1.03110416613949e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARC,SPARC,39913,0.0608885017226993,0.00711119420960215,0.0469505610718791,0.0748264423735195,1.20492018002198e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,0.0308382695527981,0.00360881439556796,0.0237649933374849,0.0379115457681113,1.41801544250632e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0303103913549828,0.00354768808103983,-0.0372638599938209,-0.0233569227161448,1.44151106950721e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0487089682948868,0.00570316826978885,0.0375307584861006,0.0598871781036729,1.45588642699758e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,0.0711824935262973,0.00833471509294833,0.0548464519441186,0.087518535108476,1.47813537771319e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.0809417202759576,0.00949018799374824,0.062340951808211,0.0995424887437041,1.63146865222043e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39453,0.0387476195025108,0.00454443671636127,0.0298405235384427,0.0476547154665789,1.6468069154857e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.0839888214556121,0.00985207716682159,0.0646787502086418,0.103298892702582,1.69328448904417e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,39720,0.0443852062158712,0.00521172409096792,0.034170226997574,0.0546001854341683,1.79156624131065e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0237937100497217,0.00279396412658354,0.0183175403616179,0.0292698797378254,1.79425089827453e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,39585,0.0494700147469084,0.00582495168236581,0.0380531094494714,0.0608869200443453,2.19597492417036e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37388,0.0475418166498177,0.00560447173380329,0.0365570520515632,0.0585265812480721,2.42395025792764e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.0672550744728404,0.00793380166316799,0.0517048232130312,0.0828053257326497,2.51069948297494e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0456476748923417,0.00539610474582805,0.0350713095905187,0.0562240401941647,2.96215548682531e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASN,Vasorin,39642,-0.0233444015075335,0.00276021840875803,-0.0287544295886993,-0.0179343734263678,2.96960207446596e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.0219371210926004,0.00259996963275234,-0.027033061572795,-0.0168411806124058,3.56927602940351e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,0.0514836104718028,0.00610581702759469,0.0395162090977172,0.0634510118458884,3.68819741743777e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40058,-0.033524127875592,0.00397655204874324,-0.0413181698911287,-0.0257300858600552,3.7298001933268e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,-0.0250062845765366,0.00296657224097754,-0.0308207661688526,-0.0191918029842206,3.82458253891815e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37388,0.0920338283796971,0.0109290466169115,0.0706128970105505,0.113454759748844,4.10465321193157e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37368,0.0337392046679842,0.00400723436098215,0.0258850253204592,0.0415933840155092,4.15630989304702e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RETN,Resistin,39790,0.0345992433938154,0.00411406059571539,0.0265356846262132,0.0426628021614175,4.44376624685925e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40058,0.0421242874873557,0.00500897583484968,0.0323066948510503,0.051941880123661,4.44684195592529e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.0541376385501807,0.00643816640652229,0.041518832393397,0.0667564447069644,4.49413998280776e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,0.0861285245890435,0.0102506084404731,0.0660373320457163,0.106219717132371,4.81050676376453e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,0.0465294137774737,0.00554231132722376,0.0356664835761151,0.0573923439788323,5.11709424858654e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0604046708573736,0.00720092725185907,0.0462908534437298,0.0745184882710174,5.33108455340681e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,0.0828592258571963,0.00987923557381829,0.0634959241325125,0.10222252758188,5.48005696520821e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40058,0.0421615252772107,0.005031515125823,0.0322997556305976,0.0520232949238238,5.74716814813195e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,39788,0.0758539667286142,0.00905969926660517,0.0580969561660681,0.0936109772911603,6.09575157213409e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBN,Nibrin,39587,0.0435116155557001,0.00519838833984615,0.0333227744096017,0.0537004567017986,6.23047878347955e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37437,0.0546926430611245,0.00653475712127507,0.0418845191034254,0.0675007670188237,6.34777165595979e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0341556910006359,0.00408232072328614,0.0261543423829951,0.0421570396182768,6.41634569369601e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0253629366324284,0.00303360954204377,-0.0313088113348342,-0.0194170619300226,6.74373890985609e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0379164226621135,0.00453593564146133,0.0290259888048493,0.0468068565193777,6.83547347193729e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0443483984207408,0.00530954465581847,0.0339416908953366,0.054755105946145,7.32264145379812e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0338960588682681,0.00406420126649624,0.0259302243859355,0.0418618933506007,8.13197676042363e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,0.0509969832106807,0.00611617518254042,0.0390092798529015,0.06298468656846,8.27538156736535e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,0.0526636068633055,0.00631951827145284,0.0402773510512579,0.065049862675353,8.59938712606311e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39477,0.0342602475643983,0.00411352084462069,0.0261977467089418,0.0423227484198549,8.84601583953354e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0273473211299302,0.00328994537762815,0.020899028189779,0.0337956140700813,1.01284609165248e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,39749,0.0814788345035953,0.00980578571758958,0.0622594944971197,0.100698174510071,1.04001848758907e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,0.0439506424203597,0.00529186568056148,0.0335785856864592,0.0543226991542602,1.07348708270483e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,0.063488551663974,0.00764408425067882,0.0485061465326435,0.0784709567953045,1.07349208854398e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0179475531598298,0.00216124530998335,-0.0221835939673972,-0.0137115123522624,1.08539531698231e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,39846,0.0320617122308794,0.0038615454824639,0.0244930830852502,0.0396303413765087,1.09724808060685e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.0787123242786198,0.00948068543474252,0.0601301808265244,0.0972944677307151,1.10261238303731e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,0.0450110280106701,0.00542333274389562,0.0343812958326346,0.0556407601887055,1.1477772366378e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0250663272697795,0.00302686842712307,0.0191336651526183,0.0309989893869407,1.31409608623452e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,-0.0279749560824083,0.00338064666624668,-0.0346010235482518,-0.0213488886165648,1.38339821807723e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,0.0314354828742586,0.00379971168552044,0.0239880479706386,0.0388829177778787,1.40919170127167e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0523504017011123,0.00632905400116348,0.0399454558588319,0.0647553475433927,1.44984013584672e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.0707332713941869,0.00856539763070966,0.053945092037996,0.0875214507503778,1.61726276079758e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0472181686312423,0.00573011014000052,0.0359871527568413,0.0584491845056433,1.84864053331815e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37382,0.056516103079363,0.00686146631322888,0.0430676291054344,0.0699645770532916,1.93112738281107e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0469597575071288,0.00570525451400011,0.0357774586596886,0.058142056354569,2.00152602669296e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,-0.0205387665865741,0.00249783394122677,-0.0254345211113786,-0.0156430120617696,2.14046834292413e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,0.0265980185604039,0.00323871574630959,0.0202501356976371,0.0329459014231707,2.36616717333362e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0258572058386294,0.00315266617720291,0.0196779801313117,0.0320364315459471,2.58258198405461e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,0.051505882169682,0.00628321070039025,0.0391907891969171,0.0638209751424469,2.68240835657418e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0305656858959051,0.00373387506378035,0.0232472907708957,0.0378840810209146,2.9009862869757e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40009,0.018247185833715,0.00223310875063703,0.0138702926824664,0.0226240789849636,3.27753387584778e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,37453,0.0342064042110036,0.00419439680948863,0.0259853864644059,0.0424274219576013,3.78771784516211e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37056,0.0345861996479256,0.00424151762034804,0.0262728251120434,0.0428995741838077,3.83042943970601e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,0.0535020548009032,0.00657115957554823,0.0406225820328287,0.0663815275689777,4.17254790536708e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0305077681979731,0.00374922901613481,0.0231592793263489,0.0378562570695973,4.39993019722161e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.0402853704906532,0.00495703760004305,0.0305695767945688,0.0500011641867376,4.72234208236542e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37368,0.0527008109215752,0.00648516960964814,0.0399898784866648,0.0654117433564856,4.80602996160476e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.0600837329306027,0.00739809999027459,0.0455834569496645,0.0745840089115408,4.9371401072727e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,0.034127423018625,0.00420385090955666,0.025887875235894,0.0423669708013561,5.14920136399633e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,0.0322410074529458,0.00398067055027759,0.0244388931744017,0.0400431217314899,5.92860953427349e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,-0.033201735492567,0.00410223026821499,-0.0412421068182684,-0.0251613641668656,6.20868383199751e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,0.0568891490090259,0.00702803928466774,0.0431141920110771,0.0706641060069746,6.24324295488435e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,-0.0196144838312684,0.00242390263682554,-0.0243653329994465,-0.0148636346630904,6.27970109987782e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,39858,-0.0374675261844349,0.00463153988616011,-0.0465453443613087,-0.0283897080075611,6.40974161482148e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,0.0246552640709687,0.00304848201355915,0.0186802393243928,0.0306302888175447,6.59102992505584e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,-0.031815757402849,0.00394470437633216,-0.0395473779804601,-0.024084136825238,7.8198890927083e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,0.0472348102259603,0.00585672365540039,0.0357556318613755,0.058713988590545,7.84742332540069e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40052,-0.0233683688953659,0.00289869475175366,-0.0290498106088031,-0.0176869271819288,8.04656421371421e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.0921893538090733,0.0114384734150525,0.0697699459155705,0.114608761702576,8.1918774350863e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0306864224105024,0.00381237543040662,0.0232141665669054,0.0381586782540994,9.02902489245961e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0554712071081983,0.00689422387244533,0.0419585283182054,0.0689838858981911,9.27448867803727e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,39908,0.0209213708421446,0.00260177377397071,0.015821894245162,0.0260208474391272,9.51271066443838e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,0.018223106588414,0.00226684135447802,0.0137800975336371,0.0226661156431909,9.8028322953294e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37368,0.0292711003329489,0.00364937965441068,0.022118316210304,0.0364238844555939,1.13623207940941e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.0820886562388455,0.0102514059162668,0.0619959006429626,0.102181411834728,1.25002740850783e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0327398497210767,0.0040954416723722,0.0247127840432272,0.0407669153989262,1.4091894360725e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37411,0.0540173295206042,0.00676318332038735,0.040761490212645,0.0672731688285634,1.49393224507636e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,-0.0241771013690615,0.00303771617413714,-0.0301310250703703,-0.0182231776677527,1.84888456293658e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,0.0333932236515866,0.00420536938459285,0.0251506996577846,0.0416357476453885,2.17293741016595e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,0.0543283369661566,0.00684411549002646,0.0409138706057047,0.0677428033266085,2.18903762938272e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,39881,0.0856680805014271,0.0107962622338151,0.0645074065231495,0.106828754479705,2.24372300318641e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,0.0186467237684962,0.00235008530446606,0.0140405565717427,0.0232528909652497,2.27839525155011e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0361444604022394,0.00456093154544139,-0.0450838862313045,-0.0272050345731743,2.43431685097293e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,0.0399981606084203,0.00505148234825089,0.0300972552058486,0.0498990660109921,2.60356144628367e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37039,0.105592461433318,0.0133620429026064,0.0794028573442094,0.131782065522427,2.95168630063047e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37411,0.0439392041533061,0.00556342306709266,0.0330348949418044,0.0548435133648077,3.05446902672967e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,0.054155463422597,0.00686996013638997,0.0406903415552726,0.0676205852899213,3.44091861704242e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,39808,0.0824293442754653,0.0104630634950673,0.0619217398251333,0.102936948725797,3.5363613995226e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,39686,0.039986396577281,0.00507707076286035,0.0300353378820747,0.0499374552724872,3.60199850876179e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,39868,0.0424168833778476,0.00538889332413008,0.0318546524625526,0.0529791142931425,3.73710387690599e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0518269692677776,0.00659245413019513,0.0389057591725952,0.0647481793629601,4.07976829887493e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,39788,0.0752181450837004,0.00957723200996166,0.0564467703441755,0.0939895198232252,4.29040634696008e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,39789,0.0594860855516579,0.00758295046922217,0.0446235026319824,0.0743486684713334,4.61323686631976e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,0.0532945526794143,0.00680405069522775,0.0399586133167679,0.0666304920420607,5.13687240051251e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,39785,0.0693752700927125,0.0088661748370533,0.0519975674120881,0.086752972773337,5.40607177572317e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37124,0.0426918197227979,0.00545945772384382,0.031991282584064,0.0533923568615318,5.6892040539016e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.0851635701721864,0.0109002827263789,0.0637990160284838,0.106528124315889,5.99443986936472e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0189709993891273,0.00242895443875402,0.0142102486891694,0.0237317500890851,6.11945745733382e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37021,0.03103205454091,0.00397315857014214,0.0232446637434314,0.0388194453383886,6.12977463733861e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0516149929779835,0.00661009181077814,0.0386592130288583,0.0645707729271086,6.22399246837165e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.0843991224324755,0.0108125070136837,0.0632066086856555,0.105591636179296,6.34980013724022e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,0.034783727896108,0.00446388819094765,0.0260345070418506,0.0435329487503654,6.98578399483377e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0296323195123918,0.00380357799558762,0.0221773066410401,0.0370873323837435,7.07408975823329e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0266489974948488,0.00342102023661605,0.0199437978310813,0.0333541971586162,7.13275330211227e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,0.015637839780802,0.00200977870718911,0.0116986735147114,0.0195770060468927,7.72265107824587e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0198831863396617,0.00255889883463265,0.0148677446237817,0.0248986280555417,8.30912891786015e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37382,0.0468390053809593,0.00603058110657799,0.0350190664120665,0.0586589443498522,8.61914227544631e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37039,0.0330256499806626,0.00425496109852069,0.0246859262275621,0.0413653737337632,8.99691168527491e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,39776,0.0304478636601317,0.00392770424413986,0.0227495633416176,0.0381461639786458,9.58437304483327e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40030,0.0293100929833348,0.00378183028155868,0.0218977056314798,0.0367224803351898,9.71457649858755e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40052,-0.0238464551324441,0.00307748092030629,-0.0298783177362444,-0.0178145925286438,9.83244006255863e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0762042842206035,0.00983799198228471,0.0569218199353255,0.0954867485058815,1.00563411875092e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,0.0593705349871257,0.00767832495879998,0.0443210180678777,0.0744200519063737,1.13112398267176e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0663540065562512,0.00859977075813197,0.0494984558703125,0.0832095572421898,1.2731146869745e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0467781870822471,0.00607042956079651,0.034880145143086,0.0586762290214083,1.39180076909123e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,0.0360885844046418,0.00469267735491079,0.0268909367890166,0.0452862320202669,1.55387506744973e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0233949006696832,0.00304458443118401,0.0174275151845626,0.0293622861548039,1.62896209975895e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,0.0604950796508421,0.0078825288773434,0.045045323051249,0.0759448362504351,1.7550853075671e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,-0.0184423486930758,0.0024039036753902,-0.0231539998968406,-0.013730697489311,1.79272599782158e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,0.0265851804841802,0.00346575408957753,0.0197923024686083,0.0333780584997522,1.80879454219394e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.0560865925366928,0.00731061592582058,0.0417577853220844,0.0704153997513011,1.81211051022485e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.11460136238321,0.0149405872458739,0.0853178113812974,0.143884913385123,1.83050246549977e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,0.0550205204714456,0.00717890548886533,0.0409498657132696,0.0690911752296217,1.90243397611052e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,0.071663632056321,0.00935078622008045,0.0533360910649633,0.0899911730476787,1.90918252639767e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,0.0703217383277738,0.00917443532844995,0.0523398450840119,0.0883036315715357,1.90990436109468e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,0.0626303743708409,0.00820606611139471,0.0465464847925073,0.0787142639491745,2.43839073322685e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37124,0.0518339647157874,0.00679163984979794,0.0385223506101834,0.0651455788213913,2.46845600892242e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,39868,0.0330574952236448,0.00433528375921485,0.0245603390555837,0.0415546513917059,2.57254963276691e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.038902268046596,0.00510730329781341,0.0288919535828817,0.0489125825103103,2.7449596567062e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,0.0647832825259674,0.00851479334505395,0.0480942875696617,0.0814722774822731,2.93086872215526e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0288413789223369,0.00379284962642344,0.021407393654547,0.0362753641901269,3.02679730516451e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37422,0.0357233324670975,0.00469718774421194,0.0265168444884421,0.0449298204457529,3.03005457424648e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,-0.0249337317838212,0.0032795911747743,-0.0313617304863788,-0.0185057330812636,3.09025531880849e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0384670295466579,0.00506297140242571,0.0285436055979035,0.0483904534954122,3.18385737793662e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,0.032778069721621,0.00431815312526585,0.0243144895961,0.0412416498471421,3.35308611370537e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.051693544664554,0.00681014707227578,0.0383456564028934,0.0650414329262145,3.39413396783424e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0453955015850148,0.00598505058924763,0.0336648024300894,0.0571262007399401,3.51673649348997e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,39858,-0.0240946381651067,0.00318026317352031,-0.0303279539852065,-0.0178613223450069,3.74945421425301e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,0.0487768504909138,0.00644132248870865,0.0361518584130448,0.0614018425687827,3.85889273654877e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39477,0.0746622678094358,0.00986385357080328,0.0553291148106613,0.0939954208082102,3.96216296611203e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,-0.0290590867834898,0.00383914379821184,-0.036583808627985,-0.0215343649389946,3.96328179917943e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37388,0.0352782198144528,0.00466244027622469,0.0261398368730524,0.0444166027558532,4.08232136525492e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40052,0.0414219361193448,0.00548397239102273,0.0306733502329403,0.0521705220057494,4.47059783511118e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.0735366739443175,0.00974546905961297,0.0544355545874761,0.0926377933011589,4.73900817291737e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0585783837676802,0.00777487990372899,0.0433396191563714,0.073817148378989,5.22042714295148e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0498449285799214,0.00661744411235075,0.036874738119714,0.0628151190401289,5.2465208915439e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0379030484645699,0.00503101189007784,0.0280422651600173,0.0477638317691224,5.25305983466723e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,0.0340405082481353,0.00452332834162306,0.0251747846985541,0.0429062317977165,5.53596487448988e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,0.0472765873498017,0.00628588897562575,0.0349562449575753,0.0595969297420282,5.72800868832236e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0272668023886989,0.00362651169089698,0.0201588394745408,0.0343747653028569,5.87880672699231e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.0582191901941156,0.00774465373255386,0.0430396688783101,0.0733987115099212,5.8849243264398e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,0.036495134468475,0.00485798484854193,0.0269734841653328,0.0460167847716171,6.1690677022303e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.042851384219659,0.00571780329326702,0.0316444897648556,0.0540582786744623,7.00946222998073e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",37453,0.0123536375243689,0.00164844732579862,0.00912268076580359,0.0155845942829342,7.08725949477672e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39489,0.0512145284618769,0.0068425420528074,0.0378031460383744,0.0646259108853794,7.55145749099102e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37043,-0.0322728395352543,0.00431172876800868,-0.0407238279205513,-0.0238218511499573,7.61426172062653e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.035369702302069,0.0047286953149093,0.0261014594848467,0.0446379451192912,7.89997121068066e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39477,0.0351269163937402,0.00471474602199888,0.0258860141906223,0.044367818596858,9.78964635597956e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0315096507145342,0.00423219992740347,0.0232145388568234,0.039804762572245,1.01675697403178e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,39866,0.0365971184058742,0.00492960092833385,0.0269351005863399,0.0462591362254086,1.19390698853264e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,39985,0.0536921604149424,0.00723302195405171,0.039515437385001,0.0678688834448837,1.20025750258389e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0257230243200576,0.00347429745246283,0.0189134013132304,0.0325326473268847,1.38948158506175e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,0.0507110430285136,0.00685038562317732,0.0372842872070861,0.0641377988499412,1.40100795251846e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0267830625236208,0.00362061560650426,0.0196866559348725,0.0338794691123692,1.46175895212691e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,39836,0.0672402055075547,0.0090932613900742,0.0494174131830093,0.0850629978321002,1.48965966693548e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,39749,-0.0313095108793955,0.00423497141751907,-0.0396100548577329,-0.0230089669010582,1.50603325196781e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0429700038925715,0.00581434533549285,0.0315738870350055,0.0543661207501375,1.53682880071063e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,-0.0129687768475863,0.00175572646184335,-0.0164100007127993,-0.00952755298237336,1.58113677516366e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,39715,0.0542131743163725,0.00734156267698937,0.0398237114694733,0.0686026371632717,1.60727009645875e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.0781824035298713,0.0105911808500677,0.0574236890637387,0.098941117996004,1.63786281932527e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.0661414732754109,0.00896221012340275,0.0485755414335415,0.0837074051172803,1.66046742302035e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37186,-0.131337624145413,0.017804252073717,-0.166233958209899,-0.0964412900809281,1.71778956932631e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37056,0.0334709280013086,0.00454180949637057,0.0245689813884222,0.0423728746141949,1.81434786963744e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,37453,0.0263849083364201,0.00358207725390177,0.0193640369187726,0.0334057797540676,1.8620740689638e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,37453,0.0229443840658869,0.00311589283493292,0.0168372341094184,0.0290515340223554,1.89219746297112e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,0.0961956282579733,0.0130713668559959,0.0705757492202214,0.121815507295725,1.93865027726796e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,39913,-0.0199645686519955,0.00271662687085541,-0.0252891573188721,-0.0146399799851189,2.09258023556607e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0455639077178884,0.00620555466703968,0.0334010205704907,0.0577267948652862,2.19790267214142e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0455084005589864,0.00620290624737658,0.0333507043141283,0.0576660968038444,2.31463199795085e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0396141599076028,0.00540090449426516,0.0290283870988431,0.0501999327163625,2.35067285097654e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0349311694666989,0.00476512652226919,0.0255915214830512,0.0442708174503465,2.39996367163569e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,0.0597521445868443,0.00815301631506475,0.0437722326093174,0.0757320565643712,2.4323323477787e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37382,0.0504267478384274,0.00688048584387585,0.0369409955844307,0.063912500092424,2.4511619236463e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37021,0.049844186928149,0.00680304897230476,0.0365102109424317,0.0631781629138664,2.49548906590689e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39403,0.0628388288596737,0.00858984018306453,0.0460027421008672,0.0796749156184802,2.68977466970121e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0502838230878582,0.00687284218274311,0.0368130524096817,0.0637545937660347,2.69212942977661e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37388,0.0157979625558372,0.00215983870659041,0.01156467869092,0.0200312464207544,2.730376297352e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,0.0181176008282023,0.00247936736188564,0.0132580407989064,0.0229771608574981,2.87654537624958e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0184785952916998,0.00252982595370485,0.0135201364224383,0.0234370541609613,2.91809078234381e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0411750811352112,0.00564015854639051,0.0301203703842858,0.0522297918861366,3.00769888876484e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0470059138016573,0.00643883180410563,0.0343858034656103,0.0596260241377044,3.03401318578431e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,39858,0.065960482100128,0.00904824580611781,0.0482259203201371,0.0836950438801189,3.24769262457066e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.0657867362646263,0.00902813436339914,0.048091592912364,0.0834818796168886,3.34847507332763e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37039,0.0598279676935961,0.00821052643635104,0.0437353358783481,0.0759205995088442,3.35611113114639e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,-0.0246151219171498,0.00337968157760159,-0.0312392978092489,-0.0179909460250507,3.41131954460965e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37124,0.0424606139987852,0.00582928520121757,0.0310352150043988,0.0538860129931716,3.42308572825602e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,0.0845323792612003,0.0116169707650263,0.0617631165617487,0.107301641960652,3.61084688581881e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0270781163654647,0.00372229200742282,0.019782424030916,0.0343738087000135,3.63884642124872e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0320658171806387,0.00441142750722548,0.0234194192664767,0.0407122150948006,3.830971335892e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0367978363064405,0.00506762377044067,0.0268652937163768,0.0467303788965043,4.00649140964682e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37043,0.0375269286440867,0.00516958162619402,0.0273945486567465,0.047659308631427,4.11253734095876e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,0.0879409937321845,0.0121398104610713,0.0641469652284847,0.111735022235884,4.59106502183932e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.0438000125744625,0.00605457373837874,0.0319330480472401,0.0556669771016848,4.89301508988563e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0351142833080939,0.0048543110530042,0.0255998336442057,0.0446287329719822,4.96197987275736e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,0.0581075662598231,0.00804080075364292,0.042347596782683,0.0738675357369633,5.17783297824108e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.0612304421180471,0.00848138970780152,0.0446069182907561,0.0778539659453381,5.50125388362523e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37388,0.0523801675773553,0.00726136572348509,0.0381478907593245,0.066612444395386,5.74139186354805e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,39931,0.0675972732399755,0.00938743976130674,0.0491978913078143,0.0859966551721367,6.25015210591696e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,0.0668951575597815,0.00928884890105685,0.0486890137137101,0.0851013014058529,6.27092058851235e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.0624133527033082,0.00867607422475192,0.0454082472227945,0.079418458183822,6.64564353522722e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0419563460815974,0.00583640894073359,0.0305169845577595,0.0533957076054352,6.89250808042693e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37357,0.0231840559203126,0.00322806853734713,0.0168570415871122,0.029511070253513,7.22858358065555e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.062071644479966,0.00864711876996348,0.0451232916908375,0.0790199972690944,7.42674945980146e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39477,0.0320139192728069,0.00446177491532366,0.0232688404387725,0.0407589981068413,7.54726757094251e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,0.0496697897431753,0.00692853053917495,0.0360898698863924,0.0632497095999582,7.89221594409766e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,0.0670403367889266,0.00935337372376118,0.0487077242903547,0.0853729492874985,7.97719243365476e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37445,0.0499674491465852,0.00697135210996358,0.0363035990110566,0.0636312992821139,8.02975139988057e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0193503961953698,0.00270027859303345,0.0140578501530242,0.0246429422377153,8.05686579184564e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37124,0.0401299171030014,0.00560236092864719,0.029149289682853,0.0511105445231499,8.3071693763605e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0483862158618053,0.00676155107017749,0.0351335757642574,0.0616388559593532,8.7412280503849e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,0.0650761001922702,0.00909539582485784,0.0472491243755488,0.0829030760089915,8.74194576220004e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37056,0.032733421014082,0.00457789803304881,0.0237607408693064,0.0417061011588577,9.11362871566082e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,0.0491443116818855,0.00687844824345713,0.0356625531247096,0.0626260702390615,9.41030629484264e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C3,Complement C3,36816,0.0333968586746977,0.00467800889244099,0.0242279612455134,0.0425657561038821,9.89391806320193e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,0.0307821287575853,0.00431272222479351,0.0223291931969901,0.0392350643181806,9.91133003510923e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.0792324403507861,0.0111048384025873,0.057466957081715,0.100997923619857,1.00956779407635e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0422672773615644,0.00593111504334206,0.030642291876614,0.0538922628465149,1.08409150298984e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,-0.0438998416230147,0.00616821906398741,-0.05598955098843,-0.0318101322575993,1.15749115557151e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37162,0.0163013969251827,0.00229227052917399,0.0118085466880017,0.0207942471623638,1.20685437535661e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0558710294484952,0.00785916172065845,-0.0712749864209857,-0.0404670724760046,1.21795476559378e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0197770472720799,0.00278572100654683,0.0143170340992481,0.0252370604449117,1.30543799199655e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,36991,0.0284217732717193,0.00400436342355776,0.0205732209615461,0.0362703255818925,1.33365640763907e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37043,0.0291003141204874,0.0041027462424237,0.021058931485337,0.0371416967556379,1.38044504032228e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,39713,-0.0339038488939477,0.00478205015838804,-0.0432766672043883,-0.0245310305835072,1.39958346550064e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37043,0.0498513517479128,0.00703398456276989,0.0360647420048838,0.0636379614909418,1.43798498269063e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,0.0634401041254401,0.00895689433895122,0.0458845912210958,0.0809956170297845,1.48404824980291e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,39858,0.0518947643289799,0.00733084894037722,0.0375263004058405,0.0662632282521192,1.51278402568676e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37382,0.0566230461266127,0.00800310794873785,0.0409369545470865,0.0723091377061388,1.56654972784848e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0385126979102096,0.00544455852460996,0.027841363201974,0.0491840326184451,1.5837102626095e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.0239806397704246,0.00339240171422945,0.0173315324105349,0.0306297471303143,1.62587214375988e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,39866,0.0234374804552821,0.0033163456385874,0.0169374430036508,0.0299375179069133,1.64540762077482e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.0618403087489278,0.00875713653830761,0.0446763211338449,0.0790042963640107,1.72688676632096e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0482586733334256,0.00683608197694001,0.0348599526586232,0.061657394008228,1.74253453103264e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.0748743240893903,0.0106054578276414,0.0540876267472132,0.0956610214315673,1.74813476512693e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37368,0.0232086714884149,0.00328747150746403,0.0167652273337854,0.0296521156430444,1.74970455982893e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,0.0345637005457413,0.0048994915392345,0.0249606971288417,0.0441667039626409,1.80383819995269e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,0.0663080768521946,0.00940178245352778,0.0478805832432802,0.0847355704611091,1.82772093593478e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,-0.0282179747197619,0.00400162743969986,-0.0360611645015736,-0.0203747849379501,1.84050476672113e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37021,0.0336394875343238,0.00476994918876192,0.0242903871243504,0.0429885879442972,1.84669893046473e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0297921216834548,0.00422763070108664,0.0215059655093249,0.0380782778575846,1.90179845056059e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0209623915551292,0.00297874056006154,0.0151240600574086,0.0268007230528498,2.0390020560296e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37388,0.0662399042271153,0.00941162555573062,0.0477931181378833,0.0846866903163473,2.0427512029835e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0391517758670719,0.00556601924460067,0.0282423781476546,0.0500611735864892,2.10490843021257e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40009,-0.0209701989867675,0.00298371672492574,-0.026818283767622,-0.0151221142059131,2.17559498455652e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.0605583837699862,0.00861879694493005,0.0436655417579233,0.0774512257820491,2.20823672800814e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0253531633822049,0.00360914428724254,0.0182792405792095,0.0324270861852003,2.23181317582392e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCN,Decorin,39585,-0.0153719923879971,0.00218865913106295,-0.0196617642848805,-0.0110822204911138,2.2528483942096e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,0.0136666799710082,0.00194678932678819,0.00985097289050337,0.0174823870515131,2.3222459309945e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,39587,0.0568376307584709,0.00810006326429363,0.0409615067604554,0.0727137547564864,2.36042218272808e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37388,0.0268097841704534,0.00382572523184226,0.0193113627160426,0.0343082056248642,2.53619055481481e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37382,0.0695184653769566,0.00992535774196108,0.0500647642027129,0.0889721665512003,2.60277775498286e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0781103562862184,0.0111580951906163,-0.0999802228598263,-0.0562404897126105,2.65576810059306e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40003,0.0426356271386759,0.00609250874422034,0.0306943100000041,0.0545769442773478,2.6977227792574e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0320640589922492,0.0045840789245099,0.0230792643002098,0.0410488536842886,2.78724794063571e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.0556023487667895,0.00795175182572164,0.0400169151883751,0.0711877823452039,2.81026460590374e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0462834435577756,0.00663113451175478,0.0332864199147362,0.0592804672008149,3.07678492001061e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,0.0335438509439196,0.00480933473492796,0.0241175548634608,0.0429701470243784,3.20615567334298e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,39555,0.0266788960667884,0.00382755999079922,0.0191768784848219,0.0341809136487549,3.29071980197547e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,39821,0.0476169531428827,0.00684691101415859,0.0341970075551318,0.0610368987306335,3.67500092586798e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0266202387678599,0.00382922705483688,0.0191149537403797,0.0341255237953402,3.74377528391953e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0262169215443563,0.00377275379690885,0.018822324102415,0.0336115189862976,3.85133201989074e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37039,0.031912863568248,0.00459713221280216,0.0229024844311557,0.0409232427053402,4.04953165248581e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40009,0.0809929815807492,0.0116747334993922,0.0581105039219405,0.103875459239558,4.1437232084044e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37437,0.0593400659754751,0.00855280440008989,0.0425765693512989,0.0761035625996513,4.15468111452826e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37187,0.0175356617555741,0.00253230036403016,0.012572353042075,0.0224989704690732,4.56616534035802e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0425676271420346,0.00615512153776043,0.0305035889280241,0.054631665356045,4.82811680812349e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,39856,-0.043084173727214,0.00623560033919554,-0.0553059503920373,-0.0308623970623908,5.05113628239825e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37388,0.0960410639604164,0.0139024272923275,0.0687923064674544,0.123289821453378,5.1270318542326e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0305125648046718,0.00442044749106289,0.0218484877221885,0.039176641887155,5.33973076891058e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37039,0.0344144143101232,0.00499366900160491,0.0246268230669776,0.0442020055532688,5.76733476059353e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,0.0249050315038518,0.00362053042345008,0.0178087918738896,0.0320012711338139,6.29961026608322e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,-0.0227376510621137,0.00330551413257949,-0.0292164587619694,-0.0162588433622579,6.31080291474602e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40031,-0.0283585398647177,0.00412385249286039,-0.036441290750724,-0.0202757889787113,6.34925081500968e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,0.0334698929254402,0.00487208024320987,0.0239206156487488,0.0430191702021315,6.7129093260119e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0365706969214414,0.0053249679776739,0.0261337596852006,0.0470076341576823,6.81152628700824e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0252533472986964,0.00367862323822964,0.0180432457517663,0.0324634488456265,6.90657400830393e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.045118208776336,0.00658299235336069,0.032215543763749,0.0580208737889229,7.50540249155899e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0373496801749977,0.00545617556259187,0.0266555760723176,0.0480437842776777,7.90063947843928e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,-0.0431453278480269,0.00630972861616202,-0.0555123959357044,-0.0307782597603493,8.3927744907874e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0622716705443091,0.00912945849918253,0.0443779318859113,0.0801654092027069,9.43752360873197e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0396184599665627,0.00581173880376252,0.0282274519111882,0.0510094680219373,9.70219825590938e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,39882,0.0633829657831713,0.00930159327654834,0.0451518429611365,0.081614088605206,9.81636310360974e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,0.0161787442703453,0.00237768427564332,0.0115184830900844,0.0208390054506063,1.05096022454315e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,39858,0.0359961088222683,0.00529333642662953,0.0256211694260744,0.0463710482184621,1.08120519387893e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,0.0388593112725463,0.00572392240922508,0.0276404233504651,0.0500781991946274,1.17799175326864e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,39858,0.0528616697311861,0.00779582797168308,0.0375818469066873,0.0681414925556849,1.2372513405929e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,39788,0.0198970274745332,0.00293482881350243,0.0141447630000685,0.025649291948998,1.24723750944849e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,39908,0.0596131605761954,0.00881644550821433,0.0423329273800954,0.0768933937722955,1.41196258148906e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,-0.0298657358637625,0.00441913206072967,-0.0385272347027926,-0.0212042370247323,1.44458328455577e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.0727656809344801,0.0107830494139342,0.051630904083169,0.0939004577857912,1.55935237808814e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0376955518492778,0.00559150936889167,0.0267361934862501,0.0486549102123055,1.63096945703129e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.0619786068783557,0.00921228309694896,0.0439225320083357,0.0800346817483757,1.79150503721121e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37043,0.0802266597766135,0.0119244128768318,0.0568548105380232,0.103598509015204,1.79195563687291e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0190496545588598,0.00283223648530862,0.0134984710476549,0.0246008380700647,1.80238027900068e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0295083908480087,0.00438797262477798,0.0209079645034438,0.0381088171925735,1.82967870618828e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,39858,0.0177735144771479,0.00264449755757255,0.0125902992643057,0.0229567296899901,1.86652712544956e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.0667817197303615,0.00993984641298944,0.0472996207609022,0.0862638186998208,1.8983876832421e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.083322172196656,0.012402257501216,0.0590137474942726,0.107630596899039,1.90245319474744e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,39908,0.0386077259407914,0.00575787934654333,0.0273222824215664,0.0498931694600163,2.07842230710782e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0460313693698642,0.00687085015564137,0.0325645030648071,0.0594982356749213,2.17616137285374e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,39868,-0.0471277650951905,0.007037145361362,-0.06092057000346,-0.033334960186921,2.19821757108319e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,39771,0.0379500543590872,0.00566690035430015,0.0268429296646589,0.0490571790535155,2.20177900573466e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0206237980169734,0.00308022216807965,0.0145865625675373,0.0266610334664095,2.2338401055844e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37411,-0.0304945649560921,0.00455550168917926,-0.0394233482668835,-0.0215657816453008,2.25684285382739e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,0.0332424526587314,0.00496827006919584,0.0235046433231075,0.0429802619943552,2.30416981203829e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0272734347491264,0.00407885939382879,0.019278870337222,0.0352679991610309,2.3747902236822e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.016781269904594,0.00251933631877655,0.011843370719792,0.0217191690893961,2.80817693392919e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.0505698268234713,0.00759598350341922,0.0356816991567697,0.065457954490173,2.87691529079895e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0419605756229474,0.00631285823648258,0.0295873734794416,0.0543337777664533,3.10880728357147e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0245429381644074,0.00369378461530204,0.0173031203184154,0.0317827560103994,3.16429491726542e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,0.032508920772491,0.00489596052468644,0.0229128381441056,0.0421050034008764,3.24139440502704e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,0.0239968132070973,0.00361422013937176,0.0169129417339287,0.031080684680266,3.24752360149255e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39344,0.0512375720551531,0.00773700588701422,0.0360730405166053,0.066402103593701,3.65042092581588e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELL,L-selectin,37453,-0.0151453268009876,0.00229094852364721,-0.0196355859073362,-0.0106550676946391,3.96136668412488e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,39749,-0.0221134042925592,0.00334989533905019,-0.0286791991570976,-0.0155476094280208,4.20695585320686e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPART,Spartin,37124,0.0522141130162815,0.00791273907602294,0.0367051444272765,0.0677230816052865,4.30415911203543e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37345,0.0590088048671383,0.00894318514718086,0.0414801619786638,0.0765374477556128,4.31758451093869e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.022111970870863,0.00335215541932951,0.0155417462489772,0.0286821954927488,4.34584449048192e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37124,0.0495935351691629,0.00752737861084927,0.0348398730918983,0.0643471972464274,4.61310780167273e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,39793,0.0530706991398229,0.00806680904188815,0.0372597534177222,0.0688816448619237,4.88721663091843e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.0515386447491715,0.00783608590607435,0.0361799163732658,0.0668973731250773,4.94614121232533e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.0630030986840717,0.00958445115583325,0.0442175744186385,0.0817886229495049,5.06870494762778e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37056,0.0328652410830423,0.00499908539966753,0.023067033699694,0.0426634484663907,5.07384534536907e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSG,Basigin,40040,0.0129104206868909,0.00196465902312578,0.0090596890015644,0.0167611523722175,5.13910062191246e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,-0.0265867351565591,0.00404749071613911,-0.0345198169601918,-0.0186536533529265,5.23228693710414e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,39747,0.0151163040501048,0.00230387767100977,0.0106007038149257,0.0196319042852839,5.5010517862219e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,0.0302471502383238,0.00461525162993027,0.0212012570436604,0.0392930434329871,5.78079188427607e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0399349356089381,0.00610097012068885,0.027977034172388,0.0518928370454883,6.10752650361194e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,-0.0288929031650693,0.00441471532632873,-0.0375457452046736,-0.020240061125465,6.14825137212518e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,0.0460499365588021,0.00703720635707907,0.0322570120989271,0.0598428610186771,6.2186474393034e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.063769077179386,0.00975376459705886,0.0446516985691507,0.0828864557896214,6.42973216710254e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,39931,-0.0424278100703225,0.00649438739264408,-0.0551568093599049,-0.0296988107807401,6.64033540721971e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0449024999456217,0.00687727299806594,0.0314230448694124,0.0583819550218309,6.8150640465907e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0188678332486832,0.00289240521887488,0.0131987190196884,0.024536947477678,7.12460194307093e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.0549705184567025,0.00842832222955574,0.0384510068867732,0.0714900300266317,7.13981614220325e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.0568999205262161,0.00872731934737844,0.0397943746053543,0.0740054664470778,7.29756415852672e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0375296562944836,0.00577244515473266,0.0262156637912076,0.0488436487977596,8.19259424041095e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,0.0542831629056088,0.00834889950921233,0.0379193198675527,0.070647005943665,8.21214946761018e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAX,Protein max,39489,0.0692394943986116,0.0106556237424136,0.048354471863481,0.0901245169337422,8.38961701913177e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,39812,0.0312690316260888,0.00481321984451199,0.0218351207308453,0.0407029425213323,8.46498073606302e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,0.0245598030123198,0.00378139444443613,0.0171482699012249,0.0319713361234146,8.5533896861485e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0345348441481053,0.00531854582241944,0.0241104943361631,0.0449591939600474,8.6501160540419e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,0.0585803079923182,0.00903163795210105,0.0408782976062001,0.0762823183784363,9.06647177994909e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37382,0.0680560079642349,0.0104913446114205,0.0474929725258508,0.088619043402619,9.06865103032071e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0421986554965685,0.00650764888443481,0.0294436636830763,0.0549536473100607,9.17156368711985e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,39858,0.0162210082559452,0.00250178234914464,0.0113175148516217,0.0211245016602687,9.20721658876317e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0389741050445245,0.00601638111681198,0.027181998055573,0.050766212033476,9.61575298737337e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,0.0216539074042972,0.00334353891361718,0.0151005711336076,0.0282072436749869,9.67116875126567e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,39788,0.0353941881492089,0.00546995062522474,0.0246730849237684,0.0461152913746494,1.00423761002589e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37124,0.01897051365281,0.00293162820754162,0.0132245223660284,0.0247165049395915,1.00789701266285e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.0764251431161234,0.0118215586934609,0.0532548880769401,0.0995953981553068,1.04316695653516e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,0.029731266900334,0.00460216698967183,0.0207110196005772,0.0387515142000908,1.07515962917319e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,0.0347130550607641,0.00537349381082776,0.0241810071915417,0.0452451029299865,1.07659053509269e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37021,0.0389924707171352,0.00604097320909798,0.0271521632273032,0.0508327782069673,1.12260450093258e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0165914904013066,0.00257331101314303,-0.021635179987067,-0.0115478008155463,1.1753185084421e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,-0.0186196278704335,0.00288896276189875,-0.024281994883755,-0.0129572608571119,1.18795506886803e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,39788,0.03855618476586,0.00598914779870308,0.026817455080402,0.0502949144513181,1.24787313656177e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0324631436357979,0.00505444855893167,0.0225564244602918,0.042369862811304,1.38440705256099e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,-0.0165704257270172,0.00258056816727183,-0.02162833933487,-0.0115125121191644,1.38983843018433e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37411,0.049849612409119,0.0077700285306061,0.034620356489131,0.0650788683291069,1.44904336910134e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.0640100277645434,0.0100039207273589,0.0444023431389199,0.0836177123901669,1.62066633564207e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0469874067043156,0.00734543442055372,0.0325903552400303,0.0613844581686009,1.63050166879362e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37437,0.0197233658926617,0.00308508896330792,0.0136765915245782,0.0257701402607452,1.67843262034981e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39477,0.0243830152923909,0.00381453003664787,0.016906536420561,0.0318594941642207,1.68218789012913e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37340,0.0306061275307566,0.00478821773409534,0.0212212207719297,0.0399910342895834,1.69157692181502e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37124,0.070670056018812,0.011068737053136,0.0489753313946655,0.0923647806429585,1.77508837338484e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,0.0827355015032993,0.0129751113312362,0.0573042832940763,0.108166719712522,1.86172543442923e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,39788,0.0454971373714041,0.00715573855131483,0.031471889810827,0.0595223849319812,2.09780658737643e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40009,0.0222249668113219,0.00349692195199102,0.0153709997854195,0.0290789338372243,2.13207867006257e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNC,Tenascin,39931,-0.0302230157288244,0.00475590842124409,-0.0395445962344628,-0.020901435223186,2.1426770390383e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0231156043970216,0.00363759271090763,-0.0302452861104005,-0.0159859226836426,2.14600199971777e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.050241919858209,0.00791831208088133,0.0347220281796816,0.0657618115367365,2.2945674713243e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0330469899231174,0.00521153530814331,0.0228323807191565,0.0432615991270783,2.3421116118169e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,36991,0.0412899407643605,0.00651383413932366,0.0285228258512862,0.0540570556774349,2.39124460092792e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0349300161589279,0.00551557872568333,0.0241194818565886,0.0457405504612673,2.46925572522059e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,39862,0.0158729631102488,0.00250644834926719,0.0109603243456851,0.0207856018748125,2.47092287305003e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,0.0215735266788716,0.00340631444421396,0.0148971503682122,0.028249902989531,2.47607611241516e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,0.075507973299267,0.0119269500707984,0.052131151160502,0.0988847954380319,2.50355974999374e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0268763888330781,0.00424618791590345,0.0185538605179073,0.0351989171482489,2.53676031137953e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,0.0336778339827379,0.00533168918913246,0.0232277231720383,0.0441279447934375,2.74721018731914e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,39777,0.0180630282742343,0.00286192533066532,0.0124536546261303,0.0236724019223384,2.83665224629612e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0228849188074079,0.00363201911069063,0.0157661613504543,0.0300036762643616,3.0361135790165e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.0590562344302331,0.00938396819839655,0.0406636567613759,0.0774488120990904,3.2060353547e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39405,0.0751685711718734,0.0119554817343914,0.0517358269724662,0.0986013153712805,3.31502999246601e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,0.0635954025193169,0.0101422064170304,0.0437166779419373,0.0834741270966965,3.71137820731561e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37445,0.0394923404494288,0.00630248438386296,0.0271394710570574,0.0518452098418002,3.81246476595012e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,0.0641136582980383,0.0102354125754508,0.0440522496501548,0.0841750669459219,3.85112631187905e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,39985,0.0441601823361952,0.00705217482535962,0.0303379196784904,0.0579824449939001,3.8988306868269e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.0577806932728282,0.00923290481090507,0.0396841998434542,0.0758771867022021,4.01681429413093e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40009,-0.0143530153213518,0.00229540259652252,-0.018852004410536,-0.00985402623216771,4.12920598998453e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0426635703774173,0.00682315879066551,0.0292901791477129,0.0560369616071217,4.15366283824445e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0411284279834625,0.00658343622076478,0.0282248929907636,0.0540319629761615,4.30587963871259e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0160871678057306,0.00257656541215764,0.0110370995979016,0.0211372360135595,4.38227562588543e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,39866,-0.0266555261953335,0.00427139641538996,-0.0350274631694978,-0.0182835892211691,4.47232290958803e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37437,0.03534016791419,0.00567364428317898,0.0242198251191592,0.0464605107092208,4.83794902061609e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.022345496941489,0.00358849232613937,0.0153120519822558,0.0293789419007221,4.87375219102554e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,39858,-0.0120142274514239,0.00193143873517707,-0.0157998473723709,-0.00822860753047681,5.0837299135153e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0186744993779446,0.00300232075289928,0.012789950702262,0.0245590480536271,5.09307613947863e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0207522023216656,0.00333989592232723,0.0142060063139042,0.0272983983294269,5.31101986734652e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,0.0145732651668145,0.00234607469299239,0.00997495876854945,0.0191715715650796,5.36736560051867e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37388,0.0530679681853686,0.00854899393048675,0.0363119400816146,0.0698239962891226,5.54031202398747e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,0.0150841513215505,0.0024311887588656,0.0103190213541739,0.0198492812889271,5.62446951917052e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,0.038928752711407,0.00627447643130416,0.0266307789060508,0.0512267265167631,5.65867761394461e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0250792798565162,0.00404820406098335,0.0171447998969888,0.0330137598160435,5.99065407449088e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37257,-0.067426328096711,0.0108873928607754,-0.0887656181038308,-0.0460870380895911,6.0730328446343e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.0700225693924795,0.0113461762192538,0.0477840640027421,0.092261074782217,6.92812279738912e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0435495791991661,0.00706964313995838,0.0296930786448477,0.0574060797534845,7.4454295430909e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37347,0.0174320111955988,0.00283162305768727,0.0118820300025318,0.0229819923886658,7.66285510904809e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,39857,-0.0364843862408287,0.00592779125005113,-0.0481028570909289,-0.0248659153907285,7.69630774162675e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,0.0372529654872535,0.00605329486644685,0.0253885075490177,0.0491174234254894,7.72813460913403e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37342,0.0600773736673433,0.0097620729752416,0.0409437106358697,0.0792110366988168,7.76139905463992e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0410359555920262,0.00666972345073764,-0.054108613555472,-0.0279632976285804,7.83863726038579e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40009,0.0206334469323984,0.0033576558697794,0.0140524414276307,0.027214452437166,8.17401553953397e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37088,0.0646606133241223,0.0105240860417019,0.0440334046823866,0.085287821965858,8.27466753120517e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,39866,0.0413650416827341,0.00674068430962277,0.0281533004358735,0.0545767829295948,8.62790102837264e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,39913,0.0342448289477718,0.00558173493026966,0.0233046284844433,0.0451850294111003,8.70700295870968e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.0670887403763261,0.0109392063619172,0.0456478959069683,0.0885295848456838,8.87143339076359e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0330787961501193,0.00539773623522045,0.0224992331290872,0.0436583591711514,9.13064159156069e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0313803386081953,0.00512188671267023,0.0213414406513617,0.041419236565029,9.18064526977892e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40058,0.0340659275541644,0.00556377599553514,0.0231609266029156,0.0449709285054133,9.40613498092598e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,39809,0.016945524650458,0.00276780337937409,0.0115206300268848,0.0223704192740312,9.43510226007876e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40030,0.0265493987096841,0.00433894198052838,0.0180450724278485,0.0350537249915197,9.64162229728875e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,0.0298527927216132,0.0048803919301312,0.0202872245385561,0.0394183609046704,9.80445045070131e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37039,0.04224738628809,0.00690745561782728,0.0287087732771485,0.0557859992990314,9.8543535313864e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,37453,0.0340742713487916,0.00557322961302122,0.02315074130727,0.0449978013903132,9.98754484181236e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,39788,-0.0174923926234116,0.00286312172771756,-0.023104111209738,-0.0118806740370851,1.02234594559515e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0344529954561731,0.00565039909502389,0.0233782132299263,0.04552777768242,1.10230252616103e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0240412630293864,0.00394675936544793,-0.0317769113856644,-0.0163056146731085,1.14492248995774e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37388,0.0435540211060977,0.00717456385890241,0.029491875942649,0.0576161662695465,1.30829026456547e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,0.0174107797043399,0.00287071616789672,0.0117841760152623,0.0230373833934175,1.34962195145647e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40058,0.0476510644662149,0.00786126829303208,0.032242978611872,0.0630591503205578,1.37848609920811e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37220,0.0202247181074627,0.00334488336799822,0.0136687467061862,0.0267806895087392,1.5200714927282e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0302466331143868,0.00500268529693955,0.0204413699323853,0.0400518962963883,1.52313108690381e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37073,0.0402195223893617,0.00665962786205227,0.0271666517797392,0.0532723929989841,1.58934033394568e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0351423526409663,0.00582934658843298,0.0237168333276376,0.0465678719542949,1.69124616504571e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37043,0.0552016780096199,0.00915612756883652,0.0372556679747003,0.0731476880445395,1.69455992701265e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,39892,0.022890490188191,0.00379729487423095,0.0154477922346983,0.0303331881416836,1.69529508758999e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37376,0.0387876308359091,0.00644017615368206,0.0261648855746923,0.051410376097126,1.75917928157672e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,-0.00881841249022775,0.00146505759820823,-0.0116899253827159,-0.00594689959773962,1.79855660224695e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,0.0355876528705508,0.0059131025741742,0.0239979718251694,0.0471773339159323,1.80660968425019e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,0.0442144363706039,0.00734946902451222,0.0298094770825599,0.0586193956586478,1.82656950105407e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0274075806628058,0.00455814247362362,-0.0363415399111081,-0.0184736214145035,1.86938400555668e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40030,0.0231020151510448,0.00384627487679899,0.0155633163925188,0.0306407139095709,1.93828690584693e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0427735314273459,0.00713455350403488,-0.0567572562952543,-0.0287898065594376,2.08330452316156e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.0519927859767424,0.00867276461414981,0.0349941673330087,0.068991404620476,2.08721669775717e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,-0.0274324524150597,0.00458213746767383,-0.0364134418517005,-0.018451462978419,2.18535908488574e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,0.0336982402297455,0.00563321346281065,0.0226571418426367,0.0447393386168544,2.2607340944267e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0384410056769169,0.00642720807540453,0.025843677849124,0.0510383335047098,2.26470991803989e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,0.0239862181376361,0.00401054514156906,0.0161255496601607,0.0318468866151114,2.27774867423854e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,0.0177381156064185,0.0029699821421761,0.0119169506077534,0.0235592806050837,2.38841385157763e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,0.0161280396233105,0.00270156196606125,0.0108329781698304,0.0214231010767905,2.43326902078782e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,-0.017211058816,0.0028856034474557,-0.0228668415730132,-0.0115552760589868,2.50600623674358e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,0.0202727578273606,0.00339930811708087,0.0136101139178821,0.0269354017368391,2.52578496286668e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,39788,-0.0459776138374395,0.00772287889649146,-0.0611144564745628,-0.0308407712003163,2.68096568116827e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39456,0.0550659937729348,0.00925338453944332,0.0369293600756259,0.0732026274702437,2.72379028526844e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0304662927351664,0.00512025861218511,0.0204305858552836,0.0405019996150493,2.74697996756903e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.0436245438740571,0.00733774611910587,0.0292425614806096,0.0580065262675046,2.81801323738289e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,0.0428917300406026,0.00721525353390843,0.0287498331141421,0.0570336269670632,2.83983336291605e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0284313203653513,0.00478757026083712,0.0190476826541106,0.037814958076592,2.94757751780398e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F3,Tissue factor,39931,-0.0162874313705407,0.00274416903264085,-0.0216660026745168,-0.0109088600665646,2.99364597752687e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.0589595949927519,0.00993286895034826,0.0394911718500693,0.0784280181354345,2.99561986102975e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,39585,0.0507490638992917,0.0085518412579029,0.033987455033802,0.0675106727647814,3.01329322131855e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0196728555640862,0.00331736277118395,0.0131708245325657,0.0261748865956068,3.08662802039614e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.030611659966842,0.00516785252030305,0.020482669027048,0.040740650906636,3.22868626065151e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37437,0.0320769539953958,0.00542496490970328,0.0214440227723774,0.0427098852184142,3.44335188720329e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0261627133570308,0.00443046787301644,0.0174789963259185,0.034846430388143,3.60723350082829e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,39858,0.0383670352140376,0.0065063886395247,0.0256145134805692,0.051119556947506,3.78025892773985e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,39913,0.0375431983017977,0.00637489980186576,0.0250483946901408,0.0500380019134546,3.95767206541841e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0376882497073766,0.0064047448323048,0.0251349498360592,0.050241549578694,4.07423537330977e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,39615,0.0444781401513808,0.007559202356837,0.0296621035319803,0.0592941767707814,4.0865659415577e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40058,0.0381984549206476,0.00650455510495083,0.0254495269149439,0.0509473829263512,4.37488043075626e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,36962,0.0335399739828204,0.00571932993414374,0.0223300873118987,0.0447498606537422,4.61852900739597e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0214435964079758,0.00367026447522222,0.0142498780365403,0.0286373147794114,5.26295518731488e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,39715,0.0416199858816844,0.00712894612166289,0.0276472514832252,0.0555927202801437,5.3809242067287e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37169,0.0319795550011619,0.00547818818002853,0.021242306168306,0.0427168038340178,5.41874806184597e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.0559697512400827,0.00959098519027458,0.0371714202671445,0.0747680822130209,5.48058717478004e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0333098350529898,0.00571861149366034,0.0221013565254156,0.0445183135805641,5.82792316161527e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,-0.0519963441798883,0.0089276309951292,-0.0694945009303415,-0.0344981874294351,5.84863294085947e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37368,0.0286960443827556,0.00492948384524312,0.0190342560460791,0.0383578327194321,5.97148154573667e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40052,0.0522153766017365,0.00898700831683822,0.0346008403007336,0.0698299129027395,6.36093361875998e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37287,0.0587625131088882,0.0101170015849541,0.0389331900023782,0.0785918362153983,6.45422484550874e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.047162616911553,0.00813752664898997,0.0312130646795327,0.0631121691435733,6.95939623596389e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,39970,0.0351576661113532,0.0060763716644043,0.0232479776491208,0.0470673545735857,7.34361536859502e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,39901,0.0172105986276115,0.00297493800058246,0.0113797201464699,0.0230414771087532,7.37775880284483e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,0.0342336045364266,0.00591720879917128,0.0226358752900509,0.0458313337828023,7.39245180883933e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40012,-0.0262816132418249,0.00454452865127294,-0.0351888893983199,-0.01737433708533,7.46770262687282e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37056,0.0338461757537404,0.00585651519410781,0.0223674059732891,0.0453249455341917,7.67370076700172e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0434425607728377,0.00752256576044424,0.028698331882367,0.0581867896633084,7.84308509765145e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0281545820436634,0.00487959351318816,0.0185905787578146,0.0377185853295122,8.0838335217215e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,-0.032633497885837,0.00566048150008128,-0.0437280416259963,-0.0215389541456777,8.30752621691832e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,39720,-0.0182036328957574,0.00316352678274417,-0.024404145389936,-0.0120031204015789,8.86485612702841e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37021,0.0229070454339159,0.00398130220658623,0.0151036931090069,0.0307103977588249,8.92782254063736e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40052,-0.0136090330993393,0.00236568811746391,-0.0182457818095685,-0.00897228438911002,8.94286994199045e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37043,0.030213245631259,0.00525615319255958,0.0199111853738422,0.0405153058886757,9.22142010350107e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,0.0379053012088462,0.00659789861110935,0.0249734199310719,0.0508371824866205,9.38687359499589e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,0.0514217146248867,0.00895171375473837,0.0338763556655995,0.0689670735841739,9.42653383869902e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,39868,0.0385170152688216,0.00671112077364188,0.0253632185524835,0.0516708119851597,9.67995203102234e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37382,0.0193331545528722,0.00337006889474917,0.0127278195191638,0.0259384895865805,9.85928854823044e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,0.027099354499007,0.00473163143353873,0.0178253568892711,0.0363733521087429,1.03888855758414e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,0.0135883683091617,0.00237294372651506,0.00893739860519217,0.0182393380131312,1.04418112858582e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,0.0480755470912913,0.00839615837328262,0.0316190766796574,0.0645320175029253,1.05118342554838e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,39750,0.0382096445173394,0.0066753209944816,0.0251260153681555,0.0512932736665234,1.05912181575331e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.0516800616280532,0.00902898593162117,0.0339832492020758,0.0693768740540307,1.06373100631974e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,0.0384795233584212,0.00673079002518277,0.025287174909063,0.0516718718077794,1.1039250580662e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0271511567954274,0.0047567886151377,0.0178278511097575,0.0364744624810973,1.16403612126908e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0207006456250585,0.00362851447608158,0.0135887572519386,0.0278125339981784,1.18854469088527e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0221608159647316,0.0038925467349364,0.0145314243642563,0.029790207565207,1.26927103226349e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,0.0379143352687697,0.00667755394304168,0.024826329540408,0.0510023409971314,1.38785016570979e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0293012533584563,0.0051609196527536,0.0191858508390592,0.0394166558778533,1.39087530641326e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,0.0542745650259557,0.00957033843587784,0.0355167016916352,0.0730324283602763,1.44319220502542e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,39885,-0.0185403281417616,0.00327260645384287,-0.0249546367912937,-0.0121260194922296,1.49281275137574e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,39931,-0.0171821393541704,0.00303679788547267,-0.0231342632096968,-0.0112300154986439,1.5577669675614e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,39891,-0.0159564361387392,0.00282282988029216,-0.0214891827041118,-0.0104236895733666,1.60693929420269e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0162003147852932,0.00286683957656848,0.010581309215219,0.0218193203553674,1.62872192665497e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,-0.0192428487239076,0.00341040730499325,-0.0259272470416943,-0.0125584504061208,1.71057544588315e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,0.0494582236736404,0.00876820396782411,0.0322725438967052,0.0666439034505757,1.72888600110142e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,39908,0.0331662653554175,0.00589884943140772,0.0216045204698584,0.0447280102409767,1.9135146485189e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0475119532533463,0.00845321521197677,0.0309436514378718,0.0640802550688207,1.93484757231907e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.0419335088185122,0.00746271713510664,0.0273065832337032,0.0565604344033212,1.95880688449804e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39477,0.0328454242722406,0.00584953339833245,0.021380338811509,0.0443105097329722,1.99851725396882e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.0567188781743101,0.010110077230142,0.0369031268032319,0.0765346295453884,2.06257645402951e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37445,0.0521189107266296,0.00929598073567878,0.0338987884846992,0.07033903296856,2.1035158909007e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0165084186484402,0.00294684177856344,0.0107326087624559,0.0222842285344245,2.15318109057794e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,0.0441423904921483,0.00788119201538571,0.0286952541419924,0.0595895268423043,2.16651246770958e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,0.0186844554264569,0.00334235674852476,0.0121334361993484,0.0252354746535654,2.311692621086e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.0480576609436972,0.008602925920506,0.0311959261395054,0.0649193957478889,2.35966399630298e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.0433188158571576,0.00777267062662441,0.0280843814289738,0.0585532502853415,2.54207286964689e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,0.067453878641859,0.0121138224591669,0.0437107866218918,0.0911969706618261,2.62175312408912e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,0.0388154019741808,0.00698891372264373,0.0251171310777991,0.0525136728705625,2.84699929975781e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,39563,0.0276807575410208,0.00498496053148826,0.0179102348993038,0.0374512801827378,2.85600035405515e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37382,0.0189075163836853,0.00340544129463491,0.0122328514462009,0.0255821813211698,2.87496090147805e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0237337766149287,0.00427501587778048,0.015354745494479,0.0321128077353784,2.88272099770272e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0343609499569442,0.00621014951651427,0.0221890569045762,0.0465328430093121,3.20619874624286e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,-0.0149069516426825,0.00269473003050761,-0.0201886225024774,-0.00962528078288756,3.22828184490538e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,0.0206011808204181,0.00372607060226179,0.013298082439985,0.0279042792008513,3.27320825899755e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,0.0489585970718049,0.00886649301901383,0.0315802707545378,0.066336923389072,3.41981158029706e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,39868,0.0132750466882786,0.00241350238174615,0.00854458202005611,0.018005511356501,3.84901791033228e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.0554757895080405,0.0101020840283639,0.0356757048124473,0.0752758742036338,4.05667679818618e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,-0.0605016171951519,0.0110299023513972,-0.0821202258038905,-0.0388830085864134,4.2080079041581e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39238,-0.0170744877906105,0.00311475668722439,-0.0231794108975703,-0.0109695646836507,4.27638595381779e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,0.0366482553509259,0.00669047356526361,0.0235349271630092,0.0497615835388426,4.37617397826069e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0290410085709329,0.0053069611922764,0.0186393646340712,0.0394426525077946,4.51204890898663e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0155143091994938,0.00283524240986031,-0.02107138432282,-0.00995723407616758,4.51790917968626e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0231052150390109,0.00423041689414988,0.0148135979264771,0.0313968321515446,4.79945007154922e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,39587,0.0630378166427489,0.0115510199510341,0.0403978175387221,0.0856778157467757,4.90638811437373e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0242127378854514,0.00444822232205327,0.015494222134227,0.0329312536366758,5.30901858442751e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,0.0420248357181,0.00771984822237948,0.0268939332022362,0.0571557382339638,5.30985131511831e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0201049908694661,0.00369361024341791,0.012865514792367,0.0273444669465652,5.32746230072804e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,0.012336775723114,0.00226750563763878,0.00789246467334202,0.016781086772886,5.38586931911247e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,39858,0.0248583830219283,0.00457443260217382,0.0158924951216676,0.033824270922189,5.58478088135555e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGMN,Legumain,39931,0.0196781530293538,0.00362531830178511,0.012572529157855,0.0267837769008526,5.78217579848323e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,39866,0.0375070968381975,0.00691192644505978,0.0239597210058804,0.0510544726705147,5.83276124551769e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,39829,0.0366462824331571,0.00676175880003225,0.0233932351850939,0.0498993296812203,6.05859390854529e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39489,0.0336860362865103,0.00622974745836144,0.0214757312681219,0.0458963413048987,6.49260993420879e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,39931,0.0417058321443803,0.00772470335748958,0.0265654135637007,0.0568462507250599,6.79568791885334e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.037242166098519,0.00689830781894247,0.0237214827733917,0.0507628494236462,6.80911119634532e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.0180017135007121,0.00334489229072532,-0.0245577023905337,-0.0114457246108905,7.47665454085403e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,0.0182970232876969,0.00339960861218818,0.0116337904078081,0.0249602561675858,7.48712255337095e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,0.0419060539738097,0.00779209935280357,0.0266335392423147,0.0571785687053047,7.66004645859487e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,39826,0.0142910557350553,0.00265892846319582,0.00907955594719151,0.0195025555229191,7.77690130027255e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0191021906266084,0.00355861033469726,0.0121273143706017,0.026077066882615,8.10197488607421e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,0.0333883712835677,0.00622263298231043,0.0211920106382393,0.0455847319288961,8.19897867741511e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,39587,0.0263461957148353,0.00491465205754841,0.0167134776820404,0.0359789137476301,8.4049016357267e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,0.0650354101402689,0.0121495870774134,0.0412222194685385,0.0888486008119992,8.8013111245557e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0177030371176384,0.0033148684963697,0.0112058948647538,0.024200179370523,9.42310970195338e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.014244215936749,0.00267347617659475,0.00900420263062332,0.0194842292428747,1.00658115955842e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,-0.0153255577617267,0.00287631491924441,-0.0209631350034457,-0.00968798052000764,1.00817744719433e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,39739,0.0312699891118351,0.00586982805320223,0.0197651261275588,0.0427748520961115,1.01075686276828e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0231558218264111,0.0043506715087642,0.0146285056692333,0.0316831379835889,1.03837461174754e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,0.0434560339483749,0.00816526760379856,0.0274521094449297,0.0594599584518201,1.04280348769274e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,37453,0.014351854166594,0.00269819012863018,0.00906340151447888,0.0196403068187092,1.05953999553624e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,39788,0.0406473520902699,0.0076479501400754,0.0256573698157222,0.0556373343648177,1.08210976308266e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.016862601131439,0.00317486899279589,0.0106398579055591,0.0230853443573189,1.10630602301272e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,0.0266193216848297,0.00501827008159324,0.0167835123249069,0.0364551310447525,1.14832461766195e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,0.0506504068258812,0.00955868628846609,0.0319153817004877,0.0693854319512748,1.18054684207121e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,39617,0.0372467821588025,0.00703663224381762,0.0234549829609199,0.051038581356685,1.21760169616738e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.0599534090374744,0.0113283670464818,0.0377498096263701,0.0821570084485788,1.22391716942279e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0269521266878338,0.00510177941064454,0.0169526390429705,0.0369516143326971,1.29136641356278e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,0.0375438548487167,0.00710719991971344,0.0236137430060784,0.051473966691355,1.29138223642394e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.0512606360270066,0.00971375836132364,0.0322216696388123,0.0702996024152009,1.32946759104386e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,-0.0149692957094568,0.00284164028872033,-0.0205389106753487,-0.00939968074356495,1.39813029396751e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,0.0320494020466903,0.00608356793441242,0.0201256088952419,0.0439731951981386,1.39947300974191e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39477,0.031028880587714,0.00589132959042458,0.0194818745904819,0.0425758865849462,1.40608559984055e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37437,0.0384576090004457,0.00730179856412904,0.0241460838147528,0.0527691341861386,1.40890197920475e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.0435130829877874,0.00829269102924227,0.0272594085704726,0.0597667574051023,1.56431173921572e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,39858,0.0646528312613269,0.0123267552212042,0.0404923910277666,0.0888132714948872,1.58342957734243e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0146995658908661,0.00280277224900696,0.00920613228281245,0.0201929994989197,1.59004306556253e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,36991,0.0292262783929214,0.00558269453990182,0.0182841970947139,0.040168359691129,1.67388315799019e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.0389445256576946,0.00745622507659427,0.0243303245075699,0.0535587268078194,1.78616973170768e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.0594673439862697,0.0113987288278259,0.0371258354837309,0.0818088524888084,1.84151863405462e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,-0.0111399053668704,0.0021382501951861,-0.0153308757494351,-0.00694893498430559,1.91853235147016e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,0.0477625809944823,0.00917378325124936,0.0297819658220335,0.065743196166931,1.95333515073405e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0118906030174781,0.00228429741880444,0.00741338007662143,0.0163678259583348,1.96050088129315e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,-0.0756125053955651,0.0145408049404711,-0.104112483078888,-0.0471125277122418,2.02158724499768e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0455026412813279,0.00875100356290974,0.0283506742980248,0.062654608264631,2.02588508369231e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.0461769005696447,0.00890497602007984,0.0287231475702882,0.0636306535690012,2.18513306002576e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,39868,0.0363260227365881,0.00700748902886688,0.022591344240009,0.0500607012331672,2.19953678564585e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,39836,0.0463928528789006,0.00895235191535843,0.0288462431247981,0.0639394626330032,2.21956878558767e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,39866,0.0341650203939444,0.00659635481607867,0.0212361649544302,0.0470938758334586,2.25325481748747e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,39931,0.021838965593784,0.00421724197344663,0.0135731713258286,0.0301047598617394,2.26382827146899e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40058,0.0181844656882887,0.00351428956864137,0.0112964581337516,0.0250724732428258,2.31329509316514e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40030,-0.023749761404261,0.00459488413421611,-0.0327557343073246,-0.0147437885011974,2.38483631751345e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.025682654605163,0.00497492487504609,-0.0354335073602533,-0.0159318018500726,2.47310536291744e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37149,-0.016123672722229,0.00312390419124581,-0.0222465249370708,-0.0100008205073872,2.48664772877192e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,0.0154268263423305,0.00298957523966252,0.00956725887259198,0.0212863938120691,2.50170352946891e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,0.032634627442709,0.00632921534103374,0.0202293653742829,0.0450398895111351,2.55029994490268e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0292343238328393,0.00567221472124615,0.0181167829791968,0.0403518646864817,2.58705474930153e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,39868,0.0174581659562532,0.00338763252219091,0.010818406212759,0.0240979256997474,2.58708409790481e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,0.0264070938360995,0.00512852895891237,0.0163551770766313,0.0364590105955678,2.6547387184924e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,39788,0.0431935473156863,0.00839299803846971,0.0267432711602857,0.059643823471087,2.68719511692938e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0232513185083368,0.00453344743517834,0.0143657615353872,0.0321368754812864,2.94955448259286e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,0.0385202844045431,0.00751177201755499,0.0237972112501353,0.0532433575589509,2.96965888756158e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,0.0394744177065485,0.00771452317911269,0.0243539522754876,0.0545948831376094,3.1423145031711e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0360313566975914,0.00704359144286883,0.0222259174695685,0.0498367959256143,3.17344991055451e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,39858,-0.0246125940556531,0.00481203340373802,-0.0340441795269796,-0.0151810085843266,3.17700671033835e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,39731,-0.0148451114206471,0.00290362390019752,-0.0205362142650342,-0.00915400857625997,3.21423953907704e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,39991,0.0198388815642887,0.00388364069665257,0.0122269457988496,0.0274508173297277,3.28741242302189e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,-0.0175381671793934,0.00343606776441239,-0.0242728599976417,-0.0108034743611451,3.3611048378431e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0238002485252197,0.00466904591879535,0.0146489185243808,0.0329515785260585,3.4901998543693e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0137927938224816,0.00270659190786222,0.00848787368307163,0.0190977139618915,3.50868883439161e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,-0.0131232987351004,0.00257668615921109,-0.0181736036071542,-0.00807299386304669,3.56252875163356e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0372217941138652,0.00730950793551004,0.0228951585602655,0.0515484296674649,3.57940033306928e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,36874,0.0416671612115077,0.00818381115330865,0.0256268913510227,0.0577074310719926,3.60369738448027e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,0.0234370889993476,0.00461051731727524,0.0144004750574881,0.032473702941207,3.75694589849862e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37043,-0.0337301236677589,0.00664084292039236,-0.046746175791728,-0.0207140715437899,3.84219123538983e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37388,0.0140798649301207,0.00277213769902609,0.00864647504002958,0.0195132548202119,3.84346865410661e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0609608948150721,0.0120239012182084,0.0373940484273837,0.0845277412027606,4.03125928832807e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,-0.0155434893496868,0.00307044284223652,-0.0215615573204703,-0.0095254213789032,4.19680754352951e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,39585,0.0205845897956155,0.00406906229574944,0.0126092276959466,0.0285599518952844,4.26646161763229e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,0.0133181330295202,0.00263407323501596,0.00815534948888894,0.0184809165701515,4.32627421171076e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0388913191666763,0.0076958994873117,0.0238073561715454,0.0539752821618073,4.39422864167749e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0314395136616487,0.00622254808292311,0.0192433194191194,0.043635707904178,4.41869128529583e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0241151023652207,0.00477335574095866,0.0147593251129418,0.0334708796174997,4.42844341655399e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0343211546849449,0.00679704084000318,0.0209989546385386,0.0476433547313511,4.49000157980427e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,-0.0217354429335096,0.00430622451142505,-0.0301756429759027,-0.0132952428911165,4.52643285119659e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,0.0394991368713823,0.0078321196292495,0.0241481823980533,0.0548500913447113,4.63834808017244e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,0.0313778561133366,0.00622896606269897,0.0191690826304466,0.0435866295962266,4.77948114325875e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.0512680774647179,0.010188959914852,0.0312977160316079,0.0712384388978279,4.91346214454572e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0146114989086168,0.00290922867585001,0.00890941070395081,0.0203135871132829,5.16625488337197e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.017196352796585,0.00342571910503688,0.0104819433507127,0.0239107622424573,5.23897564101517e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,39749,0.0169504272292613,0.00337829902153531,0.0103289611470521,0.0235718933114705,5.29288357974895e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,-0.0144000643277447,0.00287220478467322,-0.0200295857057043,-0.00877054294978524,5.41026958700385e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,39858,-0.0118963699263167,0.00237646253704752,-0.0165542364989299,-0.00723850335370359,5.61882195837631e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,0.0244352177775066,0.00488645932111124,0.0148577575081286,0.0340126780468846,5.78714909653183e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,0.053374076683665,0.0106745509812029,0.0324519567605073,0.0742961966068227,5.79024763257942e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37138,-0.0107273001423945,0.00214699507552365,-0.0149354104904208,-0.00651918979436813,5.91459845454388e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37021,0.0404827727309699,0.00810894228640162,0.0245892458496227,0.056376299612317,6.04087579745217e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAT,Catalase,37252,0.0266620290207861,0.00535577427972772,0.0161647114325197,0.0371593466090524,6.49819963871033e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.019357855844253,0.00389824985361235,0.0117172861311728,0.0269984255573332,6.9259437810666e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,0.0265093628811814,0.00534208548993696,0.016038875320905,0.0369798504414579,7.03691005519537e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,36654,0.0618797681129487,0.0124869976857592,0.0374052526488607,0.0863542835770367,7.30539875970743e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0212682245632693,0.00430050598279534,0.0128392328369904,0.0296972162895482,7.687664778266e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.037088563790291,0.00751114661217814,0.0223667164304218,0.0518104111501601,7.9946650547478e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,39868,0.0174184735689395,0.00353380547092055,0.0104922148459353,0.0243447322919438,8.34366979820442e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39489,0.0145062549676334,0.00294948379067212,0.00872526673791605,0.0202872431973508,8.82154038313478e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2,Brorin,39684,0.0191172992099659,0.00389116595332933,0.0114906139414404,0.0267439844784914,9.05896828344325e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,37453,-0.0150775012584571,0.00307173527196743,-0.0210981023915132,-0.00905690012540092,9.28575510136966e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40042,0.0160495589661977,0.00327034651576474,0.00963967979529884,0.0224594381370966,9.30939722751842e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,0.0145088375127825,0.00295882113275969,0.00870954809257355,0.0203081269329915,9.50397399864315e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,0.0194912259695312,0.0039758035278883,0.0116986510548701,0.0272838008841923,9.57426502332055e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39419,0.0339709224638741,0.00693943181242446,0.0203696361115222,0.0475722088162261,9.91165659465022e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,0.0238814252287766,0.00489554124505885,0.0142861643884613,0.033476686069092,1.08113715841366e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,39858,0.0189325198993777,0.00388464655219959,0.0113186126570665,0.0265464271416889,1.10588775138788e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,-0.0153514004076669,0.00315656592252349,-0.0215382696158129,-0.00916453119952086,1.16764077155872e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,-0.011964594920393,0.0024605699863533,-0.0167873120936455,-0.00714187774714051,1.16995831230393e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,0.047273847922626,0.00977728831060567,0.0281103628338389,0.0664373330114131,1.345650131902e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,0.0371574917611996,0.00768669289907224,0.022091573679018,0.0522234098433812,1.35326604738408e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.0623639399580965,0.0129026789224275,0.0370746892701385,0.0876531906460544,1.35685437398411e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39455,0.0424842324894757,0.00879531088761686,0.0252454231497467,0.0597230418292048,1.37603378928063e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0296969083386191,0.00615449279442573,0.0176341024615446,0.0417597142156935,1.41390718331338e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,0.0171618338838878,0.00355757516418292,0.0101889865620893,0.0241346812056864,1.4224832829844e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,0.0344141521928223,0.00713610185386743,0.0204273925592421,0.0484009118264025,1.4332656448811e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37388,0.0320041007986707,0.00664105378936278,0.0189876353715197,0.0450205662258217,1.45751301073825e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,39788,-0.0141646465335185,0.00294013644275378,-0.0199273139613159,-0.00840197910572107,1.46571564365319e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.0462226314972055,0.00959834204235268,0.0274098810941943,0.0650353819002168,1.48040996686322e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0165376717118692,0.00343504367545442,0.00980498610797854,0.0232703573157599,1.4899895219846e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.016210565263176,0.00336752068448179,0.00961022472159171,0.0228109058047603,1.49424580663417e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0248315706971567,0.00516567714615389,0.0147068434906951,0.0349562979036183,1.5483792890051e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39489,0.0324746450948692,0.00676009377768016,0.019224861290616,0.0457244288991223,1.57068099005898e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37437,0.0323208161748592,0.00674819515319266,0.0190943536746015,0.0455472786751168,1.68921955957705e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,0.0179950583090818,0.003757662287879,0.0106300402248389,0.0253600763933246,1.6923783910991e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0189674043548869,0.00396203736386403,0.0112018111217134,0.0267329975880604,1.70546029261678e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0185223135433907,0.00387521107199824,0.0109268998422742,0.0261177272445073,1.77161999047682e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,37453,0.0351108674795677,0.00734666753663365,0.0207113991077657,0.0495103358513696,1.77874944829184e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,0.0201090997322163,0.00421355362844401,0.011850534620466,0.0283676648439665,1.83609354787162e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0228012084012676,0.00477750177891838,0.0134373049145876,0.0321651118879476,1.83741915214859e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,0.0586186314468271,0.0123009091539482,0.0345088495050885,0.0827284133885656,1.90503387973402e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39434,-0.0436752574538472,0.00917200030316436,-0.0616523780480493,-0.0256981368596451,1.93598117055305e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0158953734307112,0.00334382348385146,0.00934147940236235,0.0224492674590601,2.01510627906887e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,39718,0.0217535400009778,0.00457910454736335,0.0127784950881457,0.03072858491381,2.04580372178314e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.0188208901500441,0.00396474395379389,0.0110499920006081,0.0265917882994801,2.08192566875149e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,-0.0134886017118434,0.00284308185549144,-0.0190610421486066,-0.00791616127508017,2.10966036862245e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37037,0.0205583876839565,0.00433435034798069,0.0120630610019143,0.0290537143659986,2.12647510820701e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0195042244971571,0.00411605024735943,0.0114367660123326,0.0275716829819816,2.17417325420195e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,36991,0.0208209166033286,0.00440311455092756,0.0121908120835106,0.0294510211231467,2.28335008036105e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.0490390286007006,0.0103954014199437,0.028664041817611,0.0694140153837903,2.41356397288956e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,0.028520648063311,0.00604727266970073,0.0166679936306976,0.0403733024959245,2.42595820111925e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.029375932417117,0.00623652648203427,0.0171523405123299,0.0415995243219042,2.49872738508666e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37382,0.0398530853718689,0.00846219052294385,0.023267191946899,0.0564389787968389,2.5073563654813e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,-0.0145399741878362,0.00310609021447595,-0.0206279110082091,-0.00845203736746338,2.87653976170723e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.017973064132776,0.00384471553945216,0.0104374216754498,0.0255087065901023,2.97156393589049e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,0.0248189139233014,0.00531023543622472,0.0144108524683009,0.0352269753783018,2.98622660791715e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,0.0243529186003367,0.0052122540996716,0.0141369005649804,0.034568936635693,3.0041351570959e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37368,0.0181612501057575,0.00389036700057818,0.0105361307846243,0.0257863694268907,3.0668103324472e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,39585,0.0218992128978573,0.00469310696182895,0.0127007232526726,0.0310977025430421,3.09274626268472e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGN,Mimecan,39858,0.0185982057904108,0.00398574827661518,0.0107861391682451,0.0264102724125766,3.09342253796138e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.0562431835946709,0.0121198507773923,0.032488276070982,0.0799980911183597,3.50177384256897e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40009,0.0140310072493905,0.00302492474471578,0.00810215474974759,0.0199598597490334,3.53760174083567e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,0.0450467687401757,0.00971551032287675,0.0260043685073373,0.0640891689730142,3.57596401821553e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,0.0194931335521331,0.00420654946180271,0.0112482966069998,0.0277379704972664,3.62110291807905e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,0.0225116053146877,0.00486225103900396,0.0129815932782399,0.0320416173511354,3.68788677940294e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,0.022818161657995,0.00493063098992867,0.0131541249177348,0.0324821983982552,3.72939859253536e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,-0.0162132574148146,0.00350486014130156,-0.0230827832917657,-0.00934373153786358,3.75832247720226e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,-0.027330979949841,0.00592166425450423,-0.0389374418886693,-0.0157245180110127,3.95312442995966e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.0142010197564503,0.00308024006008995,-0.0202382902742266,-0.00816374923867403,4.05155480004956e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0306713719462696,0.00666118805730435,0.0176154433539531,0.0437273005385861,4.16659583808735e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.031584557865303,0.00687196179446114,0.0181155127481592,0.0450536029824468,4.34373688103394e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,-0.0195153225121358,0.00424620130621046,-0.0278378770723083,-0.0111927679519633,4.346811965873e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.0126297046158557,0.00274875237626625,0.00724214995837382,0.0180172592733375,4.3728024215507e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,-0.041882425860225,0.00912517083627461,-0.0597677606993232,-0.0239970910211267,4.47850544197985e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0148900906218225,0.00324446099458526,0.00853094707243533,0.0212492341712096,4.48531313951364e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0385290429749694,0.00841355424055181,0.0220384766634878,0.055019609286451,4.69821778984992e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0158321566488759,0.0034592934285928,-0.0226123717689178,-0.00905194152883402,4.76551112065561e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0138644652875358,0.00303448437156469,0.00791687591926901,0.0198120546558026,4.94446931040207e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,0.021057160630529,0.00461456960861831,0.0120126041976371,0.0301017170634209,5.07531862626807e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,39900,0.0231541630536049,0.00507640304237735,0.0132044130905453,0.0331039130166645,5.12543913809809e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,0.0122237490887127,0.00268082905610796,0.00696932413874108,0.0174781740386843,5.16770187931434e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,39866,0.0143610152946864,0.00315165008009385,0.00818378113770246,0.0205382494516703,5.23562569708117e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0223375239805499,0.00490284126582554,0.0127279550995318,0.031947092861568,5.25837737792817e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40058,0.020638859951414,0.00453374466809559,0.0117527204019466,0.0295249995008813,5.34546733393728e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,0.0190468384310168,0.00419641685100862,0.0108218614030399,0.0272718154589937,5.69811354136069e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0317415291428483,0.00699816623790554,0.0180251233165534,0.0454579349691431,5.79091329111767e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI3,Elafin,39594,0.0242369728348414,0.00535307595144555,0.0137449439700081,0.0347290016996747,6.00746301362863e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,0.0402541116175945,0.00890798799111892,0.0227944551550014,0.0577137680801876,6.26114558842625e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,0.0487952081455347,0.0108137028665292,0.0276003505271374,0.069990065763932,6.46537351838565e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0111950686454935,0.0024830434243452,-0.0160618337572101,-0.00632830353377692,6.5813612014347e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37021,-0.0189327818285299,0.00420195445655936,-0.0271686125633863,-0.0106969510936736,6.67217487715481e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0308458541282978,0.00684755135213613,0.0174246534781109,0.0442670547784846,6.70523962973681e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37382,0.0261491999330411,0.00580621010130368,0.0147690281344859,0.0375293717315963,6.73518635706664e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37437,0.0242949182476691,0.00539972037497646,0.0137114663127153,0.034878370182623,6.87463870047851e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0324269167075636,0.00720957228883542,0.0182961550214462,0.046557678393681,6.92462977661542e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0127031963138779,0.00283615366994711,0.00714433512078159,0.0182620575069743,7.56165549862828e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,39587,0.0358160822770391,0.00799749252394365,0.0201409969301095,0.0514911676239686,7.57290273097515e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0200861937325669,0.00448511179071404,0.0112953746227674,0.0288770128423664,7.58320605578773e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0331914869409798,0.00741649814067193,0.0186551505852629,0.0477278232966968,7.68145766380169e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39489,0.0213679495356995,0.00478127622305822,0.0119966481385054,0.0307392509328936,7.91054183317594e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37380,0.0115391091547891,0.00258501123717122,0.00647248712993346,0.0166057311796446,8.11502193448694e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,0.032264815433166,0.00722867983952976,0.0180966029476876,0.0464330279186443,8.13149345769156e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,39788,0.0592377423580034,0.0132764939921883,0.0332158141333144,0.0852596705826925,8.1811376616784e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.017233263351502,0.00386220349084647,0.00966334450944292,0.0248031821935611,8.18535363753706e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39397,-0.0291544092461531,0.00653939458781844,-0.0419716226382773,-0.016337195854029,8.32011188882768e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAYN,Layilin,39713,0.0145296384342016,0.00325938394654791,0.0081412458989677,0.0209180309694355,8.33783831235443e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,39868,0.0253516516838937,0.00569244492115834,0.0141944596384234,0.0365088437293641,8.50293706517396e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39477,0.0364891369207659,0.00819870792862159,0.0204196693806676,0.0525586044608642,8.62250218319522e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39489,0.0319376216869361,0.00718122011928657,0.0178624302531344,0.0460128131207377,8.75231382383573e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,0.0150572708880033,0.00338732166560856,0.00841812042341056,0.0216964213525961,8.85334037799185e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,0.0121102623887986,0.00272798861195731,0.00676340470936229,0.0174571200682349,9.08652197504995e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39480,0.0498575815724138,0.0112354547395489,0.0278360902828979,0.0718790728619297,9.16229764787329e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37445,-0.0107407589634104,0.00242053743319516,-0.0154850123324729,-0.00599650559434785,9.17921246691962e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,0.0308656918968146,0.00696070910448299,0.0172227020520279,0.0445086817416013,9.31305535305061e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37437,-0.0135276625884916,0.00306391732985544,-0.0195329405550083,-0.00752238462197497,1.01718460095094e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0329003933933069,0.00745379298558545,0.0182909591415594,0.0475098276450543,1.02199024958467e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40009,0.0111616840433807,0.00253295292785317,0.00619709630478853,0.0161262717819729,1.05687481276832e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40011,0.0237292551654622,0.00538955560536064,0.0131657261789553,0.0342927841519691,1.07537850635934e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.0393887257539627,0.00895186485379802,0.0218430706405186,0.0569343808674068,1.09066474365939e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,39804,0.0206198139230197,0.00469438056845148,0.0114188280088548,0.0298207998371846,1.12804914846104e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0144968767974316,0.00330103762684389,0.00802684304881759,0.0209669105460457,1.13235169398627e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37043,0.0231366424190992,0.00526827528088007,0.0128108228685743,0.0334624619696241,1.13348705058894e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39489,0.0324768327632955,0.00739753363787001,0.0179776668330703,0.0469759986935207,1.13976995712186e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,-0.0266239163201501,0.00606813787189577,-0.0385174665490658,-0.0147303660912344,1.15532145094323e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,39866,0.0235350566687259,0.00536802441975277,0.0130137288060104,0.0340563845314413,1.17098498944672e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39477,0.0302361689829609,0.006897084294633,0.0167178837654802,0.0437544542004415,1.17331640628476e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,0.035734704432655,0.0081546221064026,0.0197516451041059,0.0517177637612041,1.18263654040765e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0317225599721279,0.0072388109416639,0.0175344905264666,0.0459106294177891,1.18320567364671e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0274372247283876,0.00627449724199279,0.0151392101340817,0.0397352393226935,1.23570275543291e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,39587,0.0190360785238592,0.00435452428998318,0.0105012109154921,0.0275709461322262,1.2415173291116e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,0.017945480848641,0.00410846627342814,0.0098928869527218,0.0259980747445601,1.26221933592127e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0170227545135793,0.00389944292036618,0.00937984638966163,0.0246656626374971,1.27659116095647e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,0.0146496466614907,0.00335791838511581,0.00806812662666376,0.0212311666963177,1.29260940915698e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.0131573210691665,0.00301719577768105,-0.0190710247934214,-0.00724361734491163,1.30583133593174e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.028479263854486,0.00654202954896854,0.0156568859385077,0.0413016417704643,1.34970105639516e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,-0.0113430862307387,0.00260557776668955,-0.0164500186534502,-0.00623615380802715,1.35031223749337e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,0.0287310489034987,0.00661352258500284,0.0157685446368931,0.0416935531701042,1.40591167012814e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,39587,0.0365755566992731,0.00842142034463708,0.0200695728237844,0.0530815405747617,1.41328354397931e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,0.026393183962673,0.00608331962192073,0.0144698775037084,0.0383164904216377,1.4426770302114e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0210492283139179,0.00485722497876853,0.0115290673555316,0.0305693892723042,1.47755736270952e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,39866,0.0172796813130965,0.00399490257046971,0.00944967227497587,0.0251096903512171,1.53154604566709e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,0.024670364635135,0.00571048885158905,0.0134778064860204,0.0358629227842495,1.57012971164374e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,0.0157459029146183,0.00365150706674622,0.00858894906379571,0.0229028567654409,1.62845704323954e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,0.0282366216120563,0.00655311284378143,0.0153925204382447,0.0410807227858679,1.65266307012827e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.0143571815818381,0.00333804945790128,-0.0208997585193247,-0.00781460464435163,1.70979069628552e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0186150205245472,0.00433017538442563,0.010127876771073,0.0271021642780215,1.72875634931815e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39489,0.0223992861496855,0.00521813114480349,0.0121717491058707,0.0326268231935004,1.77666341528679e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40030,-0.0191866281190271,0.00447628642972803,-0.027960149521294,-0.0104131067167601,1.82739615442655e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,0.0550021956417257,0.0128436756780167,0.0298285913128129,0.0801757999706384,1.86160453961464e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37039,0.0189737488796629,0.00443336870966432,0.0102843462087208,0.0276631515506049,1.88417651532235e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0409736111993605,0.0095929233155082,0.0221714815009644,0.0597757408977566,1.95526383400842e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,39587,-0.014252940425798,0.00334593941806333,-0.0208109816852021,-0.00769489916639389,2.05824602988685e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0426119098314284,0.0100036476085381,0.0230047605186938,0.0622190591441631,2.06181583125212e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,39788,-0.0064720401166863,0.0015206404112119,-0.00945249532266162,-0.00349158491071097,2.09187532589533e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,39818,0.0172295131475413,0.00405700369652239,0.0092777859023574,0.0251812403927252,2.18018070769855e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.0517376232507305,0.0121839534405117,0.0278570745073277,0.0756181719941334,2.18478812234126e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0181204531912302,0.0042671446419923,0.00975684969292527,0.0264840566895351,2.1857556593442e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.0086784273226877,0.00204565965913622,-0.0126879202545947,-0.0046689343907807,2.22693324122704e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39489,0.022018064917647,0.00519257228357562,0.0118406232418388,0.0321955065934552,2.24504119971019e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,-0.0100462588599149,0.00236947162105739,-0.0146904232371874,-0.00540209448264245,2.24897174741292e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00865985682152145,0.00204291310237549,-0.0126639665021774,-0.00465574714086549,2.25795151245605e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,39531,0.0254322686345005,0.00600604546241246,0.0136604195281721,0.037204117740829,2.30423385017033e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0279329400413873,0.00661161773441036,0.014974169281943,0.0408917108008316,2.4047148480629e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,-0.0174177873684006,0.00412440914456229,-0.0255016292917427,-0.00933394544505852,2.42298271271484e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,0.0237936838505392,0.00564134865799861,0.0127366404808619,0.0348507272202165,2.48132043420213e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,0.0176139752246624,0.00417688494589766,0.00942728073070298,0.0258006697186218,2.49211304264516e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0316780579665529,0.00752035386002248,0.0169381644009089,0.046417951532197,2.544370271825e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,0.0113729870617262,0.0027003693749845,0.00608026308675657,0.0166657110366958,2.54891916867364e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37056,0.0500970426860155,0.0119080933978047,0.0267571796263183,0.0734369057457126,2.60522832923426e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,-0.0134745930038244,0.00321136372376946,-0.0197688659024126,-0.0071803201052363,2.73228557324981e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39489,0.0332378692980861,0.00792329038267691,0.0177082201480394,0.0487675184481329,2.74427976360898e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,39788,0.0176587784835193,0.0042230330860227,0.00938163363491481,0.0259359233321238,2.91090576467601e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0113870540649965,0.0027256323434635,-0.016729293458185,-0.00604481467180808,2.96242723341714e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0225322426254639,0.00539485758858666,0.0119583217518341,0.0331061634990938,2.97783132723962e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,0.020453434060671,0.00490458487215734,0.0108404477112426,0.0300664204100994,3.06145775464443e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,0.0418433030066111,0.0100446449069612,0.0221557989889671,0.0615308070242551,3.12282071839047e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37056,0.0221148561030074,0.0053125114245076,0.0117023337109725,0.0325273784950423,3.16381466219589e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.0257225740098726,0.00618060458502982,0.0136085890232142,0.0378365589965311,3.17723698851646e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0110151751691358,0.00265402425158818,0.00581328763602293,0.0162170627022486,3.3365210272392e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0111342927560111,0.00268407153789756,0.0058735125417319,0.0163950729702903,3.36686855975686e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0144950174001082,0.0035009341444184,0.00763318647704816,0.0213568483231683,3.48599085339462e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.016203606329459,0.00391441854585907,0.00853134597957525,0.0238758666793428,3.50219750783055e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,0.0230803962027454,0.00557596717158021,0.0121515005464482,0.0340092918590426,3.50537156174235e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,-0.00787650037092373,0.00190669609305695,-0.0116136247133153,-0.00413937602853211,3.63405362524763e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,0.0284978419555378,0.00692244186639234,0.0149298558974088,0.0420658280136668,3.86553795742773e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFP,Properdin,37453,0.00965579549634325,0.00234617396507504,0.00505729452479616,0.0142542964678903,3.88536570534838e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0367483555843907,0.00894155706127657,0.0192229037442886,0.0542738074244928,3.97943861034474e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,-0.020718591281871,0.00504338300091003,-0.0306036219636547,-0.0108335606000873,4.01321900814308e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,0.0114879093751877,0.00279814520193206,0.00600354477940087,0.0169722739709745,4.05366466822583e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.0107758328451777,0.002628969454944,-0.0159286129768679,-0.00562305271348741,4.17643527625349e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,0.0220783267332696,0.00539694589625898,0.011500312776602,0.0326563406899372,4.32268444477758e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,0.0101117075598053,0.00247231064390006,0.00526597869776115,0.0149574364218494,4.33896722556192e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,0.0181683525658515,0.00444723802731094,0.00945176603232207,0.0268849390993809,4.42372796856919e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37021,-0.0130056467672989,0.00318615884551035,-0.0192505181044992,-0.00676077543009861,4.49289099363798e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,39862,-0.00912390594091607,0.0022397558493796,-0.0135138274057001,-0.00473398447613206,4.65117649772159e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,39967,-0.0168400840515289,0.00413694168449293,-0.024948489753135,-0.00873167834992274,4.7103881983642e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,39490,0.0173910708571152,0.00427321248480319,0.00901557438690092,0.0257665673273294,4.72871649065539e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37043,0.0125615670534151,0.00308727941116272,0.00651049940753619,0.018612634699294,4.75282056364318e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,0.0235561396868697,0.00578948285675647,0.012208753287627,0.0349035260861124,4.75349533718427e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,39585,0.0212745947810515,0.00522949765953433,0.0110247793683643,0.0315244101937388,4.7610715765892e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,0.011978337410991,0.00294452053611524,0.00620707716020517,0.0177495976617769,4.76857927420228e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0273327691575316,0.00672098078519143,0.0141596468185564,0.0405058914965068,4.79362164124148e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,39687,0.023579105657995,0.00581353903987588,0.0121845691398383,0.0349736421761517,5.01819506774024e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37056,0.0160616886931279,0.00396482003795559,0.0082906414187349,0.0238327359675208,5.12798810972408e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,0.0128169251056525,0.00316471310903051,0.00661408741195268,0.0190197627993523,5.14675150722114e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2,Complement C2,39908,0.00967820313043209,0.00239042245270442,0.00499297512313143,0.0143634311377327,5.17354560570099e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.024178109595417,0.00597486825561019,-0.035888851376413,-0.012467367814421,5.22062525960576e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.0118366447806983,0.00292628415885502,-0.0175721617320542,-0.0061011278293425,5.26357545723615e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37368,0.0167880128382929,0.00415224990052874,0.00864960303325661,0.0249264226433293,5.30390362277837e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0238503391049956,0.00590456971824937,0.0122773824572269,0.0354232957527644,5.38683060769733e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0197277917936158,0.00490413542313651,0.0101156863642682,0.0293398972229633,5.78594888812383e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0357152652014227,0.00888447415732651,0.0183016958530627,0.0531288345497826,5.85227806746104e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0114158243890147,0.00284397636326538,-0.0169900180610148,-0.00584163071701454,5.99630658025636e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,0.0205361873418236,0.00513090778091688,0.0104796080912265,0.0305927665924207,6.30343067317028e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.00973769661951256,0.00243311485453261,0.00496879150462864,0.0145066017343965,6.30535379896061e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39477,0.0299505980499338,0.00748664817897334,0.0152767676191461,0.0446244284807216,6.34907681088137e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0247514276177823,0.00619301957161369,0.0126131092574195,0.0368897459781452,6.45906015497619e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,0.00749920770982647,0.00187964647659469,0.00381510061570088,0.0111833148039521,6.6506443547725e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,-0.0112695883473751,0.00282540603964859,-0.0168073841850863,-0.00573179250966383,6.68066469404457e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,0.0235998067072303,0.00591821139548375,0.0120001123720822,0.0351995010423785,6.70303193339212e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0192091280184333,0.00482414564378988,0.00975380255660509,0.0286644534802614,6.86770082600422e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37043,0.0122775021537017,0.00309278552757636,0.006215642519652,0.0183393617877513,7.23379028618768e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,0.034904981571907,0.00881911238492008,0.0176195212974637,0.0521904418463504,7.59446875999768e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0234600267954878,0.00592873443228164,0.0118397073082158,0.0350803462827598,7.62260830700231e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,39673,0.0132970520871293,0.00336187459977967,0.00670777787156117,0.0198863263026975,7.67882504230802e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,0.0146584904096877,0.00371185585347715,0.00738325293687252,0.0219337278825029,7.88542095773683e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.02816582207857,0.00714165156208483,0.0141681850168837,0.0421634591402562,8.05126431254359e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,39559,0.0216008713493417,0.00548519356330069,0.0108498919652724,0.0323518507334111,8.25073135926721e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,-0.00920618387071124,0.00233848238824028,-0.0137896093516622,-0.0046227583897603,8.29204246246229e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37368,0.0168293995236195,0.00427962573744844,0.00844133307822055,0.0252174659690184,8.45056819415929e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0194410571475471,0.00494784028556581,0.00974329018783809,0.0291388241072561,8.56526577794544e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,0.0288956068912178,0.00735972727018995,0.0144705414416455,0.0433206723407901,8.66764743757213e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37430,0.0149760058689803,0.00382222044296189,0.00748445380077495,0.0224675579371856,8.96714083798402e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0269244290206047,0.00687583570347613,0.0134477910417915,0.0404010669994179,9.05598527571158e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0164891114705234,0.00421150370214562,-0.0247436587267288,-0.00823456421431797,9.07640498967471e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,0.0341776233086024,0.00873160655830991,0.017063674454315,0.0512915721628898,9.10659298129675e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.021302995066533,0.0054429292361899,0.0106348537636008,0.0319711363694652,9.12009886587828e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,39585,0.0177225023503298,0.00453222656616396,0.00883933828064842,0.0266056664200111,9.25570740212291e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,0.0185875481963544,0.00477232804248081,0.00923378523309198,0.0279413111596167,9.86578298096825e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,0.0259668804476257,0.00667350716250775,0.0128868064091105,0.0390469544861409,0.000100219791788326
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0181652018369884,0.00466913424274073,0.00901369872121656,0.0273167049527602,0.000100522737991816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0173953229523531,0.00449636930915197,0.00858243910641524,0.026208206798291,0.000109909009073387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39421,0.0180682913228256,0.00467338517993797,0.00890845637014713,0.027228126275504,0.000110988866224377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.00528408668589503,0.00136765368321461,0.0026034854667944,0.00796468790499567,0.000112249084908948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,-0.0112651846806943,0.00291636379355939,-0.0169812577160707,-0.00554911164531792,0.000112554024029526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0159073295748038,0.00412200115453763,0.00782820731191002,0.0239864518376975,0.000114334258737972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0109280282158039,0.00284103331630167,0.00535960291585264,0.0164964535157552,0.000120382341118444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37169,-0.0128614306536075,0.00334399801015688,-0.019415666753515,-0.00630719455370005,0.000120560502260138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.02302476227992,0.0059867669249136,0.0112906991070894,0.0347588254527507,0.000120649564730336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,0.0230242914807112,0.00599121335698428,0.011281513301022,0.0347670696604004,0.000122090288952095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37072,0.0170356637011063,0.00443609714402164,0.00834091329882386,0.0257304141033887,0.000123489539903982
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,-0.0103902204807018,0.0027075802204821,-0.0156970777128468,-0.00508336324855694,0.000124788817444478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,-0.013177007621212,0.00343439281476518,-0.0199084175381517,-0.00644559770427222,0.000125238736749597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.0140231498438859,0.0036613093475011,0.00684698352278377,0.0211993161649881,0.000128673874296967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,39749,0.0136705719608877,0.0035699255457343,0.00667351789124847,0.0206676260305269,0.000128964137576721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0118101553098375,0.00308529618694282,-0.0178573358362454,-0.0057629747834296,0.000129850905161616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0216241958865453,0.00565091858785713,0.0105483954543453,0.0326999963187453,0.000130480640513793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37056,0.0165650309919292,0.00433329596464144,0.00807177090123193,0.0250582910826264,0.000132587370325006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0239959838259944,0.0062810542126814,0.0116851175691388,0.0363068500828499,0.000133860209130819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0111757227934405,0.00292649156449093,0.00543979932703827,0.0169116462598427,0.000134595620023759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0194787286017405,0.00510440774346136,0.00947408942455627,0.0294833677789248,0.000136218825096832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,37453,-0.00857301417322755,0.00225207333547702,-0.0129870779107625,-0.0041589504356926,0.00014143984921933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0231380127366237,0.00607878451922971,0.0112235950789334,0.0350524303943139,0.000141568422196194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0155040770156893,0.00407354172988247,0.00751993522511971,0.023488218806259,0.000141848447071789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37382,0.0174522944738252,0.00458617692757214,0.00846338769578384,0.0264412012518666,0.000142192078076926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0160957982213326,0.00423147960264571,0.00780209820014695,0.0243894982425182,0.000143023772457635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39520,0.0343285399366833,0.00903446981346913,0.0166209791022838,0.0520361007710828,0.000145402275959681
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37056,-0.020638939739398,0.00544078608371721,-0.0313028804634837,-0.00997499901531229,0.000149276940332136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37088,-0.0118498960055877,0.00312588262798142,-0.0179766259564313,-0.0057231660547441,0.000150771419969007
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.014550461640298,0.00383997917374234,0.00702410245976302,0.022076820820833,0.000151804689017044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,-0.0241208519562962,0.00636647289138816,-0.036599138823417,-0.0116425650891754,0.000151979071721535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0221195029088802,0.00584008604636573,0.0106729342580034,0.0335660715597571,0.000152722437493147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37437,-0.00877491818572779,0.00231691228172406,-0.0133160662579069,-0.00423377011354863,0.000152929522027809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0100656535458066,0.00265982814455128,-0.0152789167091271,-0.00485239038248613,0.000154813026662811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,0.0169072394459622,0.00446989612166767,0.0081462430474936,0.0256682358444308,0.00015586011434106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37437,0.0378610444771523,0.0100133478334322,0.0182348827236253,0.0574872062306794,0.000156832658068118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,39908,0.0110531841611234,0.00292402266256708,0.00532209974249193,0.0167842685797549,0.000157314378364276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,0.0243562601483076,0.0064566489497473,0.0117012282068029,0.0370112920898123,0.000162347458216855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37021,0.0236682080703907,0.00627978026169419,0.0113598387574701,0.0359765773833113,0.000164648470364321
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,36962,-0.011806328662087,0.00314385061757401,-0.0179682758725321,-0.00564438145164198,0.000173833217427729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37368,0.0249077404789726,0.00663278708397545,0.0119074777943807,0.0379080031635644,0.000173898764609092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,0.0290286130077751,0.00773523434953091,0.0138675536826945,0.0441896723328557,0.000175520149846164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,0.00963253500936883,0.00256703859737123,0.00460113935852123,0.0146639306602164,0.000175768977389998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,0.0276655421783172,0.00737750608483751,0.0132056302520357,0.0421254541045987,0.000177470635986167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0123540496925582,0.00329519954016026,0.00589545859384406,0.0188126407912723,0.000178093115744676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0113783039420682,0.00303655711319965,-0.0173299558839395,-0.00542665200019685,0.000179653646148948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0153489575968682,0.0041026572528201,0.00730774938134084,0.0233901658123956,0.000183781425802101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,39831,0.00998169970814165,0.00267250916645924,0.00474358174188155,0.0152198176744018,0.000188402079707675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,0.0133629416100755,0.00358040790574111,0.00634534211482296,0.0203805411053281,0.000190560339986965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39477,0.0196159633718298,0.00526149567417008,0.00930343185045641,0.0299284948932031,0.000193525395917858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,0.020058542366739,0.00538109719209424,0.00951159187023426,0.0306054928632437,0.00019411778897764
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,0.0427355137317619,0.0114733346216442,0.0202477778733392,0.0652232495901846,0.000196304969575963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37043,0.0106115117071648,0.00285146202610153,0.00502264613600579,0.0162003772783238,0.000198922434242607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,0.00826778399609204,0.00222279714196695,0.00391110159783682,0.0126244663943473,0.000200392375464661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,0.0224310158899252,0.00603219711099898,0.0106079095523672,0.0342541222274832,0.000201047871137502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40030,-0.0225874448824732,0.00607896504775548,-0.034502216376074,-0.0106726733888725,0.000203346318861671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,-0.0186757548247826,0.00502978942180393,-0.0285341420915183,-0.00881736755804687,0.000205488248725593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,0.0197243402475921,0.00532742529786533,0.00928258666377605,0.0301660938314082,0.000214286556157401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LXN,Latexin,39682,-0.0250065247775381,0.00675764563472537,-0.0382515102215998,-0.0117615393334763,0.000215922434610805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,0.0277371908411443,0.00750053211074864,0.013036147904077,0.0424382337782117,0.000217997026348893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0126713882685441,0.00343181521077633,-0.0193977460816657,-0.00594503045542248,0.000223110682957783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0145987667115891,0.0039645528511407,0.00682824312335337,0.0223692902998249,0.000232018711973179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,0.0196285797410907,0.00535314802979098,0.00913640960270036,0.030120749879481,0.00024662625148695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,0.0346798182972288,0.00948323442773414,0.0160926788188699,0.0532669577755878,0.000256033697395944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37021,-0.0135368753846131,0.00370745609300579,-0.0208034893269045,-0.00627026144232179,0.000261971298686306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0127882563983888,0.00350343974076963,0.00592151450648037,0.0196549982902973,0.000262873001422431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,0.0163234981910084,0.00447252738303629,0.00755734452025728,0.0250896518617595,0.000263536386238489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,0.0164002575521712,0.00450290207509017,0.00757456948499442,0.0252259456193479,0.000271377419906292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0102045562567506,0.00280891241066925,-0.0157100245816623,-0.00469908793183886,0.000281285037611353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0180509161446087,0.00497685287276627,-0.0278055477752305,-0.00829628451398677,0.000287652397782427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0197833077183852,0.00545822148075649,0.00908519361610247,0.0304814218206679,0.000290426107790107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,0.0401390034951015,0.0111002131732176,0.0183825856755949,0.0618954213146081,0.000300046395392585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40030,0.00984436213351829,0.00272264830924231,0.00450797144740337,0.0151807528196332,0.000300412604551638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0225206414191397,0.00622867503917957,0.0103124383423477,0.0347288444959316,0.000300527637777588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0128231238179021,0.0035615474748831,0.0058424907671312,0.0198037568686729,0.000318668345267097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.0133847461062715,0.00372067724128682,-0.0206772734991937,-0.00609221871334937,0.000322598312315196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,39585,0.018269096137202,0.00507998001030237,0.00831233531700931,0.0282258569573946,0.000323773320713884
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,39868,0.0279474917286431,0.0077738343020736,0.0127107764965788,0.0431842069607073,0.00032527707329261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37095,0.0517449463416224,0.0144066568875268,0.0235078988420699,0.079981993841175,0.000329669544904799
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,39868,0.0244447880742335,0.00685207561605524,0.0110147198667652,0.0378748562817018,0.000361454273978203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40058,0.0303405474961998,0.00851793497774177,0.0136453949398259,0.0470357000525737,0.000369152098194854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0180668151829198,0.00507713808949208,0.00811562452751533,0.0280180058383243,0.000374307101179829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,37453,0.00930415072196186,0.00262043376704978,0.0041681005385443,0.0144402009053794,0.000385631418039795
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,0.0317707782151291,0.00895977915507488,0.0142096110711824,0.0493319453590759,0.000392549493899863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0168984025998795,0.00476938430622932,0.00755040935967001,0.0262463958400889,0.000396607510755957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.0154991419122666,0.00437794349279224,-0.0240799111581394,-0.00691837266639384,0.00040108044037831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0409452548386111,0.0115867229169874,0.0182352779213158,0.0636552317559064,0.000410985516054634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0300811927138074,0.00853019407093553,0.0133620123347737,0.046800373092841,0.000422586008294254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37169,-0.012063157307967,0.00342139560097425,-0.0187690926858765,-0.00535722193005746,0.000423624942475568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40030,-0.0210255056045643,0.0059737600113938,-0.0327340752268962,-0.00931693598223248,0.000433315062820881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,-0.0097355091452709,0.00277547789414223,-0.0151754458177897,-0.00429557247275214,0.000453255474978511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,39587,0.0234786155544949,0.00671335161808573,0.0103204463830469,0.036636784725943,0.000471287256057837
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37021,-0.0169451981832785,0.00484752574871747,-0.0264463486507647,-0.00744404771579225,0.000474485992605363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37056,0.0113048778501412,0.00325342153338413,0.00492817164470829,0.0176815840555741,0.00051294156476603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0270117369835749,0.00777779415128302,0.0117672604470602,0.0422562135200897,0.00051620304614859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,-0.0111662701355772,0.00321737893757495,-0.0174723328532241,-0.00486020741793027,0.000520669000667961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0171298513438765,0.00493802437385936,0.00745132357111211,0.0268083791166408,0.000523834864376008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,0.0205362150703663,0.00593873703817626,0.00889629047554081,0.0321761396651917,0.000545898767219054
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0215987421268999,0.00625151175567658,0.00934577908577377,0.033851705168026,0.000552049851530529
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,0.0161082713683976,0.00467633596086119,0.00694265288510965,0.0252738898516855,0.000573303187784203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,39587,0.0167073988750931,0.00485070495167693,0.00720001716980636,0.0262147805803799,0.000573982105536115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39489,0.0148690673830999,0.00431864563043021,0.00640452194745668,0.0233336128187431,0.000576821083432907
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,-0.00959696523146765,0.00279436764411773,-0.0150739258139384,-0.00412000464899689,0.000595395798240773
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37124,0.0125960126756098,0.00367208556704405,0.00539872496420348,0.0197933003870161,0.000604957972658816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.0419160440163213,0.012229062402069,0.017947081708266,0.0658850063243765,0.000610527258809451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,0.0187012489370509,0.00545883897689816,0.00800192454233047,0.0294005733317712,0.000614419442218228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0317329904648689,0.009267338193859,0.0135690076049053,0.0498969733248326,0.000618494191492189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0187408879040345,0.00547719988882798,0.00800557612193164,0.0294761996861373,0.000624330660508519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40009,0.0228569140826442,0.00668827040106708,0.00974790409655275,0.0359659240687357,0.000633636510669283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0163705851378296,0.00480806004744058,0.00694678744484611,0.0257943828308132,0.000663741557379994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00925135329667312,0.00272218322328803,0.00391587417902858,0.0145868324143177,0.000679499272120235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0315820549771974,0.00929891041756221,0.0133561905587754,0.0498079193956193,0.000685006638304473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,39868,-0.0130399661639782,0.00384544723206567,-0.020577042738827,-0.00550288958912954,0.000698027992939229
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0144559450552914,0.00426341328564941,0.00609965501541855,0.0228122350951642,0.000698864398886014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,0.0178859822122481,0.00528658860765926,0.00752426854123595,0.0282476958832602,0.000717967660511109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,-0.00922038280242191,0.00272942723277496,-0.0145700601786608,-0.00387070542618298,0.000731517787502752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37021,-0.0147022503724091,0.00435495068837022,-0.0232379537216147,-0.00616654702320346,0.000737645193232842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39489,0.0166428179217069,0.0049438442193939,0.00695288325169483,0.0263327525917189,0.000763474803546144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40009,-0.0105311505929356,0.00312845561104216,-0.0166629235905782,-0.00439937759529293,0.000763764303604218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37382,0.0122517248548857,0.00364201842880786,0.00511336873442229,0.0193900809753491,0.00077036873445361
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.0159379352982167,0.00474005506745979,0.00664742736599556,0.0252284432304379,0.000774549956815976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,0.0204330958519934,0.00608463072929171,0.00850721962258167,0.0323589720814052,0.000786824450164598
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,-0.0140478629720957,0.00418844664278258,-0.0222572183919496,-0.00583850755224188,0.000798859600936139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,39788,0.00993000116759215,0.0029651060428192,0.00411839332366653,0.0157416090115178,0.000813056353846031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,0.0215704633066891,0.00644175677221944,0.00894462003313897,0.0341963065802392,0.000814672630574588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,39858,-0.0114045425901216,0.00340675105122406,-0.0180817746505207,-0.00472731052972239,0.000816936170553911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37289,0.014674905082912,0.00438462993010544,0.00608103041990535,0.0232687797459187,0.000819458522471659
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39173,0.00714710449552416,0.00213737026095055,0.00295785878406108,0.0113363502069872,0.000828143614428077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.0112297626501603,0.00335882438576313,-0.0178130584462561,-0.0046464668540646,0.000829600607138344
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,36962,-0.0120862279022429,0.00361596180313923,-0.0191735130363958,-0.00499894276809002,0.000832701148272415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,-0.00955275423056421,0.00286091042532726,-0.0151601386642056,-0.00394536979692278,0.000842960497926748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,39866,0.0189983131746376,0.00569307351080204,0.00783988909346559,0.0301567372558096,0.000848525745974705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40030,0.02468195994636,0.00741791310831725,0.0101428502540582,0.0392210696386618,0.000878731220617515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0120910488181263,0.003638973724998,0.00495866031713023,0.0192234373191224,0.00089408029473378
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,0.0206624749130351,0.00622282158150838,0.00846574461327866,0.0328592052127915,0.000901227838817727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,0.0186394564834105,0.00561828100386217,0.00762762571584061,0.0296512872509803,0.000910255426610063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37411,0.0171657594241188,0.0051886291937498,0.00699604620436919,0.0273354726438684,0.000940946914364921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,-0.00845400496718593,0.00255975375522598,-0.0134711223274289,-0.003436887606943,0.000959787719631288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,0.0153120156045431,0.00463940904569959,0.00621877387497186,0.0244052573341142,0.000967956713608701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,0.0798687188721736,0.024240172732431,0.0323579803166089,0.127379457427738,0.000987131159411079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37169,-0.0140857532521888,0.00428182084563711,-0.0224781221096376,-0.0056933843947401,0.00100567564649769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37411,-0.0117153105976171,0.00357586554668373,-0.0187240070691172,-0.00470661412611697,0.00105472187564677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,39585,0.0125793965206552,0.00384565308566412,0.00504191647275354,0.0201168765685569,0.00107372439978134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,-0.0360536546804012,0.0110497222109608,-0.0577111102138844,-0.014396199146918,0.00110568114767051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0103804169149572,0.00319246580602679,0.00412318393514468,0.0166376498947697,0.00115021935783192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0101375400859883,0.00312006384637086,-0.0162528652248752,-0.00402221494710146,0.00116042904360926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37388,-0.0121589830682999,0.00375495498884719,-0.0195186948464404,-0.00479927129015936,0.00120611591034756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,-0.0112620555657476,0.00347937615910532,-0.018081632837594,-0.00444247829390118,0.00121123797174803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37382,0.023032721805156,0.00711921037535041,0.00907906946946924,0.0369863741408428,0.00121810691984009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37039,0.0163495384671362,0.00505359319757302,0.00644449579989307,0.0262545811343793,0.00121844401880912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,39749,-0.00401950501803067,0.00124248464075625,-0.00645477491391292,-0.00158423512214842,0.0012186843134854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,-0.0051219034019439,0.00158385316647762,-0.00822625560824002,-0.00201755119564777,0.00122389221089713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,-0.0108370224209953,0.00335175376164169,-0.017406459793813,-0.0042675850481776,0.00122687314258367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.0400910196017938,0.012403162104454,0.0157808218770639,0.0644012173265238,0.00123036924051652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,0.0174286939659665,0.00539855813500734,0.00684752002135207,0.0280098679105808,0.00124742748581656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0170021175417085,0.0052866313311151,0.00664032013272293,0.0273639149506941,0.00130228797742491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0130158797915748,0.00405259644853784,0.00507279075244065,0.020958968830709,0.00132201743369049
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00874461485733204,0.00272442916794453,-0.0140844960265033,-0.00340473368816076,0.00133130137051583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37021,-0.0231089785225488,0.0072066240612249,-0.0372339616825496,-0.008983995362548,0.00134620525403077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0171450833869562,0.00534776665798058,0.00666346073731424,0.0276267060365981,0.00134902471698035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37249,0.01976444988673,0.00617180642185045,0.00766770929990313,0.0318611904735569,0.00136617256548846
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,39703,0.0146933841492047,0.0045925263653303,0.00569203247315729,0.0236947358252521,0.00137979351194729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,0.023684206853065,0.00740338010910538,0.00917358183921844,0.0381948318669115,0.00138170355471373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0118338188456403,0.00370068329422003,0.00458047958896903,0.0190871581023116,0.00138834803993819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0123157599712071,0.00385232607562266,-0.0198663190794275,-0.00476520086298668,0.001392097821959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,0.0316937752170154,0.00993932703286891,0.0122126942325924,0.0511748562014385,0.00143237898532339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCT,Secretin,37039,0.0142963353893646,0.00448761352387092,0.00550061288257761,0.0230920578961516,0.0014472458364526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.0128192602946794,0.00402905269741661,-0.020716203581616,-0.00492231700774289,0.00146694998762905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,0.0242434249639458,0.00762569223615622,0.00929706818107959,0.039189781746812,0.0014803326464725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,-0.0103480106894499,0.00325688550115556,-0.0167315062717148,-0.00396451510718501,0.00149010647356664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39393,-0.0222180965133331,0.00701784563662576,-0.0359730739611196,-0.00846311906554656,0.00154879942294882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,36991,0.0271838501020839,0.00858876078857086,0.010349878956485,0.0440178212476828,0.00155410789639157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRN,Progranulin,39787,0.00788449578960997,0.00249306281095001,0.00299809268014795,0.012770898899072,0.00156674448531099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPS,Colipase,39836,-0.0220973684225204,0.00698849898762126,-0.0357948264382581,-0.00839991040678276,0.00157003003176395
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40002,0.00858697667952259,0.00272032167506877,0.00325514619638779,0.0139188071626574,0.00159911811075448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,0.0149053598831604,0.00472348137466442,0.00564733638881815,0.0241633833775027,0.0016052491213615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSPN,Persephin,39866,0.0300908484243176,0.00953621812265118,0.0113998609039213,0.048781835944714,0.00160559706041705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,0.0271141084724047,0.00861053153002499,0.0102374666735557,0.0439907502712537,0.0016422333766358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0257671361481949,0.00818642665834503,0.00972173989783867,0.0418125323985512,0.00164958134798134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,39791,0.034196762659177,0.0108655379999715,0.0129003081792329,0.0554932171391211,0.00165107454021598
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,0.01996224651213,0.00635847558942457,0.00749963435685781,0.0324248586674021,0.00169618066285418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37056,0.0201551400249613,0.00642084892689112,0.00757027612825475,0.0327400039216679,0.00169890482937385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,-0.0151371046818338,0.00483253160611245,-0.0246088666298142,-0.00566534273385337,0.00173791566396352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.019102827278561,0.00611443676667594,0.00711853121587611,0.0310871233412458,0.00178665644545642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0182548711913502,0.0058464888319148,-0.0297139893019032,-0.00679575308079721,0.00179793243491288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39478,0.0175982210323319,0.00564303651055696,0.00653786947164023,0.0286585725930235,0.00182059504290356
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.0229085725811286,0.00735973535079698,0.0084834912935665,0.0373336538686906,0.00185718014032519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,-0.0182248106139771,0.00585848692586985,-0.029707444988682,-0.00674217623927223,0.00186883092464249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,0.0113990559420733,0.00366781992568878,0.00421012888772331,0.0185879829964233,0.00188853172458772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,0.0132845192755705,0.0042747362242748,0.00490603627599194,0.0216630022751492,0.00188951958103242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0170951863583802,0.00550586605214729,-0.0278866838205889,-0.0063036888961715,0.00190673744774962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0186138669588758,0.00600916508775693,0.00683590338687224,0.0303918305308794,0.00195506047636743
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0281457892505251,0.00909053662046117,0.0103283374744212,0.045963241026629,0.00196450811842389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37382,0.0189279271196472,0.00611462476650156,0.00694326257730412,0.0309125916619903,0.00196871330044085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37169,-0.00911320174633131,0.0029451116285253,-0.0148856205382409,-0.00334078295442172,0.00197654575541852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,0.0151775166970176,0.00491653805354289,0.00554110211207355,0.0248139312819617,0.00202510840279214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40052,-0.00527323881301642,0.00171257280147121,-0.00862988150389999,-0.00191659612213286,0.00207951627049333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,39868,-0.0109841725034559,0.00356784988640187,-0.0179771582808036,-0.00399118672610829,0.00208290337333197
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,36962,-0.0112806767185468,0.00366763544090886,-0.0184692421827281,-0.00409211125436541,0.00210416536603791
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0146056438299307,0.00475084756827842,0.00529398259610496,0.0239173050637564,0.00211344816980264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,39587,-0.0092118576458515,0.00299840965149824,-0.0150887405627881,-0.00333497472891495,0.00212816269283997
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0146724367431938,0.00477908408311209,-0.0240394415460935,-0.00530543194029408,0.0021432084245971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0216879047798192,0.00706641395340531,0.00783773343114474,0.0355380761284936,0.00215091610997193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0230025973285929,0.00749928924787691,0.00830399040275412,0.0377012042544316,0.00216439790538227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,0.0176618679249011,0.00576016065654705,0.00637195303806886,0.0289517828117333,0.00217158062880607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,-0.0114594591845051,0.00373821487100076,-0.0187863603316666,-0.00413255803734359,0.0021774918187357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37021,-0.0168174647526024,0.00549759323475271,-0.0275927474927177,-0.00604218201248706,0.00222479385667766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,39913,0.00876831268694811,0.00287069417251756,0.0031417521088137,0.0143948732650825,0.00225863847062821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,-0.0126413502422317,0.00414623798332624,-0.0207679766895511,-0.00451472379491225,0.00230077107108513
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.00969111109387628,0.00319652445473597,0.00342592316259377,0.0159562990251588,0.00243517717433908
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39477,-0.025735176337188,0.00849147140310575,-0.0423784602872753,-0.00909189238710077,0.00244379937427853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0156778523199073,0.00518268015641973,0.00551979921332463,0.02583590542649,0.00248998509904237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0146523333155117,0.00484680197192216,-0.0241520651804791,-0.00515260145054423,0.00250686960625445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0187014645516687,0.00619003727356136,0.00656899149548844,0.030833937607849,0.00252163018892466
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,-0.0083310279656323,0.0027581540904665,-0.0137370099829466,-0.00292504594831797,0.0025274417849841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0117507030333242,0.00389047376165619,0.00412537446047804,0.0193760316061703,0.00252866909913561
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,37453,0.00640583513345269,0.0021223698631375,0.00224599020170319,0.0105656800652022,0.00254713214655362
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.00739495918242418,0.00245761262982587,0.00257803842796548,0.0122118799368829,0.00262516499973484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,0.00883441404705195,0.00294950207866542,0.00305338997286773,0.0146154381212362,0.00274660898890973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37437,-0.0153743047914265,0.00513505400758569,-0.0254390106462944,-0.00530959893655852,0.00275850167151199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37420,-0.010824966205082,0.00361571338320915,-0.017911764436172,-0.00373816797399208,0.00275962415814426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,0.0102692947518575,0.00343197232440698,0.00354262899601979,0.0169959605076952,0.00277365911833691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLU,Clusterin,37453,-0.00961892870757208,0.0032292137199204,-0.0159481875986161,-0.00328966981652809,0.00289964761914325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,-0.00788028142064415,0.00264735762421228,-0.0130691023641002,-0.00269146047718807,0.00291921032754329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0115193746752134,0.00387338025434861,0.00392754937669011,0.0191111999737367,0.0029439987062123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0214861169690965,0.00723252778471965,0.00731036251104602,0.0356618714271471,0.00297592696129168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,0.0202402921441478,0.00681599038932705,0.00688095098106682,0.0335996333072288,0.0029870517301392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.0092030679008803,0.00309923863558651,0.00312856017513074,0.0152775756266299,0.00298772936543341
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,39984,0.018501588896815,0.00623318255339588,0.00628455109215908,0.0307186267014709,0.00299949404364914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0216233920706724,0.00729287556183832,0.00732935596946933,0.0359174281718755,0.00303217558335441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37411,0.0207994259742505,0.00703463058305443,0.00701155003146382,0.0345873019170372,0.00311467406268495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0140197664127279,0.00474591001666402,0.00471778278006642,0.0233217500453894,0.0031407704411543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0129737576912732,0.0043986428706804,0.00435241766473959,0.0215950977178068,0.00318769738732746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,39558,0.0126075384365009,0.00428143999238416,0.00421591605142793,0.0209991608215738,0.00323746321848092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,-0.00827954449973752,0.00281391750819954,-0.0137948228158086,-0.00276426618366643,0.00326292757244081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,39657,0.0313790190939797,0.010680183651289,0.0104458591374533,0.0523121790505062,0.00330750531452811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37021,-0.0137365135041974,0.00468562533543359,-0.0229203391616472,-0.00455268784674752,0.00337769966971961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,36962,-0.0138237923384161,0.00474232786170299,-0.0231187549473539,-0.0045288297294782,0.0035631331242249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,0.0284098220155339,0.00981023952666839,0.00918175254326383,0.0476378914878039,0.00378651170837331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0121179056051947,0.00418543937595356,0.00391444442832576,0.0203213667820637,0.00379475175289904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0188584217493967,0.00652181665759459,0.00607566110051131,0.0316411823982821,0.00383920053291016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,0.0115093531040894,0.00399645057559855,0.0036763099759162,0.0193423962322625,0.00398341686108089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37368,0.0235029294924945,0.00817134023206983,0.00748710263763768,0.0395187563473514,0.00403042942843503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0148026329263367,0.0051512160812572,-0.0248990164456008,-0.00470624940707263,0.00406447515684793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37021,-0.015115249668058,0.00527288581389126,-0.0254501058632848,-0.0047803934728311,0.00415566443238209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,39952,-0.0114264836361136,0.00398889930815403,-0.0192447262800955,-0.00360824099213165,0.00418115418326509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,-0.0125741735546401,0.00439526971755468,-0.0211889022010473,-0.0039594449082329,0.00423180789030873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,39866,0.0247590715833297,0.00866008009547274,0.00778531459620312,0.0417328285704563,0.00425542859646767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0165788010204772,0.00581831606596922,0.00517490153117753,0.0279827005097769,0.00438555007723919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37021,-0.00978046224296313,0.00343440768918853,-0.0165119013137726,-0.00304902317215362,0.00440925441959534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,35640,0.0291561018724968,0.0102632975541885,0.0090400386662874,0.0492721650787062,0.00450759783585271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_DRA,,39799,-0.0101905963587273,0.00359141005161815,-0.0172297600598989,-0.00315143265755576,0.00455269177806398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,0.0225021278326556,0.00794135949287048,0.00693706322662946,0.0380671924386817,0.00461041352508178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,-0.010386033424741,0.00366567660493662,-0.0175707595704168,-0.00320130727906527,0.00461372367756088
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00936676852394017,0.00331488597548657,0.0028695920119865,0.0158639450358938,0.004725120368201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0191664718105567,0.00678589737683175,0.00586611295196644,0.0324668306691469,0.00474315361945839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,-0.0172655533071782,0.00612271194191907,-0.0292660687133396,-0.0052650379010168,0.00481077046305206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,39815,0.0169467642035365,0.00603122051396272,0.00512557199616959,0.0287679564109034,0.00496264748006376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.0089672139565169,0.00319494421996698,-0.0152293046276522,-0.00270512328538162,0.00501133686596858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.00936474959506742,0.00335100759341154,-0.015932724478154,-0.00279677471198081,0.00520257510043641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0248124912790581,0.00889658275576186,0.00737518907776483,0.0422497934803513,0.00529489706489247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.00861507137727947,0.00309741120989514,-0.0146859973486739,-0.002544145405885,0.00541918100389017
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0824843340079678,0.0297006267633141,0.0242711055518721,0.140697562464063,0.00548946237989558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00972791284003061,0.00351142343077447,-0.0166103027643486,-0.00284552291571264,0.00560727750846721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,-0.0167267567263295,0.00606026855465316,-0.0286048830934496,-0.00484863035920927,0.0057854302571458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00646190583407536,0.002353651901918,0.00184874810631609,0.0110750635618346,0.0060489161723741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,-0.0127369217668249,0.00464444393648909,-0.0218400318823436,-0.00363381165130634,0.00610604899953953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.0156044158784472,0.00569188103476215,-0.026760502706581,-0.00444832905031338,0.00612382583455555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,0.0148964752163534,0.00544529657372597,0.00422369393185051,0.0255692565008563,0.00623363461124589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,39866,-0.0163502646292365,0.00598290793528774,-0.0280767641824005,-0.00462376507607254,0.00628618398528251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0101281544088858,0.00370904738146216,0.00285842154121995,0.0173978872765516,0.0063289258302011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37056,-0.00744503622175856,0.00272646707781713,-0.0127889116942801,-0.00210116074923697,0.00632928568686589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39489,0.0107601279668614,0.00395134278822841,0.0030154961019337,0.0185047598317891,0.00647330317305917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37437,-0.0137765046522921,0.00505929870184835,-0.0236927301079149,-0.00386027919666938,0.00647733721697894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0147291086273572,0.00542195560450693,0.00410207564252357,0.0253561416121907,0.00660467138625466
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,-0.00571631971275442,0.00210575720886488,-0.00984360384212959,-0.00158903558337924,0.00664243497814692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.0119298898427284,0.00439909440037514,-0.0205521148674636,-0.00330766481799308,0.00669838051052302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,0.0161624101818825,0.00596739299989268,0.00446631990209288,0.0278585004616722,0.00676698371930563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,39868,0.00744322443045829,0.00274967670821862,0.0020538580823498,0.0128325907785668,0.006797747125666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,-0.0114825879344384,0.00425427367085455,-0.0198209643293133,-0.00314421153956343,0.00696218217667251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,37453,0.00526974819188628,0.0019606571202836,0.00142686023613043,0.00911263614764212,0.00720237047287345
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.015347243049262,0.00571931331963047,0.00413738894278628,0.0265570971557377,0.00729674562703489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,39585,0.0203657578978812,0.00759596900306757,0.00547765865186881,0.0352538571438937,0.0073451206467502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,0.021508253054299,0.00804576664201459,0.00573855043595037,0.0372779556726476,0.0075213014795556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,0.00772737183114204,0.00289242495344002,0.00205821892239961,0.0133965247398845,0.0075570715206841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,39764,0.0182787991415499,0.00684795217502513,0.00485681287850069,0.0317007854045992,0.00761012413804271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0403001367858333,0.015108161645585,0.0106881399604868,0.0699121336111798,0.0076508121623003
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.00991709198331706,0.00372884759533619,0.00260855069645813,0.017225633270176,0.00783352241814794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37021,-0.00942752164782758,0.0035459266712274,-0.0163775379234333,-0.00247750537222187,0.0078539876565321
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37388,0.0258740389875884,0.00976968217124866,0.00672546193194102,0.0450226160432357,0.00809673271296196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,0.00874028202603567,0.00330295428057093,0.00226649163611666,0.0152140724159547,0.00814828853069638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,0.0253987566011496,0.00960912301756971,0.00656487548671292,0.0442326377155862,0.00822084542541943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37388,-0.00996610635120709,0.00378273472986295,-0.0173802664217385,-0.00255194628067571,0.00843250044991924
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,39725,-0.0130579392233587,0.00496711216962688,-0.0227934790758274,-0.00332239937089004,0.00857492878385227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,-0.00993272723508755,0.00378633129061507,-0.0173539365646931,-0.002511517905482,0.00871799798447878
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,36991,-0.0254784613897141,0.00977431448704812,-0.0446361177843284,-0.00632080499509982,0.00915293899149642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37411,0.0079297394161027,0.00304607237897308,0.00195943755331546,0.0139000412788899,0.0092440665944874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,0.0063970892912395,0.00245804104567099,0.00157932884172436,0.0112148497407546,0.00926462621758227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40058,0.0160379935614205,0.0061635925784054,0.00395735210774594,0.0281186350150951,0.00927519153604996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,0.00949917242524888,0.00365322743488663,0.00233884665287108,0.0166594981976267,0.00932510392221127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,36962,-0.0115902641984678,0.00445821848945478,-0.0203283724377991,-0.00285215595913638,0.00933956938735825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00882086487881746,0.00339472791770149,-0.0154745315975124,-0.00216719816012254,0.009376340665105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0120898306782786,0.00465862106138699,0.00295893339796008,0.0212207279585971,0.00946537859400009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.00958377357790868,0.00369429134837775,0.00234296253508829,0.0168245846207291,0.00948960451744094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37411,0.0163014059119983,0.00629467115531187,0.00396385044758701,0.0286389613764095,0.00961581019451313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37056,-0.00687001860280662,0.00265329964925517,-0.0120704859153467,-0.00166955129026649,0.00962947813067157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37445,-0.00593861184013576,0.00229859290592918,-0.010443853935757,-0.00143336974451456,0.0097882621598848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,36962,0.0191696711878932,0.00742177485235588,0.00462299247727563,0.0337163498985107,0.00980822927076705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00962860756961878,0.00373064770578167,-0.0169406770729509,-0.0023165380662867,0.00986365109412456
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37021,-0.00926266083478331,0.00359328834616098,-0.0163055059932588,-0.00221981567630778,0.00995487090906464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0105664707335151,0.00410545820129752,0.00251977265897196,0.0186131688080582,0.010069090574478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,36991,-0.0124479654359045,0.00485219014152501,-0.0219582581132935,-0.00293767275851545,0.0103157334605772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,36962,-0.0116548327121467,0.00455745755942799,-0.0205874495286256,-0.00272221589566787,0.0105596706710173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0167508821042311,0.00656625842697821,0.00388101558735379,0.0296207486211084,0.0107508467459541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,39885,-0.00817872676054799,0.00321847381568925,-0.0144869354392989,-0.00187051808179705,0.011057193027932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,-0.00850026781531953,0.00335497790381921,-0.0150760245068052,-0.00192451112383387,0.0113003365810801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,36962,-0.0152999389029581,0.00604190559263976,-0.027142073864532,-0.00345780394138412,0.0113431633364876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39315,0.00887200414295645,0.00350956376985211,0.0019932591540463,0.0157507491318666,0.0114829239185774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37056,-0.00880765390497282,0.00348679155227678,-0.0156417653474353,-0.00197354246251033,0.0115483756226333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,-0.00557255341512404,0.0022128882895523,-0.00990981446264656,-0.00123529236760152,0.0118064842823928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0176176681366314,0.00699973992210607,0.00389817788930351,0.0313371583839593,0.011848708948634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.023500408089828,0.00937446041491716,0.00512646567659039,0.0418743505030657,0.0121909150418454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,39868,0.0291529755078423,0.0116481429698931,0.00632261528685187,0.0519833357288327,0.0123313907684942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0138447559036437,0.00553356456695126,0.00299896935241926,0.0246905424548682,0.0123609333446182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,-0.017725130110491,0.00708589224297892,-0.0316134789067297,-0.00383678131425233,0.0123779529976017
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37124,0.00941536517131672,0.00377099528147754,0.00202421441962074,0.0168065159230127,0.012544517439001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37021,0.0152498544051499,0.00610853257699171,0.00327713055424611,0.0272225782560536,0.0125552613538815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,39788,0.0105780176456419,0.00423948783044004,0.00226862149797944,0.0188874137933044,0.0126016080370289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0185615775203072,0.00744098087838779,0.00397725499866718,0.0331459000419473,0.012625023189076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,-0.00951066349521012,0.00382453806422404,-0.0170067581010892,-0.002014568889331,0.0129021989334723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37056,-0.0148135235289345,0.00596457698909225,-0.0265040944275553,-0.00312295263031364,0.0130191123010865
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,36703,-0.0176147787397783,0.00711090869742579,-0.0315521597867328,-0.00367739769282372,0.013256440091166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37106,-0.00908662762591491,0.00367225305823239,-0.0162842436200504,-0.00188901163177942,0.0133584001471686
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0119555354433402,0.0048379454179027,0.00247316242425086,0.0214379084624294,0.0134785767629753
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,0.0158146822318772,0.00639970784893384,0.00327125484796691,0.0283581096157876,0.0134800030441546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0254894252185567,0.0103387862871249,0.00522540409579186,0.0457534463413216,0.0136958566513047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39344,0.0149217013194922,0.0060557262955173,0.00305247778027825,0.0267909248587061,0.0137479160794079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.0129182059886077,0.00525946601173133,-0.0232267593716011,-0.00260965260561431,0.0140550247860893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,0.00682474070685465,0.00278258637569417,0.00137087141049407,0.0122786100032152,0.0141929105569002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,0.00882764807987258,0.00360138818256306,0.00176892724204898,0.0158863689176962,0.0142497820291001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.00761577812200377,0.00311200002027916,0.00151625808225662,0.0137152981617509,0.0144066403369948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,-0.00724198111736278,0.00296174987890269,-0.013047010880012,-0.00143695135471351,0.014491380211235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0349749187585791,0.01430802624574,0.00693118731692871,0.0630186502002295,0.0145192341269035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37021,-0.0122310106391042,0.00501025632827144,-0.0220511130425162,-0.00241090823569214,0.0146518492489648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0151871305233525,0.00622516918124011,-0.0273884621185831,-0.00298579892812189,0.0147153160003933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0136797930390025,0.00560855607777555,0.00268702312656243,0.0246725629514426,0.0147369205744295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0207207068522156,0.00850686240890095,0.00404725653076979,0.0373941571736615,0.0148714855102798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,0.00893766716587491,0.00367010758634954,0.00174425629662981,0.01613107803512,0.0148939415622203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,-0.00867071201636585,0.00356434946967344,-0.0156568369769258,-0.0016845870558059,0.0150008383588325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,0.0113888866127452,0.00468252917455867,0.00221112943061018,0.0205666437948802,0.0150201654427336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37388,0.00933737624922568,0.00385529792584906,0.00178099231456152,0.0168937601838898,0.0154501180200848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,-0.0106487395064027,0.00440272480640177,-0.0192780801269502,-0.00201939888585525,0.0155908135176755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,0.00621089520629451,0.00257003015718255,0.00117363609821672,0.0112481543143723,0.0156766290362652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.0268161952659825,0.011119580353411,0.00502181777329702,0.048610572758668,0.0158957840201068
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0111403580097319,0.00462102350836688,0.00208315193333282,0.020197564086131,0.0159312055988029
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0159139339972857,0.00660201620616586,0.00297398223320065,0.0288538857613708,0.0159432663013564
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,0.00687708807640047,0.002857212901616,0.00127695078923311,0.0124772253635678,0.0161011908004296
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0171356434172347,0.0071394925191521,0.00314223807969658,0.0311290487547728,0.0164030746906774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0102750661326677,0.0042945577872294,0.00185773286969805,0.0186923993956373,0.0167440176426138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0137148006314852,0.00573448894604017,-0.024954398965724,-0.00247520229724652,0.016787528869907
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,0.0187930110172124,0.00788690916816879,0.00333466904760153,0.0342513529868232,0.0171929187231247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,36931,-0.00976931915406336,0.00410388268426565,-0.017812929215224,-0.00172570909290268,0.0173031046827306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,-0.00623824103550053,0.00262803905677414,-0.0113891975867778,-0.00108728448422322,0.0176240102972424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.00878584086097106,0.00370421443338374,0.00152558057153893,0.0160461011504032,0.0177135578735445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,0.0110843686480574,0.00468356962849288,0.00190457217621134,0.0202641651199034,0.0179616567448926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,0.00519608860207883,0.00219608672313987,0.000891758624724692,0.00950041857943297,0.0179900851574298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00883548792479661,0.00373806121425108,-0.0161620879047287,-0.0015088879448645,0.0181100898686666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37149,-0.00767526478434046,0.00325387291684446,-0.0140528557013556,-0.00129767386732532,0.0183480796273507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,39783,0.0172900002661816,0.00733185729451039,0.00291955996894123,0.031660440563422,0.0183757183687166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,-0.0111171261702102,0.00472180077084038,-0.0203718556810574,-0.00186239665936306,0.0185659528295746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0104600258620567,0.00444848037240873,0.00174100433213562,0.0191790473919778,0.0187188949291887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.00745964160106815,0.00317536043585969,0.00123593514678315,0.0136833480553531,0.0188271093580569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,0.00943171978063406,0.0040174397653174,0.00155753784061196,0.0173059017206562,0.018902350711339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.0075888744541863,0.00323629654773328,0.00124573322062908,0.0139320156877435,0.019045230744397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERVV_1,,37021,-0.0114200552750079,0.00488176252527472,-0.0209883098245463,-0.0018518007254694,0.0193332183450064
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.0116801399470545,0.00499955868721357,-0.0214792749739931,-0.00188100492011593,0.0194914059123679
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00776722060093258,0.00333765453866193,-0.01430902349671,-0.00122541770515521,0.0199698401506128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.00873842738512528,0.00375577535615464,0.0013771076870622,0.0160997470831884,0.0199981366265423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,39856,0.00925484709314973,0.00398010848789032,0.00145383445688469,0.0170558597294148,0.0200696991866045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,-0.00661269788642514,0.00284751591496324,-0.0121938290797531,-0.0010315666930972,0.0202309343822876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,-0.0150253400127777,0.00647834682178188,-0.0277228997834701,-0.00232778024208516,0.0203931515776861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.0112577157729893,0.00485553066196349,-0.0207745558704378,-0.00174087567554091,0.0204354884165766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0199110443176502,0.0085944138996527,-0.0367560955609695,-0.00306599307433095,0.0205307378250928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.00484918843460664,0.00209500157403527,0.000742985349497516,0.00895539151971577,0.0206449278737938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37043,0.0170900759365732,0.00739578382400988,0.00259433964151384,0.0315858122316326,0.0208600161828521
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37368,0.011846406287891,0.00513346069774468,0.00178482332031148,0.0219079892554706,0.0210317444183053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,0.00743545508121062,0.00323246724100633,0.00109981928883822,0.013771090873583,0.0214499911922263
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,39749,0.033509718130882,0.0146403513085951,0.00481462956603559,0.0622048066957285,0.0221005334484589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,-0.00806382582756361,0.00352488882373321,-0.0149726079220807,-0.00115504373304651,0.0221688606234625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.00642320935347158,0.00280875857742414,0.000918042541720262,0.0119283761652229,0.022217504923603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,39779,0.00670400099382488,0.00293876968161462,0.000944012417860221,0.0124639895697895,0.0225481592648002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,39691,-0.0109804433042758,0.00481601627725544,-0.0204198352076965,-0.00154105140085517,0.0226218351434576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37021,0.00986400993330108,0.00433944054823607,0.00135870645875838,0.0183693134078438,0.0230358154711571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37039,0.0151799267743305,0.00668501287104886,0.00207730154707477,0.0282825520015863,0.0231787803319879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,-0.00747627567720806,0.00329660920604814,-0.0139376297210624,-0.00101492163335369,0.0233533416407584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00957266859574675,0.00422237113861625,-0.0178485160274346,-0.0012968211640589,0.023398329679108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39477,-0.0129344013692624,0.00570875832324719,-0.0241235676828269,-0.00174523505569794,0.0234826622248082
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37124,0.00749179005921845,0.00331837129832912,0.000987782314493368,0.0139957978039435,0.0239823783409813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0137452217584987,0.00608936286535792,0.00181007054239715,0.0256803729746002,0.0240059016219346
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37021,-0.00926598743883569,0.00410490733839568,-0.0173116058220912,-0.00122036905558015,0.0240059600735208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,0.0111254196368191,0.00493221263695622,0.00145828286838488,0.0207925564052533,0.0241050478359534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37424,0.00514578016002425,0.00228941444214525,0.000658527853419569,0.00963303246662894,0.0246151367018653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,-0.0106426692846289,0.00474309065513846,-0.0199391269687003,-0.00134621160055756,0.0248596511270426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0052645081925347,0.00234665837379077,0.0006650577799048,0.0098639586051646,0.0248843713953312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,0.00626196902046086,0.00279369139124348,0.000786333893623641,0.0117376041472981,0.0250118760621996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37169,-0.00904242318651449,0.0040355222718367,-0.0169520468393144,-0.00113279953371455,0.0250614847041523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37388,-0.0068689004285643,0.00306775414952833,-0.0128816985616398,-0.000856102295488772,0.0251678872779792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37368,0.0098949429268486,0.0044306234859177,0.00121092089444991,0.0185789649592473,0.0255450098917495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C5,Complement C5,37453,0.00344118136858382,0.00154269763471908,0.000417494004534414,0.00646486873263323,0.0257221707303086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,0.0115392875894078,0.00517981602742911,0.00138684817564676,0.0216917270031689,0.0259120120736536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,0.0098825194032072,0.00443904954297128,0.00118198229898349,0.0185830565074309,0.0260100171929762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0196440569381204,0.00884171433439484,0.00231429684270652,0.0369738170335343,0.0263173144583906
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0188794103570594,0.00851846941696165,0.00218321029981462,0.0355756104143043,0.0266883994836116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00513685047172148,0.00232199585197381,0.000585738601852825,0.00968796234159014,0.0269631139636509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.00722342661530593,0.00326930164370747,-0.0136312578369726,-0.000815595393639284,0.0271563651680847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,0.005681540520681,0.00257172943620679,0.000640950825715692,0.0107221302156463,0.0271757071938575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,0.00674865693883283,0.00305688042069685,0.000757171314266994,0.0127401425633987,0.0272798690062552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,39998,0.00912068331677371,0.00413873455785747,0.00100876358337307,0.0172326030501744,0.0275569009903994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37388,-0.00600247973234006,0.00272374240482365,-0.0113410148457944,-0.000663944618885708,0.0275578775932843
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39489,0.0099990473836267,0.00454116812907621,0.00109835785063732,0.0188997369166161,0.0276892731703423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37411,0.00815139895775774,0.00371421016439573,0.000871547035542109,0.0154312508799734,0.0282054741956748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00657950272329635,0.00299872456138646,-0.0124570028636138,-0.000702002582978882,0.0282450777114461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.00964663702511297,0.00440063164309909,0.00102139900463875,0.0182718750455872,0.0283894892867468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37056,-0.00954333895383183,0.00435588138506113,-0.0180808664685516,-0.00100581143911202,0.02847581753333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00590724334766771,0.00270126233714081,0.000612769166871714,0.0112017175284637,0.0287683019831149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0057539595484601,0.00263978864091124,-0.0109279452846461,-0.000579973812274065,0.0292969966782958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00600158746038332,0.00275721678831603,-0.0114057323654828,-0.000597442555283895,0.0295187198480025
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,0.00926804293319587,0.00426003024910971,0.000918383644940847,0.0176177022214509,0.029603792419198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,36962,-0.0107825590644632,0.00495752777347918,-0.0204993135004823,-0.00106580462844398,0.0296489051955418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,-0.0149738213597612,0.0068921456235485,-0.0284824267819162,-0.00146521593760611,0.0298287658017828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37043,0.0189685625816652,0.00874298400032326,0.00183231394103161,0.0361048112222988,0.0300568360925635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00830757700101118,0.00384370248329072,-0.015841233868261,-0.000773920133761376,0.030686475599851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00800633643007754,0.00370860794786703,-0.0152752080078969,-0.00073746485225817,0.0308796514417133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37039,-0.00758657032805747,0.00351702456176741,-0.0144799384691216,-0.000693202186993353,0.0310159689623333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.00446991730707821,0.00207426926098255,0.000404349555552419,0.00853548505860401,0.031181790827725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37437,0.0188540796287391,0.00875933857574531,0.0016857760202783,0.0360223832371999,0.0313791263842996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,-0.0121567843694721,0.00565593897318618,-0.023242424756917,-0.00107114398202722,0.0316216857753242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00415510305310839,0.0019424302078579,-0.00796226626050988,-0.000347939845706901,0.0324432239260203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0136328669744125,0.00637463620439619,-0.026127153935029,-0.00113858001379591,0.0324855166762696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37178,0.00783848902708548,0.00366540556487039,0.000654294119939516,0.0150226839342315,0.0324938983712106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40030,0.00440437131877348,0.00206968351747296,0.000347791624526488,0.00846095101302048,0.0333487675561405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0149894432019382,0.00704836073866047,-0.0288042302497127,-0.00117465615416367,0.0334672161716645
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.00913979879455569,0.0043001920257757,0.000711422424035329,0.0175681751650761,0.0335651502342349
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,39862,-0.00753954858397906,0.0035547395525569,-0.0145068381069906,-0.000572259060967537,0.0339384152151795
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.0133041423618633,0.0062779495473643,-0.0256089234746973,-0.000999361249029258,0.0340934307040168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.0131401348283812,0.00620126957984368,0.000985646451887558,0.0252946232048748,0.0341107817553398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,0.0060128777944105,0.00284089555224896,0.000444722512002544,0.0115810330768185,0.034316824543829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.00671916762090667,0.00317609934765893,0.000494012899495165,0.0129443223423182,0.0344025687409496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0103365624385139,0.00490075639391031,0.000731079906449687,0.0199420449705781,0.034947605216041
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37056,-0.00870298300085577,0.00412888667644358,-0.0167956008866852,-0.000610365115026355,0.0350646775174009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00530086778206901,0.00251563297633159,0.000370227148459095,0.0102315084156789,0.0351210770924696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,0.00872827799321992,0.00415115939710889,0.000592005574886499,0.0168645504115533,0.0355155663959969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.013345304181353,0.00634973281542729,-0.0257907804995905,-0.000899827863115491,0.0355973340458254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.00579542893525859,0.00275776556784023,0.000390208422291744,0.0112006494482254,0.0356135545877717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.0168570410898725,0.00804199591440258,0.00109472909764342,0.0326193530821015,0.0360870064136312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.00629744810675295,0.00300817260987901,0.00040142979139009,0.0121934664221158,0.0363251868498217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00675281973572159,0.00322643150616497,-0.0130766254878049,-0.000429013983638246,0.0363710320903515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,-0.00532205073143934,0.00254658152458078,-0.0103133505196177,-0.000330750943261012,0.0366441315974983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37056,-0.00724728956511693,0.00347306066322985,-0.0140544884650474,-0.000440090665186418,0.0369330046895137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00541719316269859,0.00259720420890864,-0.0105077134121595,-0.000326672913237662,0.0370179745557652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,0.00717668002436798,0.00344333601492963,0.000427741435105903,0.0139256186136301,0.0371557851526929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,0.00997419387171114,0.00479108814492053,0.000583661107666902,0.0193647266357554,0.037374952873815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00860218939204562,0.00413911416828213,-0.0167148531618786,-0.000489525622212654,0.0377040381478151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,0.00762358621191536,0.00369120157939015,0.000388831116310676,0.0148583413075201,0.038909874721789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.0096038982923713,0.00465200292314723,-0.0187218240217399,-0.000485972563002717,0.0389931225968666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00675959259989123,0.00327511118979771,-0.0131788105318947,-0.000340374667887712,0.0390441753338762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,-0.001691289192819,0.000819699522141112,-0.00329790025621558,-8.4678129422415e-05,0.0391030020452063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,-0.00589258493939379,0.00285855836515168,-0.0114953593350911,-0.000289810543696501,0.0392830197009894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,39868,0.00945262566172645,0.00458788770108822,0.000460365767593529,0.0184448855558594,0.0393818153605044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,-0.00958684315943254,0.00465588142363296,-0.0187123707497531,-0.000461315569111944,0.0395024937894105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,-0.0096974712532384,0.00472032907212668,-0.0189493162346067,-0.000445626271870116,0.0399556124653392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0178782731569034,0.00876183233925345,0.000705081771966615,0.0350514645418401,0.0413233467048719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,0.0161449635812846,0.00793029709551533,0.000601581274074571,0.0316883458884947,0.0417809400926182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00711574625408774,0.00349953598523637,-0.013974836785151,-0.000256655723024463,0.0420382848054882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,39866,0.0132827559804268,0.00655448561279003,0.000435964179358376,0.0261295477814953,0.0427287008527172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37411,0.0165814546527882,0.00819033661744278,0.000528394882600342,0.032634514422976,0.0429368234531809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00523181406166811,0.00258482082462233,-0.0102980628779279,-0.000165565245408337,0.0429842536751472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,-0.00512571734249028,0.00253345613538429,-0.0100912913678435,-0.000160143317137069,0.0430709122343158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,39587,0.0126917465847765,0.00629003423546789,0.000363279483259472,0.0250202136862936,0.0436337571588824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0146261088618503,0.00725884046551472,-0.0288534361742591,-0.000398781549441419,0.0439315547380777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40052,0.010561245515755,0.00524194227582326,0.000287038655141453,0.0208354523763686,0.0439465027380736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,39587,-0.00579902852727762,0.00288452423344368,-0.0114526960248272,-0.000145361029728006,0.0444066065722692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,39796,0.00648015400601992,0.00325648652386533,9.74404192438704e-05,0.012862867592796,0.0466165933008269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0124437702102335,0.00626237004443475,-0.0247180154973256,-0.000169524923141344,0.0469353384194272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39456,0.012482939179679,0.00628538704508654,0.000163580571309397,0.0248022977880487,0.0470479657939811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0117123345298358,0.00590573246645832,0.000137098895577489,0.0232875701640941,0.0473608345920058
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,-0.00660084842317332,0.00333318194559665,-0.0131338850365427,-6.78118098038924e-05,0.0476857196192845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00724278816071086,0.00366947427664787,-0.0144349577429407,-5.0618578481024e-05,0.0484225883490763
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,-0.0073743475065547,0.00375964434511697,-0.014743250422984,-5.44459012543144e-06,0.0498445054680871
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.00589258347634161,0.00300552887293046,1.74688539791509e-06,0.0117834200672853,0.0499451091903324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0119414547314922,0.00609768987160335,-0.0238929268798347,1.00174168503921e-05,0.0502091515385288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,-0.00627273184508199,0.0032095991985891,-0.0125635462743166,1.80825841526507e-05,0.0506756349901992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0129931359982304,0.00665866670944324,-5.7850752278368e-05,0.0260441227487391,0.0510411328738827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37039,0.0183184132662554,0.00939401849289155,-9.38629798120129e-05,0.0367306895123229,0.0511963136830435
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00947014827281078,0.00486636432776777,-6.79258096140459e-05,0.0190082223552356,0.0516704312545319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.00787150174798127,0.00404873883826589,-0.0158070298709824,6.40263750198659e-05,0.0518905136724105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0132764259829826,0.00684722843240223,-0.000144141744525813,0.0266969937104909,0.0525283615102755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,36962,-0.00809180603019835,0.00417890517502226,-0.016282460173242,9.88481128452682e-05,0.0528468251652402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.0110343271511976,0.00570134958353112,-0.0222089723349186,0.000140318032523422,0.0529640668900841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,36991,0.0218199633608332,0.0113176390436974,-0.000362609164813787,0.0440025358864802,0.0538815524463496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,36962,-0.0116819039029887,0.00606052665051922,-0.0235605361380064,0.000196728332028927,0.0539340344104766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,0.0103484556645118,0.0053797436765754,-0.000195841941576015,0.0208927532705995,0.0544260626937156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37056,-0.0198822717045836,0.0103438407336751,-0.0401561995425869,0.000391656133419651,0.0546101160460438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37169,0.0141696692993896,0.00738076694206412,-0.000296633907056081,0.0286359725058353,0.0549032705402603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00907529780614046,0.00473885696104526,-0.000212861837508247,0.0183634574497892,0.0555037481472024
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,36991,-0.00680662562055551,0.00357096345444661,-0.0138057139912709,0.000192462750159855,0.0566586012775905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00772443744910719,0.00406414337464729,-0.0156901584634159,0.000241283565201488,0.0573681535820372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37056,-0.00916794199527875,0.00482587499808036,-0.0186266569915162,0.00029077300095875,0.057488097188584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,-0.0043335665963262,0.00228374091166416,-0.00880969878318796,0.00014256559053556,0.0577740731809655
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00835535444858367,0.0044098598779738,-0.0169986798094123,0.000287970912244985,0.0581543668362094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.00777994650711381,0.00410706376291529,-0.00026989846820015,0.0158297914824278,0.0582091835931474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESPL1,Separin,36962,-0.0102904978371412,0.00545264810980813,-0.0209776881323652,0.000396692458082685,0.0591490962659716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00511967697226478,0.00271313588207652,-0.000198069356605199,0.0104374233011348,0.0591792463680147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.0114712697234771,0.00608132065295388,-0.00044811875631252,0.0233906582032667,0.0592748476156927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,0.00698393496056785,0.00371193530328933,-0.000291458233879242,0.0142593281550149,0.0599285986978833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.00649550551561252,0.00346710868400305,-0.000300027505033456,0.0132910385362585,0.0610227821066725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00995207468620867,0.00533778951832752,-0.0204141421421306,0.000509992769713268,0.062280066095775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,0.00482265292669176,0.00258725881911232,-0.000248374358768387,0.00989368021215191,0.06234321468781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,-0.00513505835023555,0.00276903144360812,-0.0105623599797075,0.00029224327923636,0.0636915305770969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37411,0.00476505055290189,0.00256985721252893,-0.000271869583654809,0.0098019706894586,0.0637310781212927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.0077108822613667,0.00417767939619383,-0.0158991338779066,0.000477369355173201,0.0649533747310528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,39720,-0.0233901903279766,0.0127067711863092,-0.0482954618531426,0.00151508119718935,0.0656745490415364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,39587,0.0110283155360652,0.00599334240438642,-0.00071863557653221,0.0227752666486626,0.0657732175159719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37021,-0.0154306164220609,0.00841063405755205,-0.0319154591748629,0.00105422633074114,0.0665793019065192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0114492262446564,0.00627353821031304,-0.000846908647557104,0.02374536113687,0.0680232792412792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,-0.0065816933110465,0.00362082386819048,-0.0136785080926998,0.000515121470606833,0.0691269647191145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.00476702190688233,0.00262405940535446,-0.00991017834137708,0.000376134527612419,0.0692880778170979
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,0.0118655174247243,0.00658117725759028,-0.00103359000015268,0.0247646248496012,0.0714192561238835
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIM,Vimentin,39585,0.0212229368322295,0.0118251365322057,-0.00195433077089375,0.0444002044353528,0.072715798239534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.00847002550556847,0.00473236168594546,-0.0177454544100216,0.000805403398884635,0.0735032928399691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,-0.0143327543868347,0.00801170745843591,-0.0300357010053691,0.00137019223169972,0.0736417877408265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00742568982385912,0.00415261529888456,-0.0155648158096729,0.000713436161954623,0.0737630923020249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40058,0.00725125694679473,0.0040572592057248,-0.00070097109642588,0.0152034849900153,0.0739189509569744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,-0.00615367810009793,0.00345004926302942,-0.0129157746556356,0.000608418455439737,0.074503750226453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,-0.00980487088898484,0.00550258145336048,-0.0205899305375714,0.000980188759601706,0.0747938968649002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0080152863848374,0.00449898550055108,-0.0168332979659175,0.000802725196242705,0.0748411324792873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.00949633533664647,0.00533280829595446,-0.000955968923424269,0.0199486395967172,0.0749777003374235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00605173480586683,0.00340443655808989,-0.012724430459723,0.000620960847989352,0.0754923592867642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.00844804864006757,0.00476557080970945,-0.000892470146962957,0.0177885674270981,0.0762937017527923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,39587,-0.00848822841873331,0.00479701240856768,-0.017890372739526,0.000913915902059342,0.0768328015531115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.00804174063722245,0.00454898677777518,-0.000874273447216901,0.0169577547216618,0.0771154289088497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,39841,-0.011863528937067,0.00673729444311454,-0.0250686260455715,0.00134156817143751,0.0782787961505716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,0.00506124143462235,0.00287493548562485,-0.000573632117202355,0.010696114986447,0.0783510902553552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.00788166387787347,0.00448253902632292,-0.000904112613719458,0.0166674403694664,0.0787150924371521
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,36962,-0.00746104084177522,0.00424437606300751,-0.0157800179252699,0.000857936241719496,0.0787938021288958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.00527654538114168,0.00300424176955902,-0.000611768487193988,0.0111648592494774,0.0790494487620181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,39587,0.00767596442847401,0.00438425902206089,-0.000917183254765344,0.0162691121117134,0.079999715772399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,39754,0.00913273368825256,0.00522628455020506,-0.00111078403014935,0.0193762514066545,0.0805765411007031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00970981428425814,0.00558904629443516,-0.0206643450213511,0.00124471645283477,0.0823586948599964
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.00779768411020002,0.00449995669166273,-0.00102223100545893,0.016617599225859,0.0831440249621901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00570186022785148,0.00329555479780974,-0.0121611476315586,0.000757427175855616,0.0836239347612748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,36991,-0.0076417160676401,0.00441792126210146,-0.0163008417413589,0.00101740960607875,0.0837058640869908
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,0.00735693945176848,0.00425951476145133,-0.000991709480676113,0.0157055883842131,0.0841589035183191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,39788,0.00492931544485707,0.00286570878305001,-0.000687473769920952,0.0105461046596351,0.0854330706521642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,-0.0131352184611873,0.0076404625070205,-0.0281105249749475,0.00184008805257284,0.0856078344923482
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37124,-0.0163275033322499,0.00950651796949309,-0.0349602785524563,0.00230527188795657,0.0859100686432123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,36962,-0.00519435281952679,0.00304009021934518,-0.0111529296494434,0.000764224010389769,0.0875454200842889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37039,0.00856748945896934,0.00502090546042866,-0.00127348524347084,0.0184084641614095,0.0879639947971358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.0030291744265184,0.0017775746965862,-0.00651322083182735,0.00045487197879055,0.0883808272084501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00488769493819463,0.0028821187388734,-0.000761257789997227,0.0105366476663865,0.0899337934478187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,39587,-0.0069118413485767,0.0040788657912268,-0.0149064182993812,0.00108273560222783,0.0901806488642103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,0.00916935072091293,0.00541866084278113,-0.00145122453093808,0.0197899259727639,0.0906346789442403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0177216231535075,0.0104874636487009,-0.00283380559794639,0.0382770519049613,0.0910909709329265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.00380900423091354,0.0022584825909993,-0.000617621647445099,0.00823563010927217,0.0917162602373839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.00656398414957774,0.0038937791380449,-0.00106782296099026,0.0141957912601457,0.0918653288654526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,0.00817273995385906,0.00484816759548259,-0.00132966853328681,0.0176751484410049,0.091866126914164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,-0.00492505416690175,0.00292897429742796,-0.0106658437898605,0.000815735456057043,0.0926905977516609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.00932376005385494,0.0055642723744717,-0.00158221380010959,0.0202297339078195,0.0938272435922304
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00820908982837822,0.00489921123877633,-0.0178115438563798,0.00139336419962337,0.0938415186974409
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.00555938944660631,0.00332233766959542,-0.0120711712790133,0.000952392385800716,0.0942848027715551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,39918,-0.00659567581788404,0.00395352077229726,-0.0143445765315867,0.00115322489581859,0.0952748254174026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,39913,0.00364092272802249,0.00218898846053441,-0.000649494654624951,0.00793134011066993,0.0962739095775107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.00594523385173988,0.0035902277723023,-0.0129820802854524,0.00109161258197263,0.0977559374138816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,39546,0.0120599484558254,0.00729892994992131,-0.00224595424602041,0.0263658511576711,0.0984954755392619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.00648067336785739,0.00392259697893088,-0.00120761671084713,0.0141689634465619,0.0985295443106324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37021,0.0064269786218231,0.00389514376298436,-0.00120750315362624,0.0140614603972724,0.0989672498927434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00495992934280282,0.00301102510987361,-0.000941679872549467,0.0108615385581551,0.09952923623913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37043,0.0038308501812266,0.00232845175941055,-0.000732915267218074,0.00839461562967128,0.0999452120969085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,-0.00857516758460833,0.00521892759838499,-0.0188042656774429,0.00165393050822626,0.100387594344491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39489,0.0100860433969049,0.00614094120249644,-0.00195020135998816,0.0221222881537979,0.100521803944965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSND,Barttin,36962,-0.00560021203115393,0.00341731275396255,-0.0122981450289205,0.00109772096661267,0.101283813383386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,0.00595873145878537,0.003638601083759,-0.00117292666538226,0.013090389582953,0.101516086455947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.00627507025316061,0.00383419581944691,-0.00123995355295532,0.0137900940592766,0.101736538286536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,36991,-0.00783685393144923,0.00479230362127065,-0.0172297690291397,0.00155606116624125,0.102010150107643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,-0.00823885693173228,0.00504107188696728,-0.0181193578301881,0.00164164396672359,0.10221008464671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37056,-0.00456273054478353,0.0027949047660285,-0.0100407438861994,0.000915282796632338,0.102594404121388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37169,0.00711708437150995,0.00437739698238728,-0.00146261371396911,0.015696782456989,0.104000700692322
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00865781108507427,0.0053256514382307,-0.0190960879040065,0.00178046573385791,0.10404122073287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,39844,0.0204825704170446,0.0126048798853774,-0.00422299415829509,0.0451881349923842,0.104188350274896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37311,-0.0118524191377704,0.00730994456007764,-0.0261799104755226,0.00247507219998175,0.104953119199798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.0094477108239973,0.00582857513846117,-0.00197629644738659,0.0208717180953812,0.105056012377472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,0.00770094747070989,0.00475764362804797,-0.00162403404026413,0.0170259289816839,0.105543329144034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,-0.00330123162236417,0.00203954818076386,-0.00729874605666135,0.000696282811933005,0.105550979254546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37031,-0.0114398076051303,0.00708775143669504,-0.0253318004210525,0.00245218521079203,0.106545971244345
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.00433945011524607,0.00269700969743,-0.000946688891716741,0.00962558912220888,0.107639160257203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00645243623418344,0.00402857510023888,-0.00144357096228477,0.0143484434306517,0.109253241719666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0191669618213907,0.011981994036112,-0.00431774648938888,0.0426516701321702,0.109696643702719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00478517534346213,0.00299262006140202,-0.00108035997688582,0.0106507106638101,0.109846366292882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.00695612217481966,0.00435400716855649,-0.0154899762251904,0.00157773187555105,0.110147888417358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.00640672744474341,0.00402119271748191,-0.014288265171008,0.00147481028152112,0.111129507754319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.0103181069895791,0.00650004335638688,-0.0230581919680974,0.00242197798893914,0.112443938422438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,0.00967244909097883,0.00612139983397478,-0.00232549458361174,0.0216703927655694,0.114103134578677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37083,0.0132146205001742,0.00838940572874095,-0.00322861472815807,0.0296578557285065,0.115244426236039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.0104709070580142,0.00667788891002595,-0.023559569321665,0.00261775520563669,0.116906076740901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.00979901307269689,0.00625795930937608,-0.00246658717368023,0.022064613319074,0.117404327786031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,-0.00647783866949365,0.00413791183009163,-0.0145881458564732,0.00163246851748595,0.117493395463516
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,39587,0.00783902625127937,0.00501846889197365,-0.00199717277698897,0.0176752252795477,0.11829976153288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39438,0.00686632265979831,0.00439991705408499,-0.00175751476620827,0.0154901600858049,0.118648554850702
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,39587,-0.00443053527097036,0.00284324808415255,-0.0100033015159094,0.00114223097396865,0.119190455760297
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40012,-0.00459937944500045,0.00295637632692665,-0.0103938770457767,0.00119511815577579,0.119787387716655
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.0115903402781103,0.00745290699758296,-0.0261980379933729,0.00301735743715232,0.119935983829236
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,39766,0.00820595523455327,0.00531256012894754,-0.0022066626181839,0.0186185730872905,0.122454974130684
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,39868,0.00620439604612171,0.00401766338626414,-0.001670224190956,0.0140790162831994,0.12254035311201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00540680668917604,0.00350732144150894,-0.0122811567145336,0.00146754333618148,0.12320041700978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.00466666568610134,0.00303538502358783,-0.0012826889601308,0.0106160203323335,0.124210424935126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.00572068795235046,0.00373497032937809,-0.0130412297979315,0.0015998538932306,0.125630805568258
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,-0.00645882534427751,0.00422349531197969,-0.0147368761557577,0.00181922546720268,0.126223972393572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,0.00402899142007724,0.00263463327310142,-0.00113488979520154,0.00919287263535601,0.126224361127559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37235,-0.0052994063363506,0.00346803191398144,-0.0120967488877542,0.00149793621505301,0.126518032496813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,0.00345992872145729,0.00227319847999369,-0.00099554029933035,0.00791539774224492,0.12801563542995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.00932764176738167,0.00612907106318467,-0.00268533751646028,0.0213406210512236,0.128065929610297
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37021,0.0169345609117095,0.0111993747904907,-0.00501621367765234,0.0388853355010714,0.130532746455162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,0.00604694256858094,0.00400150772265949,-0.00179601256783166,0.0138898977049935,0.130765954951575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.00269139539552863,0.00178459318810787,-0.00618919804422006,0.000806407253162793,0.131544947593099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00359833201052534,0.00238856617139211,-0.00827992170645388,0.00108325768540319,0.131963185719735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,39866,-0.00588465867157866,0.0039121328649229,-0.0135524390868275,0.00178312174367022,0.13254773879573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,-0.00675799761546345,0.00452241962738327,-0.0156219400851347,0.00210594485420775,0.135112822075306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.0052728345996148,0.00352884300400826,-0.012189366887471,0.00164369768824139,0.13514078836942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00742469722362807,0.00500871603680723,-0.0172417806557702,0.0023923862085141,0.138265934276474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,0.00855182381825527,0.00579061612291046,-0.00279778378264924,0.0199014314191598,0.139737494893531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37368,0.00782008950432374,0.00532688675217833,-0.00262060852994578,0.0182607875385933,0.142116301373432
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39489,0.0052607829552186,0.00358972243953624,-0.00177507302627243,0.0122966389367096,0.142801272699543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,-0.00659801666713764,0.00450409353197856,-0.0154260399898156,0.00223000665554034,0.142973903942237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,-0.00398295467870389,0.00271930827837824,-0.00931279890432524,0.00134688954691746,0.143027644761717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.00447869235887072,0.00306512833964953,-0.00152895918684237,0.0104863439045838,0.143987215976331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,-0.00928664024552237,0.00637123737124888,-0.0217742654931702,0.00320098500212544,0.144978005496365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,-0.0110863978546544,0.00763671972416543,-0.0260543685140186,0.00388157280470984,0.146602671202365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.00545273731747613,0.00376931453635473,-0.00193511917377915,0.0128405938087314,0.148025090525976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37382,0.016661011716058,0.0115483638915157,-0.00597378151131281,0.0392958049434289,0.149123595326766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37424,0.0021280498583992,0.00147658507084089,-0.000766056880448941,0.00502215659724734,0.149552142202698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,-0.00566930650967206,0.00394811210487116,-0.0134076062352195,0.00206899321587542,0.151039258256171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.012376156413662,0.00862904125407028,-0.0292890772716398,0.00453676444431573,0.1515262129568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,0.00487992907963889,0.00340382456564674,-0.00179156706902872,0.0115514252283065,0.15168875676725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,-0.00545472691537169,0.00380906838440421,-0.0129205009488039,0.00201104711806056,0.152156792419686
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,0.0121513380094612,0.00848700180658416,-0.00448318553144371,0.0287858615503662,0.152232787962554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.00854841686002114,0.00597119178236963,-0.0202519527534656,0.00315511903342334,0.152279314854397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,0.00678432183399998,0.00476086474724499,-0.0025469730706002,0.0161156167386002,0.154175436309708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37368,-0.0156651949098088,0.0110149288559597,-0.0372544554674899,0.00592406564787226,0.154997530446039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.0166112062006567,0.0117452503300266,-0.00640948444619531,0.0396318968475088,0.157299344042843
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37382,0.0163981671975409,0.0116349360723552,-0.00640630750427536,0.0392026418993571,0.158742758312083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00700170081693807,0.00497150585891944,-0.0167458523004202,0.00274245066654403,0.159046338045108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,0.0043403500344993,0.00308360217859873,-0.00170351023555421,0.0103842103045528,0.159281771698088
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00944345428845676,0.00671013068182775,-0.0225953104248392,0.00370840184792564,0.159349425316403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37249,-0.00446121822705099,0.00317445522938942,-0.0106831504766543,0.00176071402255228,0.159940656711187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,0.00662025890654773,0.00471079246661244,-0.00261289432801265,0.0158534121411081,0.159944193124106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARTN,Artemin,39587,0.00635066319543274,0.00452985597759719,-0.00252785452065775,0.0152291809115232,0.160947830264762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,-0.00504916181074557,0.00360672858444937,-0.0121183498362663,0.0020200262147752,0.161557606900803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00798299154058422,0.00571940952119514,-0.00322705112095825,0.0191930342021267,0.162806716887027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.0115032154337698,0.00825206779949564,-0.00467083745324163,0.0276772683207813,0.1633473590204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,0.00506995931708673,0.00365008877196793,-0.00208421467597041,0.0122241333101439,0.16485336760453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37368,0.0113397074246112,0.00816906107404822,-0.00467165228052327,0.0273510671297458,0.165120777630603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,-0.00422816621588847,0.00304656357799585,-0.0101994308287603,0.00174309839698339,0.165203091387452
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,0.00458219727341624,0.00330295087235999,-0.00189158643640933,0.0110559809832418,0.16536883615384
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37368,-0.00631677015529461,0.00457512286887618,-0.0152840109782919,0.00265047066770271,0.167400922278604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39477,0.00425053613424785,0.00308951505117661,-0.0018049133660583,0.010305985634554,0.16890516336781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,39587,-0.00677909707718865,0.00493586334236131,-0.0164533892282168,0.00289519507383953,0.169636128655467
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00389609267825786,0.00283829094555669,-0.00166695757503325,0.00945914293154897,0.169871595355553
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,0.00604780342259735,0.00441498252468937,-0.00260556232579381,0.0147011691709885,0.170761423561255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,0.00279635453565605,0.00204220294259584,-0.0012063632318318,0.0067990723031439,0.170934016112121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.00414018580587136,0.00302679435893017,-0.00179233113763176,0.0100727027493745,0.171383208998138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39477,-0.0190251039698423,0.0139338175522749,-0.0463353863723011,0.00828517843261652,0.17214997267909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,-0.0099115244855186,0.00726856670722874,-0.0241579152316869,0.00433486626064973,0.172712182750447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40017,0.00828114892819213,0.00609181995412426,-0.00365881818189142,0.0202211160382757,0.174042540431253
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,39866,0.00880998593568866,0.00648659465353081,-0.00390373958523173,0.0215237114566091,0.174424602956118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,39788,0.0255178603813672,0.0188234072618406,-0.0113760178518404,0.0624117386145747,0.175231326057187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,0.00820507949525127,0.0060570908705304,-0.00366681861098831,0.0200769776014909,0.175556906477648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,39585,0.00662871683643403,0.00490683891732948,-0.00298868744153176,0.0162461211143998,0.176742456424364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00858693677166247,0.00636311212730496,-0.0210586365411802,0.00388476299785525,0.177203875029098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,39868,0.0104698544028988,0.00775928412662038,-0.00473834248527711,0.0256780512910748,0.1772492679639
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,-0.0105280122342382,0.00781272999392816,-0.0258409630223374,0.00478493855386098,0.177827647559838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,-0.0143945431514194,0.0106995931020716,-0.0353657456314798,0.006576659328641,0.178539361137503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40052,-0.00993457345912431,0.00738815060622675,-0.0244153486473287,0.00454620172908012,0.178752893085678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37437,0.00501442584064317,0.00373105358835645,-0.00229843919253547,0.0123272908738218,0.178980394059069
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39456,0.0048629672904107,0.00361952386835946,-0.00223129949157383,0.0119572340723952,0.17911742813574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,-0.00342909022832006,0.00256405647209925,-0.00845464091363459,0.00159646045699446,0.181125394714664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37039,0.00423472659733476,0.00317954927513939,-0.00199718998193845,0.010466643176608,0.182927979257735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,0.00702196570615207,0.00527396148767111,-0.0033149988096833,0.0173589302219874,0.183066928091793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.00581886643333,0.00437450762600319,-0.0143929013802963,0.00275516851363625,0.183478946279008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.012447027121327,0.00937561796062502,-0.0308232383241521,0.005929184081498,0.184330741826439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,0.00451007905136081,0.00339775016513189,-0.00214951127229768,0.0111696693750193,0.184404452476631
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0104839504010287,0.0079055858424871,-0.00501099785024596,0.0259788986523035,0.184814762786001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTN,Titin,37021,0.00919790453714151,0.00694171280393203,-0.00440785255856526,0.0228036616328483,0.185187701128935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,0.00978903946295921,0.00739690781438128,-0.00470889985322809,0.0242869787791465,0.185726592994763
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00522142908051098,0.00394868475703665,-0.0129608512043028,0.00251799304328085,0.186084057752676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,36991,-0.00710697323644682,0.00538682274982783,-0.0176651458261094,0.00345119935321573,0.187083281960134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,0.0082698614104523,0.00628571423171127,-0.00405013848370179,0.0205898613046064,0.188306958179779
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,0.00300686305042668,0.0022855202395441,-0.00147275661907976,0.00748648271993311,0.188325810953182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.00955355593813131,0.00727189794570362,-0.0238064759117104,0.00469936403544778,0.188948618765426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39489,-0.00425041052646117,0.00324619084897745,-0.010612944590457,0.00211212353753464,0.190433969252536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,39587,0.00415193625569876,0.00317405856394049,-0.0020692185296246,0.0103730910410221,0.19086382757764
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,0.00792552026284439,0.0060617498585774,-0.00395550945996731,0.0198065499856561,0.191077396116587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0102878520070254,0.0078820056832286,-0.00516087913210268,0.0257365831461534,0.191836390170767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,39866,-0.00443387345371821,0.00340762504271689,-0.0111128185374433,0.00224507163000689,0.19322161449847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37039,0.00513045413656583,0.00394927290229586,-0.00261012075193405,0.0128710290250657,0.193936361707693
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,0.00400838701835734,0.00308706451570189,-0.00204225943241835,0.010059033469133,0.194153112878992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.00848713985901112,0.00658401239248097,-0.00441752443025158,0.0213918041482738,0.1974017218487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40030,-0.00377614073042853,0.00293054510008447,-0.0095200091265941,0.00196772766573704,0.197574573229585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40009,-0.00375232163422771,0.00291321291310486,-0.00946221894391324,0.00195757567545782,0.197752063345177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,-0.0121493881886635,0.00943904350276998,-0.0306499134540926,0.00635113707676569,0.198067416963628
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0110424358124613,0.00860281832132769,-0.00581908809734099,0.0279039597222635,0.199310287552422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0120534999503734,0.00939547280010066,-0.00636162673782386,0.0304686266385707,0.199548020210692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,0.00838612321584377,0.0065378212184064,-0.00442800637223276,0.0212002528039203,0.199616576443036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37391,-0.0030779189110261,0.00241201023972023,-0.00780545898087775,0.00164962115882555,0.201949014461475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0125530177700853,0.00989281363536657,-0.0068368969552332,0.0319429324954037,0.2044976394331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00698673141126159,0.00550927530699306,-0.017784911012968,0.00381144819044481,0.204757594818865
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.00904526021293542,0.00714065751142419,-0.00495042850945599,0.0230409489353268,0.205275262726902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.00896395302901535,0.00708628238653423,-0.00492516044859173,0.0228530665066224,0.205900011958364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,0.00354060438712395,0.00279959378054374,-0.00194659942274179,0.00902780819698968,0.206002664210917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37382,0.00391705304492913,0.0031097273584574,-0.00217801257764737,0.0100121186675056,0.207830739700497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,0.00595638983135321,0.00473532028354187,-0.00332483792438886,0.0152376175870953,0.208463191898936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.00484431401588837,0.00386451779024492,-0.0124187688847684,0.00273014085299168,0.210028931710929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,-0.00401994423135049,0.00321415174284254,-0.0103196816473219,0.00227979318462088,0.211065657146838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,36991,0.00734360098233453,0.00590687605684188,-0.00423387608907556,0.0189210780537446,0.213805570538737
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00681217396325778,0.00548166673033215,-0.0175562407547088,0.00393189282819324,0.213993418121813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00610911939554883,0.00492048605804225,-0.0157532720693116,0.00353503327821398,0.214418118430981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00418874302404474,0.0033789159554429,-0.00243393224862334,0.0108114182967128,0.215115727522159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37411,0.0196828747375485,0.0159561372200261,-0.0115911542137026,0.0509569036887996,0.217387784867761
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00576350214199144,0.00468101940733713,-0.0149383001803722,0.00341129589638934,0.218251716169704
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,0.0104101800276771,0.0085147037877841,-0.0062786393963797,0.027098999451734,0.221494324428453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,0.00736739325888058,0.00602884351731966,-0.00444914003506596,0.0191839265528271,0.221720375184386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.00536106407573385,0.00440689542052384,-0.00327645094849287,0.0139985790999606,0.223806334312609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,39587,0.00607241517177489,0.00500445980488964,-0.00373632604580881,0.0158811563893586,0.224994871228653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,-0.00485970168592916,0.00401934263857248,-0.0127376132575312,0.00301820988567289,0.226654284428487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40052,0.00390323719837284,0.00323532897404402,-0.00243800759075343,0.0102444819874991,0.227664683808717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37388,-0.00275738093900382,0.00228618954743684,-0.00723831245198002,0.00172355057397237,0.227798724963099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,-0.00479765330407901,0.00399236077489823,-0.0126226804228795,0.00302737381472152,0.229497578978931
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,-0.00712799394655076,0.00595436358972127,-0.0187985465824045,0.00454255868930292,0.231287450165407
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.0101010375149446,0.00845392770802851,-0.00646866079279126,0.0266707358226805,0.232169724447483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40052,-0.00323504246868369,0.00271001354880641,-0.00854666902434425,0.00207658408697688,0.232598491778085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,-0.00263240827194971,0.00220753679227583,-0.00695918038481033,0.00169436384091091,0.233100779453694
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39453,0.00415082136434782,0.00348453432307308,-0.00267886590887542,0.0109805086375711,0.233588246419931
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37056,-0.012663877702478,0.010648067542122,-0.0335340900850371,0.00820633468008109,0.234338196075786
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.00363230135723659,0.00305946512822184,-0.00236425029407821,0.0096288530085514,0.23515275957699
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.00271241526290531,0.00229432734178425,-0.00178446632699183,0.00720929685280244,0.237133083414774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,0.0052374467292742,0.00445102119803641,-0.00348655481887716,0.0139614482774256,0.239339046920551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.00632448248200165,0.00539364783114135,-0.0042470672670354,0.0168960322310387,0.240985549110751
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37039,-0.00321837289708093,0.00274565297164084,-0.00859985272149699,0.00216310692733512,0.241149874141889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,-0.00588586376904515,0.00502428866966965,-0.0157334695615977,0.00396174202350736,0.24142564443053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,37453,0.00216846606303826,0.00185132965524621,-0.00146014006124431,0.00579707218732083,0.241497953127311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,39992,-0.00496248520128917,0.0042787217820325,-0.0133487798940729,0.00342380949149452,0.246145155498163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.00422854319537581,0.0036474401880095,-0.0113775259638744,0.00292043957312282,0.246343875606776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,36991,-0.0110319791673706,0.00958037216727658,-0.0298095086152327,0.00774555028049151,0.249539809854231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,0.00570459212453034,0.00495758136160098,-0.00401226734420757,0.0154214515932683,0.249880848678857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,-0.00306546035207063,0.00266432401964485,-0.00828753543057453,0.00215661472643328,0.249931334107216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37039,-0.0042417319594061,0.00368679066500038,-0.0114678416628068,0.00298437774399466,0.249950015397244
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0102845462484002,0.00895338349798447,-0.0072640854076494,0.0278331779044497,0.250706373104941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,0.00462522489582037,0.00403049914312019,-0.00327455342469521,0.0125250032163359,0.251172616494935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,39931,0.00525442676899331,0.00458701200377597,-0.00373611675840759,0.0142449702963942,0.25201874492892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,36991,0.00857556342925811,0.00751656324106783,-0.00615690052323483,0.0233080273817511,0.253936973715412
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37388,0.00655825559336741,0.00575962186881519,-0.00473060326951036,0.0178471144562452,0.25486482588537
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,39913,0.00338202756377044,0.00297170086951662,-0.00244250614048213,0.00920656126802301,0.255104872905201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,0.00919545659340526,0.00808325562360728,-0.006647724428865,0.0250386376156755,0.25531119216408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,-0.00505121714212607,0.00444610643912703,-0.0137655857628151,0.00366315147856291,0.255935283051833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,0.00533965775682021,0.00470143378669582,-0.00387515246510361,0.014554467978744,0.256078251490657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,0.00707231857489586,0.0062463021885222,-0.00517043371460765,0.0193150708643994,0.257550447533296
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,-0.00386697005715995,0.00341580051266539,-0.0105619390619841,0.00282799894766421,0.257620093613608
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,-0.00387387370811028,0.0034421021092016,-0.0106203938421454,0.00287264642592486,0.260423898920958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.00619642515096908,0.005527093174537,-0.00463667747112345,0.0170295277730616,0.262265649670698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37056,-0.00465178673688992,0.00415477668568349,-0.0127951490408296,0.00349157556704973,0.262894499896834
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,39858,-0.00575160778475835,0.00514705354453752,-0.0158398327320519,0.00433661716253519,0.263816024286202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0136807450112968,0.0122496070373886,-0.0103284847819849,0.0376899748045786,0.264083509014721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,39749,-0.00397613292610753,0.00356715172733363,-0.0109677503116814,0.00301548445946639,0.265016422880391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,0.00443359261060962,0.00398355875749351,-0.00337418255407765,0.0122413677752969,0.265740377934703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39489,0.00628193515143727,0.00564685581419812,-0.00478590224439105,0.0173497725472656,0.26595494781896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,0.00480856691322938,0.00432312331837375,-0.00366475479078317,0.0132818886172419,0.26603388245985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37021,0.00849389590311543,0.0076788504569982,-0.00655665099260105,0.0235444427988319,0.268685455474784
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00613324348512433,0.00554668930218656,-0.01700475451741,0.00473826754716132,0.268855686071319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.0048577592938382,0.00440715572899182,-0.0134957845226622,0.00378026593498577,0.270375927953733
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,0.00951019593386223,0.00864772618827873,-0.00743934739516408,0.0264597392628885,0.271468247855561
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0058698567285601,0.00535838216096409,-0.00463257230692952,0.0163722857640497,0.273337973597335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37056,-0.00423566663147585,0.00387111291980875,-0.011823047954301,0.0033517146913493,0.2738991510688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00715120056082182,0.00653663232626075,-0.00566059879864925,0.0199629999202929,0.273963465622778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,0.0045283128916251,0.00414294988234225,-0.00359186887776571,0.0126484946610159,0.274406528218989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00441994387700281,0.00408977089929774,-0.00359600708562077,0.0124358948396264,0.279836409166152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00815009253930617,0.0075502912872723,-0.00664847838374754,0.0229486634623599,0.280407937439224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40018,0.00227003197450491,0.00210357698721032,-0.00185297892042731,0.00639304286943713,0.280546112069417
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.00495484361253726,0.00459373340728881,-0.00404887386574881,0.0139585610908233,0.280781189896478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,-0.00431343017669104,0.00400117464982203,-0.0121557324903422,0.00352887213696014,0.281035322658078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.00746232915878253,0.00697809511601903,-0.00621473726861476,0.0211393955861798,0.284908936418937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37056,-0.00333413158054577,0.0031204731945647,-0.00945025904189257,0.00278199588080104,0.285328160571492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,0.00541800257694588,0.00507504190524528,-0.00452907955733487,0.0153650847112266,0.285730512222902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.00269637811897311,0.00253127005929532,-0.00226491119724572,0.00765766743519193,0.2867920760306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37437,-0.00313815228785018,0.00294693658879847,-0.00891414800189518,0.00263784342619482,0.286946340098068
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,39587,-0.00335248448912835,0.00315006573278375,-0.0095266133253845,0.0028216443471278,0.287227914967801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00782240626795961,0.00735414366058124,-0.0222365278426988,0.00659171530677963,0.287496021457541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00581795913657157,0.00549074296662391,-0.0165798153511544,0.00494389707801129,0.289348504581093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,36991,0.00667038830452999,0.00630009028442057,-0.00567778865293434,0.0190185652619943,0.289720999128261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37124,0.00527134418376937,0.00502307032065734,-0.00457387364471901,0.0151165620122578,0.294000888465534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,-0.00364703022090073,0.00348306596109921,-0.0104738395046552,0.00317977906285372,0.295084145389752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37021,-0.00427591660222571,0.00408599307357894,-0.0122844630264404,0.003732629821989,0.295357950600242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,36962,0.00766701617474492,0.00732958456700736,-0.00669896957658949,0.0220330019260793,0.295563277331021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00299606527917323,0.00287191200801899,-0.00263288225654398,0.00862501281489045,0.296857621192653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37056,-0.00573969236547294,0.00551100631429033,-0.016541264741482,0.0050618800105361,0.297664377015964
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,36962,0.00750602161063024,0.0072635051458561,-0.00673044847524771,0.0217424916965082,0.301441269102873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,39903,-0.00570948847617408,0.00552747876373777,-0.0165433468531001,0.00512436990075195,0.30165308926117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00389503334820389,0.00379972088186317,-0.00355241958024793,0.0113424862766557,0.305342311420251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00276011550889783,0.00269836147512645,-0.00804890400014568,0.00252867298235001,0.306380635991626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.00546176772828726,0.00535721530000848,-0.0159619097163039,0.00503837425972935,0.307976754392965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00262073070369214,0.00257134540855107,-0.00766056770445224,0.00241910629706796,0.308123398737501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00895026888529471,0.00879478256978197,-0.0261880427220674,0.00828750495147795,0.308848848127852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,-0.00517914245609166,0.00509009213418129,-0.015155723039087,0.00479743812690366,0.308936791954646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,-0.0176046899472616,0.0173445510334,-0.0516000099727256,0.0163906300782025,0.310122197156423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37039,-0.00679910876994873,0.00670590748398471,-0.0199426874385588,0.0063444698986613,0.310649855287604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37021,-0.0066209138310574,0.00653645735642177,-0.0194323702496441,0.00619054258752927,0.311116597628183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.00570318817379491,0.0056353216345291,-0.0167484185774719,0.00534204222988212,0.311532602785452
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37056,-0.00587910988228906,0.00582449688260745,-0.0172951237721997,0.00553690400762155,0.312812644294328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,0.00704193924771721,0.00698648904439603,-0.00665157927929902,0.0207354577747334,0.313503139176869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37043,0.00725805569146388,0.00721101764163239,-0.00687553888613562,0.0213916502690634,0.314182488408542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,0.00343687145418791,0.00342229500670131,-0.00327082675894665,0.0101445696673225,0.315272102605656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37299,-0.00288962158689412,0.00288436812166764,-0.0085429831053627,0.00276373993157446,0.316447917763966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.0036473908699409,0.00364282688280014,-0.00349254982034737,0.0107873315602292,0.316722775546016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00720575331717359,0.00721655190377902,-0.00693868841423329,0.0213501950485805,0.31805353458109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.00391798624928705,0.00393268016926388,-0.00379006688247015,0.0116260393810443,0.319137490665603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,0.00230074186871096,0.00232026597892986,-0.00224697944999156,0.00684846318741348,0.321414706099572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37368,-0.00277101309913617,0.00280962638182066,-0.00827788080750466,0.00273585460923232,0.324024782303149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37169,-0.0164491632700629,0.016756407356601,-0.0492917216890009,0.0163933951488751,0.326283209576732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00775242091281355,0.00791839159581164,-0.0232724684406044,0.00776762661497726,0.327578261592277
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.00560689713222375,0.0057468442676285,-0.0056569176323281,0.0168707118967756,0.329253936114525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37039,0.00593733439519295,0.00608569913725655,-0.00599063591382989,0.0178653047042158,0.329270341850232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,-0.00359608033471018,0.00371190037592271,-0.0108714050715187,0.00367924440209832,0.332660627917055
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_A,,37411,0.0031758041524785,0.00327899716029794,-0.00325103028170546,0.00960263858666246,0.332797481071686
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37169,-0.00348457091472908,0.0035993959100854,-0.0105393868984965,0.0035702450690383,0.333012613536342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.00985367493105832,0.0101946809278785,-0.0101278996875834,0.0298352495497001,0.33378647792512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,-0.00464294491677004,0.00481204457863238,-0.0140745522908895,0.00478866245734942,0.334633233568982
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.00659065443021383,0.00685537992213869,-0.0200271990776057,0.006845890217178,0.336376651983115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37021,0.00465026960481591,0.00484567220830085,-0.00484724792345376,0.0141477871330856,0.337236529409923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00833987874296875,0.00870455051825872,-0.0254007977587558,0.00872104027281835,0.338026907406194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.00232275759170284,0.00242556520266347,-0.00243135020551755,0.00707686538892324,0.338274022736542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,39585,0.0121974450291232,0.0127728837478382,-0.0128374071166396,0.0372322971748861,0.33961846625946
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37039,0.00586339194885095,0.00615239084580522,-0.00619529410892728,0.0179220780066292,0.340594086922798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37021,0.00649935886695848,0.00683319463294713,-0.0068937026136179,0.0198924203475348,0.341548243338625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,-0.00398314533315117,0.00419531177757934,-0.0122059564172067,0.00423966575090433,0.342420098529616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,39564,0.00518061062897295,0.00545724893665443,-0.00551559728686973,0.0158768185448156,0.34247854265129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,0.00370066380144685,0.00389886046642454,-0.00394110271274526,0.011342430315639,0.342553855373519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00611037416297054,0.00646122977202919,-0.0187743845161478,0.00655363619020667,0.344319839486653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00250564414062221,0.00265181982473393,-0.00770321099710071,0.00269192271585629,0.344735824217097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,-0.0057528056203118,0.00609438325319404,-0.0176977967965721,0.00619218555594853,0.345211429304674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37380,0.0030219724827587,0.00321025719554671,-0.00327013162051286,0.00931407658603026,0.346542845681622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,0.00613680551769431,0.00652586556864061,-0.00665389099684129,0.0189275020322299,0.347038965546851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,-0.00452704652929765,0.00482516377404942,-0.0139843675264345,0.0049302744678392,0.348150562745275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,0.00488840670348571,0.00521612438670727,-0.00533519709446054,0.015112010501432,0.348687166862343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,-0.0049633935680289,0.00532793190644061,-0.0154061401046525,0.00547935296859469,0.35157033942791
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37169,-0.0054008653636378,0.0058208688679325,-0.0168097683447855,0.00600803761750991,0.353504688842558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00368756743269564,0.00397769499803216,-0.0114838496288387,0.00410871476344738,0.353911143071816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00478714058423157,0.00517317046063987,-0.0149265546870857,0.00535227351862258,0.354785850610031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,39587,0.00440851544387629,0.00477327608548128,-0.00494710568366702,0.0137641365714196,0.355717768914532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00708127226493102,0.00772372066358024,-0.0222197647655483,0.00805722023568624,0.359253083150392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,-0.00854515670746219,0.00932109466240919,-0.0268145022457842,0.00972418883085981,0.359288067395159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37368,0.00368440221156214,0.0040285276212177,-0.00421151192602455,0.0115803163491488,0.360429605552116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37039,-0.00544998262576557,0.00601348427647905,-0.0172364118076645,0.00633644655613337,0.364797013713389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,0.00520704888016111,0.00576508075077703,-0.00609250939136188,0.0165066071516841,0.366431105905846
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,39906,0.0136770409769413,0.0152222512416451,-0.0161585714566831,0.0435126534105658,0.368937839837348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,0.0053926216276242,0.00605444168905499,-0.00647408408292357,0.017259327338172,0.373112657341007
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37382,-0.0229063648480793,0.0257475341246881,-0.0733715317324681,0.0275588020363094,0.373668192937527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00451659878065806,0.00508045051481653,-0.0144742817896985,0.00544108422838233,0.374011121284367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39477,-0.0147797101721821,0.0166268386233532,-0.0473683138739545,0.0178088935295903,0.374066853527521
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40009,-0.00680577597987046,0.00766307139243813,-0.0218253959090492,0.00821384394930827,0.374485992798086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,39585,0.0053888532523681,0.00607938686903813,-0.00652674501094662,0.0173044515156828,0.375408066996587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00191438419010067,0.00216896621083731,-0.00233678958314046,0.0061655579633418,0.377454509920926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37056,-0.0078632851239682,0.00891760828400602,-0.02534179736062,0.00961522711268361,0.377916914903472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37021,-0.00379459053510413,0.00430472514036226,-0.0122318518102141,0.00464267074000589,0.378066453147954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.00626394499823844,0.00712969884286666,-0.00771026473378022,0.0202381547302571,0.379650062982396
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,-0.00738616111452179,0.00841010237643004,-0.0238699617723247,0.00909763954328108,0.379824861552531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00574512588938996,0.00655735775466344,-0.0185975470885303,0.00710729530975038,0.380973031344256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37039,0.0053440291854022,0.00610727475978507,-0.00662622934377655,0.0173142877145809,0.381575261437309
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,-0.00301519502807199,0.00345791903365549,-0.00979271633403674,0.00376232627789277,0.383241209311951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.00316033959661094,0.00363826559188951,-0.0102913401567144,0.00397066096349249,0.385060401889514
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.0021301588319953,0.00246939242942971,-0.00697016799367754,0.00270985032968694,0.388356785648266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,-0.00348402645363093,0.00404874372755906,-0.0114195641596467,0.00445151125238482,0.389517941973818
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37437,-0.00228433776974322,0.00265787513025863,-0.00749377302505013,0.00292509748556369,0.39010186860651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,0.00668155134068448,0.00778962187745654,-0.00858610753913034,0.0219492102204993,0.39104587718952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,0.00399553586032788,0.00468918931535263,-0.00519527519776328,0.013186346918419,0.39418840515315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39489,0.00595331087745368,0.00700779633507394,-0.00778196993929125,0.0196885916941986,0.395601230087991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37169,0.00245753560036859,0.00289717711019436,-0.00322093153561234,0.00813600273634953,0.39631302869697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,-0.00396439363423051,0.00467802270488941,-0.0131333181358138,0.00520453086735274,0.396758967592391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,0.00257257891149789,0.00305245601981686,-0.00341023488734315,0.00855539271033894,0.399358592575483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00603388572083917,0.00716926499427359,-0.00801787366793707,0.0200856451096154,0.40000620899504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,39780,-0.00570629021182048,0.00678121053234905,-0.0189974628552246,0.00758488243158365,0.400088654482308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,-0.00529471969027539,0.0063229760732261,-0.0176877527937985,0.00709831341324776,0.402395454873678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37056,-0.00503977482994838,0.00602648353747867,-0.0168516825634066,0.00677213290350982,0.403017474225705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,36962,-0.00345620747942517,0.00413461493477415,-0.0115600527515825,0.00464763779273216,0.403215131954432
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.0029895814012664,0.00358641569078806,-0.00403979335267819,0.010018956155211,0.404527471431544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37382,0.0051821450044175,0.00622958369311097,-0.00702783903407999,0.017392129042915,0.405502343566805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.00267569491246301,0.0032233496651278,-0.00364207043118747,0.00899346025611349,0.406496112360617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00348035216327378,0.00420072673044343,-0.0117137765549429,0.00475307222839535,0.407395632364283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00451440129257953,0.00546068382292129,-0.0061885390003462,0.0152173415855053,0.408414138304093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,-0.00218605589461735,0.00264435194294659,-0.00736898570279266,0.00299687391355797,0.408428469796172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,36962,0.00497452397213798,0.00606907583130471,-0.00692086465721925,0.0168699126014952,0.412430010355359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,39985,-0.00248937313111311,0.00303799770066847,-0.0084438486244233,0.00346510236219709,0.412563246179336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,-0.0056388191253381,0.00692231275740379,-0.0192065521298495,0.00792891387917333,0.415324040308826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,-0.00527414433786477,0.00648958633906664,-0.0179937335624354,0.00744544488670583,0.416397377389405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00417862904327034,0.00514430944385637,-0.00590421746668813,0.0142614755532288,0.416644697165811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00473749156158182,0.00583741177263712,-0.00670383551278693,0.0161788186359506,0.417050864489094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,36991,0.00527898076003219,0.00652138704996606,-0.00750293785790128,0.0180608993779657,0.418249505340402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,-0.00512350077890627,0.00633659589975607,-0.0175432287424282,0.00729622718461564,0.418784458009637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00260914403082768,0.00324455896181995,-0.00375019153433942,0.00896847959599478,0.421319224251388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00340922499352811,0.00425233806395295,-0.0117438075988759,0.00492535761181967,0.422723885699618
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37124,0.00273751379324001,0.00341476641016297,-0.00395542837067941,0.00943045595715942,0.422758573074348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00301243966688282,0.0037645815431814,-0.0103910194915184,0.00436614015775273,0.423606127454283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,36962,-0.00578753487338144,0.00723418285796495,-0.0199665332749927,0.00839146352822987,0.423710198241659
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,39587,0.0072950152872168,0.00912586136700123,-0.0105916729921056,0.0251817035665392,0.424083178278721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00811668995404967,0.0101643889555326,-0.0118055123987943,0.0280388923068936,0.424570526870313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00381903158369862,0.00480762554272716,-0.00560391448004662,0.0132419776474439,0.426994651917401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37368,-0.00399447141812926,0.00505907251700282,-0.0139102535514548,0.00592131071519627,0.429795156799124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,39587,-0.0061746306044452,0.00783464404376863,-0.0215305329302317,0.00918127172134131,0.430639072415489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.00298701714095519,0.00380893201115721,-0.0104525238828233,0.00447848960091295,0.432928749025251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,0.00201856510617177,0.00258831357152832,-0.00305452949402373,0.00709165970636727,0.435477181648651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37021,-0.0046561971832838,0.00599488031021128,-0.0164061625912979,0.00709376822473031,0.43735233970147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00443448824786416,0.00571531239821936,-0.00676752405264579,0.0156365005483741,0.437824376823555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37388,-0.00567153547713446,0.00735355613531293,-0.0200845055023478,0.00874143454807888,0.44056374686223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,36991,0.00706207326432888,0.00919298508483386,-0.0109561775019455,0.0250803240306033,0.442380758696783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,0.006079031707534,0.00793938774789553,-0.00948216827834124,0.0216402316934092,0.443880345218476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.00229433288792551,0.00299827798021969,-0.00817095772915611,0.00358229195330509,0.444153701736079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39123,0.00215667934044155,0.00284096572057485,-0.00341161347188516,0.00772497215276826,0.44778293193281
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,0.00675690677243428,0.00890144184285967,-0.0106899192395707,0.0242037327844392,0.447816138871081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,0.00397853122964102,0.00524576051798573,-0.006303159385611,0.014260221844893,0.448208412217312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,36962,0.0041712888331983,0.00551477736756019,-0.00663767480721966,0.0149802524736163,0.449432655547189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.00169491127969846,0.00225026539066284,-0.00610543144539762,0.00271560888600071,0.451337792361374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37039,0.00368523688348436,0.00489824356702907,-0.00591532050789262,0.0132857942748613,0.451848724709188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,0.00369018113139589,0.00490630992026485,-0.00592618631232321,0.013306548575115,0.451986531086887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00358024817550871,0.00480154625250245,-0.0129912788304135,0.00583078247939609,0.455895306371892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,0.00671087901314968,0.00900481744239998,-0.0109385631739543,0.0243603212002536,0.456131304635754
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,0.0028424894200079,0.00382036182588143,-0.00464541975871971,0.0103303985987355,0.456867212415297
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37043,-0.00134730073157257,0.00181169738878638,-0.00489822761359387,0.00220362615044874,0.457090821337984
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00563993364860651,0.00759870013590027,-0.00925351861775803,0.020533385914971,0.457965221543805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37039,0.00264300690394249,0.00356511161914415,-0.00434461186958005,0.00963062567746503,0.458492523020475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.00672736695520322,0.00911269434240591,-0.0111335139559124,0.0245882478663188,0.460380982565271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37437,-0.00329920855907747,0.00450681173834579,-0.0121325595662352,0.00553414244808029,0.464151088826675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,39587,-0.00392471976036299,0.00539787705674967,-0.0145045587915924,0.00665511927086637,0.467184219227273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,0.00314824431340119,0.0043570982434921,-0.00539166824384332,0.0116881568706457,0.469963900708004
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00304738858335902,0.00421842652129681,-0.0113155045651008,0.00522072739838272,0.470061678373536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.00442107434360391,0.00612070408763761,-0.0164176543553736,0.0075755056681658,0.470111776455784
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37056,0.00213705623441245,0.00296540026392207,-0.00367512828287481,0.0079492407516997,0.471129236256706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.0023179160870074,0.00323164199886783,-0.00865193440478835,0.00401610223077353,0.473226523663741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,39587,-0.00245453911746401,0.00342514130705301,-0.00916781607928791,0.00425873784435988,0.473616655334276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,-0.00472493074696664,0.00659590025843361,-0.0176528952534965,0.00820303375956322,0.47378986549739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,-0.00286958136308946,0.00400703107788164,-0.0107233622757375,0.00498419954955855,0.473919384995739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40009,0.00184008107448972,0.0025762286122724,-0.00320932700556418,0.00688948915454362,0.475080578482133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37368,-0.00250942597794741,0.00351609763069781,-0.00940097733411512,0.0043821253782203,0.475427306317758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00491687994747964,0.00691001560998954,-0.0184605105430591,0.00862675064809985,0.476750719826439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.00349075660598582,0.00495675601941189,-0.00622448519206148,0.0132059984040331,0.481292467382744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37411,0.0025072484664005,0.00357538328964487,-0.00450050278130345,0.00951499971410444,0.483157144804683
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,39587,-0.00370793278864363,0.00532882306938966,-0.0141524260046474,0.00673656042736011,0.486548186714118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37169,-0.00361622663748644,0.0052161444539007,-0.0138398697671318,0.00660741649215893,0.48814859480663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,0.00231955235921973,0.00335363443524816,-0.00425357113386666,0.00889267585230613,0.489166949216011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,0.00193281221629008,0.00279866203360168,-0.00355256536956922,0.00741818980214939,0.489816127130461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40030,-0.00173541702338275,0.00251629280479543,-0.00666735092078179,0.0031965168740163,0.490410291863098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.00521225907056729,0.00757300430344607,-0.0200553475053216,0.00963082936418701,0.491293790996879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,0.0027670578406581,0.00404832210100672,-0.00516765347731506,0.0107017691586313,0.494298378634797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39415,0.00208755303888481,0.00306063250632201,-0.00391128667350633,0.00808639275127594,0.495207442797773
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00389361976428688,0.00571277347469449,-0.0150906557746881,0.00730341624611432,0.495526785937043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37437,-0.00323711770867448,0.00475465422838559,-0.0125562399963102,0.00608200457896128,0.495989814509978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00254263098717237,0.00374178876216067,-0.00479127498666255,0.00987653696100729,0.496818564976226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,-0.0021894221270846,0.0032379118291553,-0.00853572931222898,0.00415688505805979,0.498936081246051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,0.00983776052775122,0.0145932760434111,-0.0187650605173346,0.038440581572837,0.50024076385648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00297157552746831,0.00442038942369449,-0.00569238774297289,0.0116355387979095,0.50144072631431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,-0.00503768705218282,0.00754200389285325,-0.0198200146821752,0.00974464057780955,0.504176622122706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00397039285568185,0.00597463103819932,-0.00773988397918881,0.0156806696905525,0.50635516309224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37169,0.00151838073592876,0.00230705697710388,-0.00300345093919484,0.00604021241105237,0.510455588142089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,-0.00295927273582698,0.00450122687344022,-0.0117816774077698,0.00586313193611585,0.510911220063311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37411,0.00194830269479861,0.00297022466764679,-0.0038733376537891,0.00776994304338632,0.51187093656775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,0.00700324759100897,0.0106924881140062,-0.0139540291124432,0.0279605242944611,0.512499225719006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,-0.00509791243519395,0.00779814867001517,-0.0203822838284237,0.0101864589580358,0.513294694246845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.00227042915737096,0.0034735820849117,-0.00453779172905596,0.00907865004379789,0.513361029716617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37411,-0.00296064191793533,0.00454495273002565,-0.0118687492687856,0.00594746543291494,0.514790878871099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.00285073667107296,0.00438772099680044,-0.0114506698248018,0.00574919648265591,0.515892003966571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37169,-0.00275265586002554,0.00424196683490638,-0.011066910856442,0.00556159913639096,0.516407570604584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,39585,-0.00211230791378879,0.00327285859761228,-0.00852711076510887,0.00430249493753128,0.518676435194104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37021,-0.00307637301239234,0.00476940595379473,-0.01242440868183,0.00627166265704533,0.5189240030739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00196861420226426,0.00305290828713198,-0.00795231444504295,0.00401508604051443,0.519047062902828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00302994159613327,0.00470057106535171,-0.00618317769195607,0.0122430608842226,0.519204083472005
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,0.00333731675479259,0.00518816583379841,-0.00683148827945231,0.0135061217890375,0.520069449563713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,39866,0.00375492659193986,0.00584172796899817,-0.00769486022729655,0.0152047134111763,0.520378214980904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37368,0.00242898823622213,0.00381635834446136,-0.00505107411892214,0.00990905059136641,0.524482510973252
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,-0.00301112918644151,0.00475967533220613,-0.0123400928375655,0.0063178344646825,0.526982527211523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,39749,0.00356413468485512,0.00565403527089383,-0.00751777444609679,0.014646043815807,0.52846154516093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,39587,0.00330578115082559,0.00524763293105058,-0.00697957939403354,0.0135911416956847,0.528732112835195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.00268247843238901,0.00426195829266075,-0.00567095982122607,0.0110359166860041,0.529097573160585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,39913,-0.00240102676776769,0.00383468621615816,-0.00991701175143768,0.00511495821590231,0.531236066713203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37021,-0.00386030635750957,0.00618725561036537,-0.0159873273538257,0.00826671463880656,0.532695838553314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,-0.00251583733150665,0.0040324793606771,-0.0104194968784338,0.00538782221542047,0.532708396292555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00575459244212693,0.00926268393703625,-0.023909452958718,0.0124002680744641,0.534435297752748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,0.00248328039438083,0.00399835424849533,-0.00535349393267002,0.0103200547214317,0.534560497477016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37437,0.00492170788471866,0.00793882334651073,-0.0106383858744424,0.0204818016438797,0.535298261375139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,0.00290706811161003,0.00471374189513148,-0.00633186600284768,0.0121460022260677,0.537428830175359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,39964,0.00207284794971285,0.00336988964646689,-0.00453213575736225,0.00867783165678795,0.538491724456321
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37056,-0.00306617583177831,0.00498650416181148,-0.0128397239889288,0.00670737232537219,0.53863475300113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00239259186368732,0.00390621206271258,-0.00526358377922934,0.010048767506604,0.54021103258567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,39889,-0.00182284447050062,0.00298739204130909,-0.00767813287146643,0.00403244393046519,0.54175176046056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,0.0041179393697865,0.00675285495253263,-0.00911765633717745,0.0173535350767505,0.542000064635473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,-0.00361894810621626,0.00593790132347978,-0.0152572347002366,0.00801933848780411,0.542226243617113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00347664177306965,0.00570793862618053,-0.0146642014803835,0.00771091793424418,0.542476085194546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,0.00174284047052972,0.00286676772725588,-0.00387602427489181,0.00736170521595125,0.543231825721478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,39699,-0.00413934117896361,0.00683057654624029,-0.0175272712095946,0.00924858885166736,0.544522290869473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00324679499609472,0.00536169581963906,-0.00726212881039783,0.0137557188025873,0.544821612895652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,-0.00259957165531759,0.0042952202095407,-0.0110182032660174,0.00581905995538219,0.545038646718825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00330914109122274,0.00556171673212944,-0.00759182370375097,0.0142101058861964,0.551863382302936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,0.00205476595625965,0.00348122679238914,-0.00476843855682306,0.00887797046934236,0.555037017491768
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00224748034951584,0.00381361047583409,-0.00522719618311898,0.00972215688215066,0.555647459243741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39477,-0.00559745270653935,0.00951327981649863,-0.0242434811468767,0.013048575733798,0.556283713155954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37437,-0.00536223114038743,0.00913751748529414,-0.0232717654115639,0.0125473031307891,0.557323104153157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00459840869345832,0.00784791450914065,-0.019980321131374,0.0107835037444574,0.557925451757856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37056,0.000982991723801936,0.00168749564351167,-0.00232449973748093,0.00429048318508481,0.560229714156537
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.00353220593147234,0.00607215946588776,-0.00836922662166766,0.0154336384846123,0.560775294216459
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00287998809507713,0.00495209829637221,-0.00682612456581239,0.0125861007559667,0.560866564433713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.00315657964941194,0.00544688397568075,-0.0138324722417462,0.00751931294292234,0.562247830809119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00306605619044481,0.00529308904347088,-0.00730839833475811,0.0134405107156477,0.562425921755719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.00219343848863181,0.00379863126808991,-0.00963875577408803,0.00525187879682442,0.563658249131974
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00297513487551386,0.00515616594795535,-0.0130812201335063,0.00713095038247862,0.563945771078545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0034313331055053,0.00604083409137004,-0.00840870171357997,0.0152713679245906,0.570029039191163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37039,-0.00280580977089391,0.00494124817111398,-0.0124906561862773,0.00687903664448949,0.570157218718251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37124,-0.00251343407006282,0.00444761142948766,-0.0112307524718586,0.00620388433173299,0.572001719039212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00433238048375591,0.0077742327341342,-0.0195698766426589,0.0109051156751471,0.577349232375548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,-0.00374516997413868,0.00673841236510187,-0.0169524582097383,0.00946211826146099,0.578361095609983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,0.00468619523019664,0.00846111619219019,-0.0118975925064961,0.0212699829668894,0.57969047045103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00166800443706915,0.0030140427955855,-0.00423951944227844,0.00757552831641674,0.579991384199239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37100,0.00317735122520885,0.00576466976087274,-0.00812140150610171,0.0144761039565194,0.581521902720004
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40011,-0.00170411046161962,0.00311150270773417,-0.0078026557687786,0.00439443484553936,0.583918628770825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,36991,-0.00295836197497713,0.00540374710804305,-0.0135497063067415,0.00763298235678725,0.584068669723628
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37039,-0.00235765434933876,0.00431868389967877,-0.0108222747927092,0.00610696609403164,0.585130419336372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37445,-0.00339852658897796,0.00622727234036862,-0.0156039803761005,0.00880692719814454,0.58524756299497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,0.00362460005726948,0.00665003617178445,-0.00940947083942804,0.016658670953967,0.585727081866394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,-0.00304249075313499,0.00559999880524922,-0.0140184884114235,0.00793350690515348,0.586929428612311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.0036190231907163,0.00666938237278683,-0.0166910126413785,0.00945296625994589,0.587391989107273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,-0.00292242655957809,0.00552952165438411,-0.0137602890021709,0.00791543588301477,0.597150473022909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,-0.00148708887160287,0.0028163733781157,-0.00700718069270965,0.0040330029495039,0.597497438169267
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37021,0.00275640124571339,0.00522886716307829,-0.00749217839392005,0.0130049808853468,0.598097791871199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00363914247196792,0.00693118382484112,-0.0172242627686565,0.00994597782472068,0.599564835414272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,39858,-0.00998912225068748,0.019113252964979,-0.0474510980620464,0.0274728535606714,0.60124034934476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37388,-0.0046026468477721,0.0088257357198665,-0.0219010888587104,0.0126957951631663,0.602025017192881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00273860223710632,0.00525295028585615,-0.00755718032317174,0.0130343847973844,0.602135262349754
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37021,0.00197750102970648,0.00381043657588251,-0.00549095465902325,0.0094459567184362,0.603790614839737
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,-0.00208027398511145,0.00401603765324355,-0.00995170778546881,0.00579115981524592,0.604472799738526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,-0.00353551932605214,0.00689001939482017,-0.0170399573398997,0.00996891868779539,0.607864554963494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00245643778512955,0.00479664666010768,-0.0118578652389406,0.00694498966868149,0.608578659065503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37039,0.00390085245395387,0.00761937063626579,-0.0110331139931271,0.0188348189010348,0.60868395822216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.00259375441713044,0.00509417543623677,-0.00739082943789362,0.0125783382721545,0.610646708777424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37056,-0.00391659190504706,0.00774759563206885,-0.019101879343902,0.0112686955338079,0.613199618393292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37169,0.00270260946060438,0.00537403760217455,-0.00783050423965775,0.0132357231608665,0.615042124334338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37021,0.002487438932377,0.00494924463700857,-0.0072130805561598,0.0121879584209138,0.615261244924617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.00249452030838899,0.00498654871964143,-0.00727911518210821,0.0122681557988862,0.61690620190851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,-0.00180348822650911,0.00362303807038329,-0.00890464284446037,0.00529766639144214,0.618644791526948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,-0.00170158506442805,0.00343515582159079,-0.008434490474746,0.00503132034588991,0.620363812740373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,-0.00168187565063035,0.0034004182321353,-0.00834669538561554,0.00498294408435485,0.620884542324492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37388,0.00253915894139934,0.0051523276661204,-0.00755940328419664,0.0126377211669953,0.622149309593833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00384365867104365,0.00780455764420035,-0.0191405916536763,0.011453274311589,0.622381941143844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,-0.00288868777004912,0.00593328782554311,-0.0145179319081136,0.00874055636801537,0.626364697598664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37161,-0.0048270101417353,0.00993309738609639,-0.0242958810184842,0.0146418607350136,0.627009089702042
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37039,0.00344777706263263,0.0071372447819448,-0.0105412227099792,0.0174367768352444,0.629055230133315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,0.00159541444925206,0.0033862950622789,-0.00504172387281459,0.0082325527713187,0.637549521797595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39477,-0.00421631707275167,0.00895203109176279,-0.0217622980126067,0.0133296638671034,0.637654458711965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,-0.00127491201408163,0.00271573274595876,-0.0065977481961608,0.00404792416799755,0.63875260215738
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37368,0.00162151553250799,0.0034638806584038,-0.00516769055796347,0.00841072162297945,0.639705562731662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37056,0.0021993046365008,0.00472849861228631,-0.00706855264358036,0.011467161916582,0.641855415936852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37411,0.00178922970813919,0.00387545226886469,-0.00580665673883561,0.00938511615511399,0.644316208419091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37348,-0.00269200469770063,0.00588066783010724,-0.0142181136447108,0.00883410424930956,0.64712367397991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,-0.00132220341725307,0.00293449884923463,-0.00707382116175293,0.0044294143272468,0.652304377080053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,0.00528169357626394,0.0117575660497522,-0.0177631358812503,0.0283265230337782,0.653282827198141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,36991,0.00194289371228248,0.00432824467433163,-0.00654046584940752,0.0104262532739725,0.653520424598108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,0.00126819307652887,0.00283430721457982,-0.00428704906404757,0.00682343521710531,0.654560716615553
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.00247037624572385,0.00553225210639385,-0.0083728378828081,0.0133135903742558,0.655212843954801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,39885,0.00105911826885812,0.00238557040242492,-0.00361659971989473,0.00573483625761096,0.657071305722019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,-0.00163639466283807,0.0036925330988476,-0.00887375953657938,0.00560097021090323,0.657654992552966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00227100075371508,0.0051485816805324,-0.0123622208475586,0.00782021934012842,0.659153217894759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.00175102374261419,0.00397999617946435,-0.00604976876913594,0.00955181625436433,0.659976091251337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,38832,-0.0021326946522329,0.00486397970377248,-0.011666094871627,0.00740070556716116,0.661054103889828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,39585,-0.00477874996412282,0.0109127083796001,-0.0261676583881391,0.0166101584598934,0.661459810399755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,39788,0.00139152735079791,0.00322353741762411,-0.00492660598774535,0.00770966068934117,0.665981941162661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00277408898974685,0.00645631141918459,-0.0154284593713486,0.00988028139185495,0.667442136960332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.00112979163297922,0.00264007081563245,-0.00404474716566038,0.00630433043161881,0.668701869554978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,-0.00247285058526437,0.00581032227356642,-0.0138610822414546,0.00891538107092581,0.670408952113387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00147884188773319,0.003477098334219,-0.00533627084733606,0.00829395462280244,0.670616976317656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,36962,-0.00195130740701224,0.00462909773123438,-0.0110243389602316,0.00712172414620715,0.673374419060406
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.00408357332366097,0.00969839791837642,-0.0230924332436788,0.0149252865963568,0.673720694414033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,-0.00292637235860782,0.00705461477602435,-0.0167534173196155,0.0109006726023999,0.678281554002983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,-0.00121079855317286,0.00295945911523511,-0.00701133841903368,0.00458974131268795,0.682451943486588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,39830,-0.00323446595682042,0.00798451997602276,-0.018884125109825,0.0124151931961842,0.685415239963963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40052,-0.000793563212236477,0.00196242655682471,-0.00463991926361291,0.00305279283913996,0.68593970970273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37368,0.00449989105585718,0.0111305140287859,-0.0173159164405632,0.0263156985522775,0.686010137072845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,39892,-0.00182021970352853,0.00452285316133628,-0.0106850118997476,0.00704457249269057,0.687358659537635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37169,0.0024177838594501,0.00605297704775987,-0.00944605115415925,0.0142816188730594,0.689577539648326
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37056,-0.00119095789282209,0.00300034996709121,-0.00707164382832085,0.00468972804267668,0.691418377177827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,39885,0.00119123290082217,0.00300750627294905,-0.00470347939415796,0.00708594519580231,0.692046424881125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,0.00134620194481209,0.00340441386539943,-0.00532644923137079,0.00801885312099497,0.69253315849322
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,36818,-0.00156107506585598,0.00396701399368791,-0.00933642249348428,0.00621427236177232,0.693946449343541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,39788,0.000731284011818838,0.00190762187774421,-0.00300765486855981,0.00447022289219749,0.701466488875675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00224415646578297,0.00586639608802179,-0.00925397986673974,0.0137422927983057,0.702063857555111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,0.00188966193608013,0.00494491011890003,-0.00780236189696394,0.0115816857691242,0.702361624072491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.00178445047628051,0.0046887499657907,-0.0109744004092303,0.00740549945666926,0.703520106024387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.00718759489764392,0.018892399365169,-0.0298415078580873,0.0442166976533752,0.703617198812361
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,-0.00307946452065229,0.00815013461164781,-0.019053728359482,0.0128947993181774,0.705553967931801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37039,0.00305338914230251,0.00810276015393332,-0.0128280207594068,0.0189347990440118,0.706303623817152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00185376394528841,0.00494754775676781,-0.00784342965797649,0.0115509575485533,0.707901002411866
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00215498827054402,0.00577038777867843,-0.0091549717756657,0.0134649483167537,0.708813729020223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,39587,0.00146274242972441,0.00395711924821934,-0.0062932112967855,0.00921869615623432,0.711649529937996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,36991,-0.00181597506429071,0.00494311741555712,-0.0115044851987827,0.00787253507020124,0.713345644313637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,36931,0.00129010512742513,0.00358022677365616,-0.00572713934894094,0.0083073496037912,0.718597415020212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.00936597111904229,0.0262261245196523,-0.0607691751775608,0.0420372329394763,0.721004904974197
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,39585,0.00096702104974841,0.00275770405603519,-0.00443807890008057,0.00637212099957739,0.72584689811049
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.00447994931677306,0.0128424533048958,-0.0296511577943688,0.0206912591608226,0.727214841589332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.00199739825288548,0.00575406168587806,-0.0132753591572065,0.00928056265143552,0.728500430324196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37169,0.00147610599017102,0.00425687029402378,-0.00686735978611559,0.00981957176645763,0.728778233591284
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,-0.00302823630886401,0.00879186738495902,-0.0202602963833837,0.0142038237656557,0.730523889555816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.00341601380106477,0.0100035820149544,-0.0161910069482458,0.0230230345503754,0.732747434441309
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.00236370628141564,0.00693413017486048,-0.0159546014241422,0.0112271888613109,0.733199349910503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,0.000932962763421494,0.00274270124749057,-0.00444273168166002,0.00630865720850301,0.733738978027069
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,0.00356916802098632,0.0105092557852582,-0.0170289733181197,0.0241673093600923,0.734147082275315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,39775,0.00115012369077204,0.00339407312989099,-0.00550225964381429,0.00780250702535838,0.734717878222866
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00168530288175179,0.00498387707567486,-0.00808309618657094,0.0114537019500745,0.735254813494245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00169272441058609,0.00500649934453028,-0.00812001430469327,0.0115054631258654,0.735288310605341
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,36991,-0.00264850486216864,0.00786933438482363,-0.018072400256423,0.0127753905320857,0.736453831236541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00165895031738827,0.00493550005384786,-0.00801462978815355,0.0113325304229301,0.736781158355663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,0.00134462019291849,0.00402476814371641,-0.00654392536876567,0.00923316575460265,0.738319729408907
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,0.00395245155259458,0.0118460692170187,-0.019265844112762,0.0271707472179511,0.738648338620163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FST,Follistatin,39908,-0.00171171748897624,0.00519869565614825,-0.0119011609750268,0.00847772599707434,0.741964205340115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37411,-0.000719959644224422,0.00219426545154312,-0.00502071992924894,0.0035808006408001,0.742833835872045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,-0.00283464860040815,0.00867116217697566,-0.0198301264672805,0.0141608292664641,0.743744746703008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37169,0.0029082367043711,0.0089102402659229,-0.0145558342168378,0.02037230762558,0.744132449314977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00115695024391439,0.00357599450134574,-0.00585199897872326,0.00816589946655204,0.74629717365567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,-0.00135529232597331,0.00419440388619547,-0.00957632394291644,0.00686573929096982,0.746610113342268
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,-0.00391964726358364,0.0121750584552625,-0.0277827618358981,0.0199434673087308,0.74750190187164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00118375483438092,0.00368273676472487,-0.00840191889324166,0.00603440922447981,0.747887022941864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.00188330340210692,0.00592530733008838,-0.0134969057690802,0.00973029896486631,0.750609991234504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00146054444846588,0.00463189514521097,-0.00761797003614763,0.0105390589330794,0.752521184300691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,-0.00147035226476115,0.00469853564223948,-0.0106794821235505,0.00773877759402823,0.754331497597584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.00246613312951911,0.00791029195558323,-0.013038039103424,0.0179703053624622,0.755225087953696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.000733481057949037,0.00235988416271022,-0.00389189190096299,0.00535885401686107,0.755947374740458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39477,-0.00124353294383895,0.0040233487109614,-0.0091292964173233,0.00664223052964539,0.757265490619039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00226781231785241,0.00734001515171795,-0.0121186173795148,0.0166542420152196,0.757352582699682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.000823285620146126,0.00269882553496539,-0.00611298366867829,0.00446641242838604,0.76032951860376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37437,-0.00241956658571012,0.00797200712383321,-0.0180447005484232,0.013205567377003,0.761507531569893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00155911897785945,0.00515625065659978,-0.011665370264795,0.00854713230907612,0.762371330869601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,-0.00392450007549267,0.0130406054308391,-0.0294840867199374,0.0216350865689521,0.763460597361914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.00255371857585278,0.00848777014525999,-0.0191897480605624,0.0140823109088568,0.763517973145186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,-0.00150002767401163,0.0049960064378935,-0.0112922002922829,0.00829214494425963,0.763994772672938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,0.000893471023022535,0.00302268720557339,-0.0050309958999013,0.00681793794594637,0.767549026014232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00142349699366643,0.00491086953179341,-0.0110488012759815,0.00820180728864865,0.771922864103576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,0.00282423077190056,0.00976494825297683,-0.016315067803934,0.0219635293477352,0.772416619049851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39524,0.00135310587184529,0.00474016511623009,-0.00793761775596569,0.0106438294996563,0.775299020412687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,36962,0.00173602869046588,0.0061825903723847,-0.0103818484394081,0.0138539058203399,0.778873533123402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0010323798190644,0.00369043042085886,-0.00620086380581897,0.00826562344394777,0.779677359307433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,0.00205801040564008,0.00737966483359502,-0.0124061326682062,0.0165221534794863,0.780344483477383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,-0.00145604900868311,0.00523340326431171,-0.0117135194067341,0.00880142138936784,0.780846159202477
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00109535293024649,0.00395831589226943,-0.0066629462186016,0.00885365207909458,0.781997954361891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.000865331087265061,0.00312800255352081,-0.00699621609216585,0.00526555391763573,0.782060730061585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.0017768333159265,0.0064271745053619,-0.0108204287145828,0.0143740953464358,0.782201860852543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0011626847890128,0.00421143897064943,-0.00709173559346009,0.00941710517148569,0.78249194193276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00208415196270596,0.00762347472060059,-0.0170261624150831,0.0128578584896712,0.784560742163844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,-0.000988112440863903,0.00362391903285006,-0.00809099374525002,0.00611476886352221,0.785115051520962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.00173172287177604,0.00636892383833607,-0.0142148135949147,0.0107513678513627,0.785701662400034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.000715882187736158,0.00265990537503815,-0.00592929672281094,0.00449753234733863,0.787827560754181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00195184365842956,0.00742417491076765,-0.012599539166675,0.0165032264835341,0.792628811143176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00152655460898489,0.00584956533088627,-0.012991702657522,0.0099385934395522,0.794119934427825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,0.000660950995897114,0.00256444686984455,-0.00436536486899821,0.00568726686079244,0.796613718705522
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,0.000903093151323044,0.00350521361449644,-0.00596712553308998,0.00777331183573607,0.796686484817889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,0.00216976448589764,0.00844094597743144,-0.014374489629868,0.0187140186016633,0.797142432122703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,0.0014530630240197,0.00566179310228751,-0.00964405145646383,0.0125501775045032,0.797457935559913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37056,0.00105230096519436,0.00412837603259619,-0.00703931605869418,0.00914391798908289,0.798808440393832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,0.0027693450754585,0.0111114164441965,-0.0190090311551667,0.0245477213060837,0.803183499140366
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.000742276740462187,0.00298050097381251,-0.0065840586491347,0.00509950516821032,0.803330403927158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39489,0.00118747192168349,0.00478663956115898,-0.00819434161818811,0.0105692854615551,0.804075384310778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,36991,0.00116964218120127,0.00475907356438295,-0.00815814200498931,0.0104974263673919,0.805863362703262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,-0.000777509142099515,0.00317368107367648,-0.00699792404650542,0.00544290576230639,0.806470073009317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,0.00189175921197349,0.00796249691416473,-0.0137147347397894,0.0174982531637364,0.812207677113205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,-0.000997921847989743,0.00423047013908473,-0.00928964332059582,0.00729379962461633,0.813522403653179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39489,-0.00125043060598877,0.00532690370845552,-0.0116911618745616,0.00919030066258405,0.81441460117735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37056,-0.00148897224703839,0.00640622463095694,-0.014045172523714,0.0110672280296372,0.816210872551975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.000954162859079525,0.00414337177785543,-0.00907517154367616,0.00716684582551711,0.81787267195018
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.00129261355973212,0.0056294743642469,-0.00974115619419181,0.0123263833136561,0.818394264347589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.000677417444441377,0.00296473721596053,-0.00648830238772402,0.00513346749884127,0.819266998777379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.00132040119766787,0.00582616676545864,-0.0100988856626311,0.0127396880579668,0.820712098594732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39477,0.00229759840940151,0.0102746939093267,-0.0178408016528788,0.0224359984716818,0.823058094251404
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,0.000893388601004297,0.00409978381181226,-0.00714218767014773,0.00892896487215633,0.827501681022632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39405,-0.00148193890853505,0.00681452738645515,-0.0148384125859871,0.011874534768917,0.827846809254311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.00100745046215796,0.00470854303099392,-0.010236194802906,0.00822129387859013,0.830579809957627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.000904205192473137,0.00423221826709864,-0.00919935299598646,0.00739094261104019,0.830824748075269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00182615251287587,0.0085834512632928,-0.0186497169889298,0.014997411963178,0.83152262628629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37368,0.00127976250781323,0.00603323671524596,-0.0105453814540688,0.0131049064696953,0.83201760843308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.000953590325454707,0.00460791431619636,-0.00807792173429017,0.00998510238519958,0.836054559661977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.000467863807102487,0.00228888706545986,-0.00495408245540382,0.00401835484119884,0.838038279174182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37351,0.00102301156489367,0.0051073675850791,-0.00898742890186136,0.0110334520316487,0.841248087860752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.0010535317635178,0.00527132487502554,-0.0113853285185679,0.00927826499153226,0.841591950303842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37039,0.00045769739162462,0.00229807145458553,-0.00404652265936303,0.00496191744261227,0.842136071874947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.0029403059253329,0.0147849351201588,-0.0319187787608441,0.0260381669101783,0.842366058065743
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.000507024751201955,0.00258638317635465,-0.00557633577685707,0.00456228627445316,0.84458475951753
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.000670152927400474,0.00353795651706264,-0.00760454770084325,0.0062642418460423,0.849767615596357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.00095793092413677,0.00510479120318604,-0.0109633216823814,0.00904745983410787,0.85115132479905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00120706722388321,0.00643314677747798,-0.01381603490774,0.0114019004599736,0.851167675952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,-0.00035145804901128,0.00188887780198549,-0.00405365854090284,0.00335074244288028,0.852394904040742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.00107909989891716,0.00593369521010139,-0.0105509427128816,0.0127091425107159,0.855695125688096
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,39585,0.00130037602438348,0.00719135673918382,-0.0127946831844168,0.0153954352331838,0.856507385219625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00166254055975247,0.00922331891826746,-0.0164151645200518,0.0197402456395567,0.856955897937462
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00109106112624905,0.00655056543681702,-0.0139301693824104,0.0117480471299123,0.867718931762829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,-0.000844594171624882,0.00507764632387985,-0.0107967809664294,0.00910759262317962,0.867895290509231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.00102595068738335,0.00628544004075867,-0.0133454131672704,0.0112935117925036,0.87034249132706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40052,0.000672133883039063,0.00413627825948239,-0.00743497150554641,0.00877923927162454,0.87091631365962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,36962,0.00184494503713063,0.0117151163381764,-0.0211166829856952,0.0248065730599565,0.87486573209629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000679696695923391,0.00434761978139972,-0.00920103146746684,0.00784163807562006,0.875769268836121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.000594645105644733,0.00400568087471817,-0.00725648940880287,0.00844577962009234,0.881989495567001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37039,0.00101292145151813,0.00683651141191021,-0.0123866409158259,0.0144124838188621,0.882216004154483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,36962,-0.000790984928027092,0.00538329310311504,-0.0113422394101326,0.00976026955407838,0.883186941849984
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.00053505073308538,0.00366113440423672,-0.00771087416538936,0.0066407726992186,0.883810337472839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.000871573185137526,0.00597953075284876,-0.0125914534607211,0.0108483070904461,0.884113486147717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.00037740820926791,0.00264555889458135,-0.00556270364264735,0.00480788722411153,0.886563043137418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,36868,-0.000623848706881158,0.00442263398476595,-0.00929221131702243,0.00804451390326011,0.887826163899572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.000897191992588138,0.00646332666759458,-0.0135653122610735,0.0117709282758972,0.889600255800806
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.00104896589908764,0.00775065868329791,-0.0141423251201763,0.0162402569183515,0.892345911993486
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,36962,-0.00125813929507232,0.00934727668947414,-0.0195788016064416,0.017062523016297,0.892930559932141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.000740955527582487,0.00551739937021316,-0.0115550582932003,0.0100731472380353,0.893171859473297
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40030,0.000416882964701125,0.00313418252366295,-0.00572611478167826,0.00655988071108051,0.894185777761311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.000356602222916893,0.00271371645151932,-0.00567548646789476,0.00496228202206097,0.895455040514667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.000697146321802518,0.00549410070735153,-0.0114655837082115,0.0100712910646065,0.899029072257285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,39908,0.00104155332883683,0.00833233293617222,-0.0152898192260607,0.0173729258837344,0.900524003281008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.000735755149635322,0.00597770895867404,-0.0124520647086364,0.0109805544093658,0.902043150977425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,36903,-0.000426382040957705,0.00347746435688446,-0.00724221218045125,0.00638944809853584,0.902415516155245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37056,0.000595135688055902,0.00489691446645952,-0.00900281666620477,0.0101930880423166,0.903270893305861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.000719202582954998,0.00601715198040705,-0.0125128204645528,0.0110744152986428,0.904860910765385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.000505316061357071,0.00425162152659057,-0.00883849425347459,0.00782786213076045,0.905393988507756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2,Prothrombin,37453,0.00017675607192396,0.00148922693291901,-0.00274212871659731,0.00309564086044523,0.905522858331652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,0.000379865564967905,0.0032060476394779,-0.00590398780840878,0.00666371893834459,0.905685605090551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.000622959202577832,0.00530796175314209,-0.00978064583358067,0.0110265642387363,0.906573778740913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.000655319772772112,0.0056209953358594,-0.0116724706310565,0.0103618310855123,0.907191215776672
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37039,0.000492699246000794,0.00424980881325136,-0.00783692602797187,0.00882232451997346,0.907706259265929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,0.000463777559975148,0.00400631960396363,-0.00738860886379357,0.00831616398374387,0.907843052462243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.000591820827173137,0.00513193870374987,-0.0106504206865229,0.00946677903217661,0.908192372220469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.000573578102186338,0.00503058176088204,-0.00928636214914247,0.0104335183535151,0.909225016487555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.000446890266236289,0.00392661622265366,-0.00814305806263746,0.00724927753016488,0.909389426963023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,36991,0.000438445566827625,0.00385409342680534,-0.00711557754971084,0.0079924686833661,0.909428985350249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.000914695223089313,0.00806650259836943,-0.0167250403158934,0.0148956498697148,0.909719714770696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.000943589087523116,0.0085297842537167,-0.0157747880497616,0.0176619662248078,0.911917107442599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,39749,-0.000465505059216298,0.00425142542123255,-0.00879829888483209,0.0078672887663995,0.912812159444228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.000755829781777459,0.00690619363170317,-0.0127803097363607,0.0142919692999157,0.912853327048481
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,-0.000918405983085936,0.00851497715024132,-0.0176077611975589,0.0157709492313871,0.914110185354601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.00095393199294422,0.00906087324308542,-0.0168053795635032,0.0187132435493916,0.916154662939186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,39971,0.00118832778075638,0.0115403480503115,-0.0214307543978542,0.023807409959367,0.917986814801552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.000637507780075412,0.00620600128604123,-0.0115262547405654,0.0128012703007162,0.918183229773625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,39782,0.000426025972737427,0.00417037139652709,-0.00774790196445566,0.00859995390993052,0.918634611776179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.000488976306419121,0.00496471225219515,-0.0102198123207216,0.00924185970788336,0.921544465257224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,0.000858345102415807,0.00988508217891204,-0.0185164159682518,0.0202331061730834,0.930806079093044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,39587,-0.000427630406086337,0.00492797587111915,-0.0100864631134799,0.00923120230130719,0.930850609609582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.000421858732945012,0.00497047656783382,-0.00932027534000928,0.0101639928058993,0.932363732084445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,0.000448578103567056,0.00535348654787369,-0.0100442555302654,0.0109414117373995,0.933223265724361
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39315,-0.000215071915390255,0.00257158937305127,-0.00525538708657074,0.00482524325579023,0.933348637362725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37056,0.000266342674431416,0.00352500909512456,-0.00664267515201272,0.00717536050087555,0.93977188901454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37039,-0.000460892596098524,0.00612109304326974,-0.0124582349609072,0.0115364497687102,0.939980506151368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,-0.000341331332672442,0.00455269183876834,-0.00926460733665838,0.0085819446713135,0.940236907365448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,36991,0.000487013127133251,0.0065309664801022,-0.0123136811738671,0.0132877074281336,0.940558107185028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,0.000229981021574487,0.00326277179213297,-0.00616505169100614,0.00662501373415511,0.94380760453919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,0.000455902501580529,0.00665921326441353,-0.01259615549667,0.013507960499831,0.945418963725372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37380,-0.000321990648735453,0.0047397932231794,-0.00961198536616707,0.00896800406869617,0.94583959158805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37056,0.000280097109842595,0.00442461210921181,-0.00839214262421256,0.00895233684389775,0.94952512579627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,39585,-0.000327791169475162,0.00541930673444839,-0.010949632368994,0.0102940500300437,0.951769484026726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.000776617474074823,0.013623474429501,-0.0274786273558967,0.0259253924077471,0.954541389503541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39489,0.000254067655773224,0.00450411674885145,-0.00857400117197562,0.00908213648352207,0.955017604451572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.000861881474249211,0.0172773759027366,-0.0330017752951145,0.0347255382436129,0.960214786971574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,39587,0.000709193773718399,0.0145864364829849,-0.0278802217329319,0.0292986092803687,0.961222681199566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.000194875687360213,0.00415834410924164,-0.0079554787667534,0.00834523014147383,0.962622496471113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.000292044976417364,0.00654938486875418,-0.0125447493663408,0.0131288393191755,0.964433827060958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.000240996725108919,0.00644887396848787,-0.0128807897033452,0.0123987962531273,0.970190276848481
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.000355101767072527,0.0100502052785284,-0.0193433005788432,0.0200535041129883,0.971814909231122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,-0.000142564246357062,0.00407074786032163,-0.00812123005258746,0.00783610155987334,0.97206293041545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.000182495217379333,0.00623092490792684,-0.0123951080369159,0.0120301176021573,0.976634779516482
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37056,0.000126397706160606,0.00475073858496003,-0.00918504992036105,0.00943784533268226,0.978774464610344
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000103287937916536,0.00415217467039672,-0.0082415502918941,0.00803497441606103,0.980154546674688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,0.000109115665641191,0.00446243169526517,-0.00863725045707855,0.00885548178836093,0.980492324392663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-4.66895820153972e-05,0.00249302787326043,-0.00493302421360584,0.00483964504957505,0.985058274971139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,9.61734463093082e-05,0.00525223633143153,-0.0101982097632965,0.0103905566559151,0.985391068227558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-5.37992089013093e-05,0.0033341352574474,-0.00658870431349821,0.00648110589569559,0.987126232722155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-4.87052587044997e-05,0.00359086847493131,-0.00708680746956987,0.00698939695216087,0.989178277673587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-4.28560800285843e-05,0.00353162663493514,-0.00696484428450146,0.00687913212444429,0.990318133931353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37445,1.55316946965726e-05,0.0026019532983348,-0.00508429677003964,0.00511536015943278,0.995237348126747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37437,1.71010621908919e-05,0.00435339956423748,-0.00851556208371456,0.00854976420809634,0.996865808672732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,36991,1.2737210927469e-05,0.00481914897165764,-0.00943279477352151,0.00945826919537645,0.99789120056546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37056,-5.69824880049552e-06,0.00325308012056721,-0.00638173528511222,0.00637033878751123,0.998602414907164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-7.53199820330391e-07,0.00411945755771422,-0.0080748900129402,0.00807338361329954,0.999854117903607
